200,000+ products from a single source!

sales@angenechem.com

Home > Fluorides > 95058-81-4

95058-81-4

95058-81-4 | 2'-Deoxy-2',2'-difluorocytidine

CAS No: 95058-81-4 Catalog No: AG0038IE MDL No:MFCD00869720

Product Description

Catalog Number:
AG0038IE
Chemical Name:
2'-Deoxy-2',2'-difluorocytidine
CAS Number:
95058-81-4
Molecular Formula:
C9H11F2N3O4
Molecular Weight:
263.1981
MDL Number:
MFCD00869720
IUPAC Name:
4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI:
InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1
InChI Key:
SDUQYLNIPVEERB-QPPQHZFASA-N
SMILES:
OC[C@H]1O[C@H](C([C@@H]1O)(F)F)n1ccc(nc1=O)N
UNII:
B76N6SBZ8R

Properties

Complexity:
426  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0
Exact Mass:
263.072g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
263.201g/mol
Monoisotopic Mass:
263.072g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
108A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.5  

Literature

Title Journal
Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways. Chemico-biological interactions 20180625
Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function. Toxicology and applied pharmacology 20170201
Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts. International journal of cancer 20170101
Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients. Toxicology and applied pharmacology 20161115
Selective GPR55 antagonism reduces chemoresistance in cancer cells. Pharmacological research 20160901
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Molecular oncology 20160601
14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression. Oncotarget 20160405
The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models. Oncogene 20160218
The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eµ-MYC driven B-cell lymphoma. Oncotarget 20160119
Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities. Clinical cancer research : an official journal of the American Association for Cancer Research 20160115
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo. Oncotarget 20151229
Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression. Clinical lung cancer 20151101
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nature medicine 20151001
Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer research 20150915
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20150901
Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. Toxicological sciences : an official journal of the Society of Toxicology 20150601
Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines. Chemico-biological interactions 20150525
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20150501
Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma. European journal of haematology 20150301
Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proceedings of the National Academy of Sciences of the United States of America 20150210
Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1. Molecular pharmacology 20141101
Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer. Molecular carcinogenesis 20140901
Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. International journal of oncology 20140701
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma. Annals of hematology 20140501
Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor. Investigational new drugs 20140401
Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development. Journal of medicinal chemistry 20140227
Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin. Urologia internationalis 20140101
Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine. Anticancer research 20140101
Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways. PloS one 20140101
Rat N-ERC/mesothelin as a marker for in vivo screening of drugs against pancreas cancer. PloS one 20140101
GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. PloS one 20140101
5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & medicinal chemistry 20131115
Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer. Toxicology letters 20130912
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters 20130801
Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells. Biochemical and biophysical research communications 20130426
Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma. International journal of cancer 20130101
sVEGF R1 and Tie-2 levels during chemotherapy of lung cancer patients. Advances in experimental medicine and biology 20130101
Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. Current pharmaceutical design 20130101
Enhancement of gene gun-induced vaccine-specific cytotoxic T-cell response by administration of chemotherapeutic drugs. Methods in molecular biology (Clifton, N.J.) 20130101
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors. Bioorganic & medicinal chemistry letters 20121215
The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines. Investigational new drugs 20121201
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy. Investigational new drugs 20121201
Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer. Medical oncology (Northwood, London, England) 20121201
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib. Medical oncology (Northwood, London, England) 20121201
Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma. Medical oncology (Northwood, London, England) 20121201
Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. Investigational new drugs 20121201
Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: a case report. Lung cancer (Amsterdam, Netherlands) 20121201
Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor. International journal of molecular medicine 20121201
Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer. Oncology reports 20121201
Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition. International journal of oncology 20121201
Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: baseline results of an observational study (FRAME). Lung cancer (Amsterdam, Netherlands) 20121201
Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice. International journal of oncology 20121201
Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes. Molecular biology reports 20121201
Conditionally replicating adenovirus SG500-expressed mutant Dm-dNK gene for breast cancer therapy. International journal of oncology 20121201
Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors. Journal of medicinal chemistry 20121126
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial. Cancer 20121115
Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway. Acta histochemica 20121101
Systemic treatment of advanced pancreatic cancer. Cancer treatment reviews 20121101
Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas. Pediatric blood & cancer 20121101
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin. BJU international 20121101
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 20121101
Tumor macrophages as a target for Capsaicin mediated immunotherapy. Cancer letters 20121101
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101
Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma. Surgery 20121101
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial. International journal of radiation oncology, biology, physics 20121101
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20121101
Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. Oral oncology 20121101
Extracellular release of annexin II from pancreatic cancer cells and resistance to anticancer drug-induced apoptosis by supplementation of recombinant annexin II. Pancreas 20121101
UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. Journal of cancer research and clinical oncology 20121101
VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA. Annals of oncology : official journal of the European Society for Medical Oncology 20121101
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20121101
Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma. Annals of hematology 20121101
Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells. Human molecular genetics 20121101
Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix. Gynecologic oncology 20121101
Role of chitosan nanoparticles in the oral absorption of Gemcitabine. International journal of pharmaceutics 20121101
Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance. International journal of oncology 20121101
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. The American journal of pathology 20121101
The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20121101
Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells. Stem cell research 20121101
Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines. Lasers in surgery and medicine 20121101
Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950) 20121101
Safety and effectiveness of gemcitabine in 260 patients with biliary tract cancer in a Japanese clinical practice based on post-marketing surveillance in Japan. Japanese journal of clinical oncology 20121101
Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer. Therapeutic advances in medical oncology 20121101
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. British journal of cancer 20121023
[Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20121020
[A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20121020
CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs. Clinical cancer research : an official journal of the American Association for Cancer Research 20121015
Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection. The Journal of biological chemistry 20121012
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer. American journal of clinical oncology 20121001
Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas. American journal of clinical oncology 20121001
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial. American journal of clinical oncology 20121001
Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review. American journal of clinical oncology 20121001
Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704. The pharmacogenomics journal 20121001
Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study. Breast cancer (Tokyo, Japan) 20121001
A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer. International journal of clinical oncology 20121001
Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126. Investigational new drugs 20121001
A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer. Investigational new drugs 20121001
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum. Investigational new drugs 20121001
Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20121001
Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy. International journal of radiation oncology, biology, physics 20121001
Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Pancreas 20121001
Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer. Journal of cancer research and clinical oncology 20121001
Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma. Journal of cancer research and clinical oncology 20121001
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines. Experimental hematology 20121001
Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma. Chinese journal of cancer 20121001
Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB. Journal of cancer research and clinical oncology 20121001
Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine. Biochimica et biophysica acta 20121001
Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20121001
Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer. Carcinogenesis 20121001
Localized delivery of chemotherapy to the cervix for radiosensitization. Gynecologic oncology 20121001
[The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma]. Actas urologicas espanolas 20121001
Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer. Japanese journal of clinical oncology 20121001
Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses. Molecular medicine reports 20121001
Enantioselective supramolecular carriers for nucleoside drugs. A thermodynamic and kinetic gas phase investigation. Journal of the American Society for Mass Spectrometry 20121001
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors. Cancer chemotherapy and pharmacology 20121001
Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. Cancer biology & therapy 20121001
Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients? The Journal of urology 20121001
sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR. Apoptosis : an international journal on programmed cell death 20121001
Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121001
Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. Clinical cancer research : an official journal of the American Association for Cancer Research 20121001
Liquid chromatography-tandem mass spectrometry method for simultaneous determination of seven commonly used anticancer drugs in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20121001
Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas. Journal of immunotherapy (Hagerstown, Md. : 1997) 20121001
Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas. Journal of pediatric hematology/oncology 20121001
Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells. Nucleic acid therapeutics 20121001
Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer. Clinical breast cancer 20121001
Management of non-muscle-invasive (superficial) bladder cancer. Seminars in oncology 20121001
Urachal adenocarcinoma: a clinician's guide for treatment. Seminars in oncology 20121001
Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer. Asian Pacific journal of tropical medicine 20121001
Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. British journal of cancer 20120925
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? World journal of gastroenterology 20120921
[Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120920
Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 20120915
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20120915
Role of taxanes in pancreatic cancer. World journal of gastroenterology 20120907
FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts. World journal of gastroenterology 20120907
Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma. Journal of gastrointestinal cancer 20120901
GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma. Medical oncology (Northwood, London, England) 20120901
Langerhans/dendritic cell sarcoma arising from hairy cell leukemia: a rare phenomenon. Annals of hematology 20120901
A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts. Anti-cancer agents in medicinal chemistry 20120901
Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancer. Clinical lung cancer 20120901
Chemotherapy for the biliary tract cancers: moving toward improved survival time. Journal of gastrointestinal cancer 20120901
Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20120901
Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120901
Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma. Acta oncologica (Stockholm, Sweden) 20120901
[Recurrent bladder cancer after BCG instillation therapy. Local therapy options?]. Der Urologe. Ausg. A 20120901
Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression. Journal of cancer research and clinical oncology 20120901
Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine. Chemical biology & drug design 20120901
Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20120901
Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial. Gynecologic oncology 20120901
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology 20120901
Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase-II study. Lung cancer (Amsterdam, Netherlands) 20120901
Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120901
Lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase driven by the hTERT promoter combined with gemcitabine: a potential strategy for cancer therapy. International journal of molecular medicine 20120901
A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer. Oncology reports 20120901
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells. International journal of oncology 20120901
Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. International journal of oncology 20120901
The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Molecular cancer therapeutics 20120901
Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120901
Targeting the MAGE A3 antigen in pancreatic cancer. Surgery 20120901
Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer. Japanese journal of clinical oncology 20120901
The antitumor activity of recombinant antitumor antiviral protein and the associated molecular mechanism in pancreatic tumor cells. Cancer biotherapy & radiopharmaceuticals 20120901
Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer. Cancer chemotherapy and pharmacology 20120901
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer biology & therapy 20120901
A retrospective study of S-1 monotherapy as second-line treatment for patients with advanced biliary tract cancer. Japanese journal of clinical oncology 20120901
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120901
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis. Cancer chemotherapy and pharmacology 20120901
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). The oncologist 20120901
Therapeutic options in older patients with metastatic non-small cell lung cancer. Therapeutic advances in medical oncology 20120901
Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas. Annals of oncology : official journal of the European Society for Medical Oncology 20120901
Salvage chemotherapy using gemcitabine for taxane/platinum-resistant recurrent ovarian cancer: a single institutional experience. Anticancer research 20120901
Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study. Anticancer research 20120901
Gemcitabine-induced pulmonary toxicity. Anticancer research 20120901
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1. Neoplasia (New York, N.Y.) 20120901
Gemcitabine associated with posterior reversible encephalopathy syndrome (PRES): a case report and review of the literature. Clinical advances in hematology & oncology : H&O 20120901
[Expression of RRM1 and ERCC1 genes in tumor tissues and peripheral blood lymphocytes of advanced non-small cell lung cancer]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20120901
Constitutive Expression of MAP Kinase Phosphatase-1 Confers Multi-drug Resistance in Human Glioblastoma Cells. Cancer research and treatment : official journal of Korean Cancer Association 20120901
Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo. Journal of medicinal chemistry 20120823
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120820
[Thermo-chemotherapy of GP or TP for advanced non-small cell lung cancer: a systematic review]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120820
High incidence of severe neutropenia after gemcitabine-based chemotherapy in Chinese cancer patients with CDA 79A>C mutation. Clinica chimica acta; international journal of clinical chemistry 20120816
Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas. Clinical cancer research : an official journal of the American Association for Cancer Research 20120815
Occupational exposure to antineoplastic drugs in four Italian health care settings. Toxicology letters 20120813
Tangled up in knots: structures of inactivated forms of E. coli class Ia ribonucleotide reductase. Structure (London, England : 1993) 20120808
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma. Investigational new drugs 20120801
Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer. Investigational new drugs 20120801
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets. International journal of cancer 20120801
Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. International journal of cancer 20120801
Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Journal of cellular and molecular medicine 20120801
Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head & neck 20120801
Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. The Journal of surgical research 20120801
Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma. Annals of surgical oncology 20120801
High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer. International journal of radiation oncology, biology, physics 20120801
Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients. Journal of surgical oncology 20120801
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. Journal of surgical oncology 20120801
Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment. Cancer letters 20120801
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1. Cancer science 20120801
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin. Journal of magnetic resonance imaging : JMRI 20120801
EGFR mutations as a predictive marker of cytotoxic chemotherapy. Lung cancer (Amsterdam, Netherlands) 20120801
Analytical detection and method development of anticancer drug Gemcitabine HCl using gold nanoparticles. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120801
Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. The journal of obstetrics and gynaecology research 20120801
Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. International journal of radiation oncology, biology, physics 20120801
Induction of pancreatic cancer cell apoptosis and enhancement of gemcitabine sensitivity by RAP80 siRNA. Digestive diseases and sciences 20120801
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China. Lung cancer (Amsterdam, Netherlands) 20120801
Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection. Annals of surgery 20120801
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function. European journal of cancer (Oxford, England : 1990) 20120801
Sorafenib in locally advanced or metastatic breast cancer. Expert opinion on investigational drugs 20120801
SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine. Toxicology and applied pharmacology 20120801
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Molecular cancer therapeutics 20120801
Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. Oncology reports 20120801
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. The British journal of surgery 20120801
Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses. European journal of immunology 20120801
Gefitinib enhances cytotoxicities of antimicrotubule agents in non-small-cell lung cancer cells exhibiting no sensitizing epidermal growth factor receptor mutation. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120801
Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2. Anti-cancer drugs 20120801
Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks. Chinese journal of cancer 20120801
hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20120801
Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells. Cancer biology & therapy 20120801
Establishment and characterization of a new human gallbladder carcinoma cell line. Anticancer research 20120801
Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines. American journal of veterinary research 20120801
[Soft-tissue sarcoma: recent developments]. Deutsche medizinische Wochenschrift (1946) 20120801
[A case of cancer of the pancreatic tail with disseminated carcinomatosis of the bone marrow]. Gan to kagaku ryoho. Cancer & chemotherapy 20120801
[A case of unresectable hilar cholangiocarcinoma successfully treated by gemcitabine and S-1 combination chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20120801
Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation. PLoS genetics 20120801
[The effect of presurgical gemcitabine cisplatin chemotherapy for urothelial carcinoma]. Hinyokika kiyo. Acta urologica Japonica 20120801
[A case of renal salt wasting syndrome progressing to severe hyponatremia after gemcitabine-cisplatin chemotherapy]. Hinyokika kiyo. Acta urologica Japonica 20120801
Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge. Cancer letters 20120728
Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells. Gene 20120725
Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. British journal of cancer 20120724
Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas. British journal of cancer 20120724
Squalenoylation: a generic platform for nanoparticular drug delivery. Journal of controlled release : official journal of the Controlled Release Society 20120720
Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma. International journal of radiation oncology, biology, physics 20120715
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 20120711
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710
Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer. JOP : Journal of the pancreas 20120710
Adjuvant therapy of pancreatic cancer. JOP : Journal of the pancreas 20120710
New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma. JOP : Journal of the pancreas 20120710
Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer. International journal of cancer 20120701
Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy. Journal of hepato-biliary-pancreatic sciences 20120701
Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy. Annals of surgical oncology 20120701
Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection. Annals of surgical oncology 20120701
Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. The British journal of nutrition 20120701
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo. European journal of cancer (Oxford, England : 1990) 20120701
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study). Annals of oncology : official journal of the European Society for Medical Oncology 20120701
Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy. International journal of radiation oncology, biology, physics 20120701
Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. International journal of radiation oncology, biology, physics 20120701
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Annals of surgical oncology 20120701
Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction. Journal of hepato-biliary-pancreatic sciences 20120701
Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors. Journal of hepato-biliary-pancreatic sciences 20120701
Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial). Journal of hepato-biliary-pancreatic sciences 20120701
Analysis of local control in patients receiving IMRT for resected pancreatic cancers. International journal of radiation oncology, biology, physics 20120701
A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905. Lung cancer (Amsterdam, Netherlands) 20120701
Targeted therapy for biliary tract cancers. Journal of hepato-biliary-pancreatic sciences 20120701
The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice. Journal of hepatology 20120701
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study). Lung cancer (Amsterdam, Netherlands) 20120701
Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells. Pharmaceutical research 20120701
Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine. International journal of radiation oncology, biology, physics 20120701
Role of chemotherapy in treatments for biliary tract cancer. Journal of hepato-biliary-pancreatic sciences 20120701
ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines. International journal of oncology 20120701
Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies. International journal of pharmaceutics 20120701
Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells. Biochemical pharmacology 20120701
Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases. Archives of dermatology 20120701
Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterology 20120701
CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Molecular cancer therapeutics 20120701
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors. Cancer investigation 20120701
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor? Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120701
Involvement of the mitochondrial pathway in bruceine D-induced apoptosis in Capan-2 human pancreatic adenocarcinoma cells. International journal of molecular medicine 20120701
The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer. International journal of oncology 20120701
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials. The Lancet. Oncology 20120701
Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes. Journal of cutaneous pathology 20120701
A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA. Cancer biology & therapy 20120701
Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120701
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial. The Lancet. Oncology 20120701
Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer. Pancreas 20120701
Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis. Omics : a journal of integrative biology 20120701
Recurrent lower extremity pseudocellulitis. American journal of therapeutics 20120701
[Resection of cholangiolocellular carcinoma successfully responding to neoadjuvant hepatic arterial infusion chemotherapy - report of a case]. Gan to kagaku ryoho. Cancer & chemotherapy 20120701
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors. Pharmacogenomics 20120701
Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine. Pharmacogenomics 20120701
Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape? Pharmacogenomics 20120701
Toward personalized treatment of advanced biliary tract cancers. Discovery medicine 20120701
Systemic therapy of advanced pancreatic cancer: has the landscape changed? Clinical advances in hematology & oncology : H&O 20120701
[Curative effect of 3D-CRT combined with gemcitabine concurrently with addition of Kanglaite Injection in treatment of locally advanced pancreatic]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120701
Antiausterity agents from Uvaria dac and their preferential cytotoxic activity against human pancreatic cancer cell lines in a nutrient-deprived condition. Journal of natural products 20120622
Label-free Raman spectroscopy for accessing intracellular anticancer drug release on gold nanoparticles. The Analyst 20120621
Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. World journal of gastroenterology 20120621
Management of non-small cell lung in cancer patients with stable disease. Drugs 20120619
Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. Cancer 20120615
Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles. International journal of pharmaceutics 20120615
Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones. Biochemical pharmacology 20120615
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 20120615
A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 20120615
Simple, fast and efficient synthesis of β-keto esters from the esters of heteroaryl compounds, its antimicrobial study and cytotoxicity towards various cancer cell lines. Bioorganic & medicinal chemistry letters 20120615
Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas. Journal of medicinal chemistry 20120614
Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts. World journal of gastroenterology 20120614
[Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer]. Zhonghua yi xue za zhi 20120612
Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models. Journal of controlled release : official journal of the Controlled Release Society 20120610
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120610
A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study. British journal of cancer 20120605
Functional pancreatic acinar cell carcinoma extending into the main pancreatic duct and splenic vein. Journal of gastrointestinal cancer 20120601
A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer. Investigational new drugs 20120601
Cost-effectiveness of gemcitabine + cisplatin vs. gemcitabine monotherapy in advanced biliary tract cancer. Journal of gastrointestinal cancer 20120601
Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation. Journal of gastrointestinal cancer 20120601
Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients. Medical oncology (Northwood, London, England) 20120601
A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Medical oncology (Northwood, London, England) 20120601
Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC. Medical oncology (Northwood, London, England) 20120601
A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma. American journal of clinical oncology 20120601
Real-world impact of availability of adjuvant therapy on outcomes in patients with resected pancreatic adenocarcinoma: a Canadian Cancer Agency experience. American journal of clinical oncology 20120601
Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells. Integrative cancer therapies 20120601
Multidisciplinary treatment with chemotherapy, targeted drug, and high-intensity focused ultrasound in advanced pancreatic carcinoma. Medical oncology (Northwood, London, England) 20120601
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research. Investigational new drugs 20120601
A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. Investigational new drugs 20120601
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group). Investigational new drugs 20120601
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer. Investigational new drugs 20120601
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy. Investigational new drugs 20120601
Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20120601
Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. International journal of radiation oncology, biology, physics 20120601
Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation. Hematological oncology 20120601
Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. European journal of cancer (Oxford, England : 1990) 20120601
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer metastasis reviews 20120601
Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids. Cancer letters 20120601
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20120601
Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. Cancer letters 20120601
Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601
Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway. Anti-cancer agents in medicinal chemistry 20120601
Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines. Anti-cancer drugs 20120601
The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum. Cancer chemotherapy and pharmacology 20120601
Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis. International journal of oncology 20120601
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers. Angiogenesis 20120601
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules. Cancer chemotherapy and pharmacology 20120601
Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial. Breast cancer research and treatment 20120601
CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells. Oncology reports 20120601
Molecular and genetic bases of pancreatic cancer. Current drug targets 20120601
Neoadjuvant therapy for resectable and borderline resectable adenocarcinoma of the pancreas. Current drug targets 20120601
Conventional chemotherapy of advanced pancreatic cancer. Current drug targets 20120601
Targeting EGFR in pancreatic cancer treatment. Current drug targets 20120601
Prognostic significance of aquaporins in human biliary tract carcinoma. Oncology reports 20120601
Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 20120601
Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120601
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study. Cancer chemotherapy and pharmacology 20120601
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients. Journal of immunotherapy (Hagerstown, Md. : 1997) 20120601
Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest. Acta pharmacologica Sinica 20120601
[Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy]. Der Urologe. Ausg. A 20120601
Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabine. AJR. American journal of roentgenology 20120601
Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1. Cancer discovery 20120601
Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120601
Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20120601
Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells. Anticancer research 20120601
Gemcitabine-induced severe peripheral edema in a patient with lung cancer. Journal of pharmacy practice 20120601
Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. Neoplasia (New York, N.Y.) 20120601
A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer. Cancer research and treatment : official journal of Korean Cancer Association 20120601
Molecular changes in pancreatic cancer: implications for molecular targeting therapy. Acta gastro-enterologica Belgica 20120601
[A case of micropapillary bladder carcinoma]. Hinyokika kiyo. Acta urologica Japonica 20120601
Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma. World journal of gastroenterology 20120521
[Efficacy of gemcitabine and vinorelbine in first-line treatment with advanced non-small cell lung cancer: a multicentre retrospective study]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520
[Selected arterial infusion chemotherapy combined with target drugs for non-small cell lung cancer with multiple brain metastase]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520
Synthesis, σ₁, σ₂-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes. Bioorganic & medicinal chemistry 20120515
KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer research 20120515
Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer. International journal of pharmaceutics 20120510
Fluorocyclopentenyl-cytosine with broad spectrum and potent antitumor activity. Journal of medicinal chemistry 20120510
Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles. Journal of the American Chemical Society 20120509
[Cerebral infarction after cisplatin-gemcitabine chemotherapy: probable cause-effect]. Neurologia (Barcelona, Spain) 20120501
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology 20120501
Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome. The Journal of dermatology 20120501
A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20120501
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Annals of surgical oncology 20120501
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines. Leukemia & lymphoma 20120501
Factors predicting the appearance of neutropenia in patients with advanced pancreatic cancer undergoing gemcitabine therapy. Hepato-gastroenterology 20120501
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis. Cancer 20120501
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study. Cancer 20120501
Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts. Annals of oncology : official journal of the European Society for Medical Oncology 20120501
Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case. Surgery today 20120501
Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials. Lung cancer (Amsterdam, Netherlands) 20120501
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell death and differentiation 20120501
Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Annals of surgical oncology 20120501
Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors. Leukemia & lymphoma 20120501
Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma. European journal of cancer (Oxford, England : 1990) 20120501
Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma. Cancer letters 20120501
RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis. Leukemia 20120501
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy. Haematologica 20120501
DESI-MS2: a rapid and innovative method for trace analysis of six cytostatic drugs in health care setting. Analytical and bioanalytical chemistry 20120501
Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies. Cancer chemotherapy and pharmacology 20120501
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures. Cancer chemotherapy and pharmacology 20120501
Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002). Cancer chemotherapy and pharmacology 20120501
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study). Cancer chemotherapy and pharmacology 20120501
Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. International journal of oncology 20120501
Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. Journal of cancer research and clinical oncology 20120501
Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials. Cancer chemotherapy and pharmacology 20120501
RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology 20120501
Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer. Cancer chemotherapy and pharmacology 20120501
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors. Current cancer drug targets 20120501
Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. Cancer science 20120501
Primary hepatocellular carcinoma of the pancreas: a case report and review of the heterogeneous group of pancreatic hepatoid carcinomas. Histopathology 20120501
Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer. Oncology reports 20120501
A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Cancer chemotherapy and pharmacology 20120501
Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines. Gene 20120501
Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma. Acta oncologica (Stockholm, Sweden) 20120501
Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen. European journal of cancer (Oxford, England : 1990) 20120501
High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Molecular cancer therapeutics 20120501
Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin. International journal of antimicrobial agents 20120501
Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients. Japanese journal of clinical oncology 20120501
A Bayesian integrative genomic model for pathway analysis of complex traits. Genetic epidemiology 20120501
Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer. Cancer investigation 20120501
An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer. Hepato-gastroenterology 20120501
Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute. Hepato-gastroenterology 20120501
Noxa enhances the cytotoxic effect of gemcitabine in human ovarian cancer cells. Cancer biotherapy & radiopharmaceuticals 20120501
Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma. Pancreas 20120501
An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells. Cell cycle (Georgetown, Tex.) 20120501
Advances in first-line treatment for patients with HER-2+ metastatic breast cancer. The oncologist 20120501
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: two case reports. Cancer biology & therapy 20120501
Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL). Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20120501
Radiation recall dermatitis after treatment with Paclitaxel and Cisplatin. Annals of dermatology 20120501
[Chemotherapy and hormone therapy for uterine sarcomas]. Gan to kagaku ryoho. Cancer & chemotherapy 20120501
[Analysis of risk factors of drug-induced lung injury in patients receiving gemcitabine treatment]. Gan to kagaku ryoho. Cancer & chemotherapy 20120501
The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2. Anticancer research 20120501
Combination therapy with gemcitabine (GEM) and erlotinib (E) in exocrine pancreatic cancer under special reference to RASH and the tumour marker CA19-9. Anticancer research 20120501
Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS computational biology 20120501
Variability of gemcitabine accumulation and its relationship to expression of nucleoside transporters in peripheral blood mononuclear cells. Archives of pharmacal research 20120501
[Emodin combined gemcitabine inhibited the growth of pancreatic cancer in vitro and in vivo and its mechanisms study]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120501
[Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20120501
Combinational therapy: new hope for pancreatic cancer? Cancer letters 20120428
DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells. Biochemical and biophysical research communications 20120427
Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma. Acta histochemica et cytochemica 20120426
Targeting carbon nanotubes against cancer. Chemical communications (Cambridge, England) 20120425
A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 20120415
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine. Investigational new drugs 20120401
The expression of interferon receptor α/β in human pancreatic cancer in nude mice is essential for tumor response to interferon α treatment. The Journal of surgical research 20120401
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer. Investigational new drugs 20120401
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer. Investigational new drugs 20120401
(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20120401
Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract. International journal of cancer 20120401
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro. International journal of cancer 20120401
Current chemotherapeutic strategies against bladder cancer. International urology and nephrology 20120401
A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 20120401
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01. Breast cancer research and treatment 20120401
Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients. Cancer chemotherapy and pharmacology 20120401
Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlates. Acta oncologica (Stockholm, Sweden) 20120401
Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. International journal of oncology 20120401
A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors. Cancer chemotherapy and pharmacology 20120401
Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120401
Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts. Oncology reports 20120401
Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer. Molecular therapy : the journal of the American Society of Gene Therapy 20120401
Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120401
Discovery of drugs that possess activity against feline leukemia virus. The Journal of general virology 20120401
Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. European journal of gastroenterology & hepatology 20120401
Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma. Academic radiology 20120401
CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy. Molecular cancer therapeutics 20120401
Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1. Antimicrobial agents and chemotherapy 20120401
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. Pharmacogenetics and genomics 20120401
A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120401
Navitoclax (ABT-263) reduces Bcl-x(L)-mediated chemoresistance in ovarian cancer models. Molecular cancer therapeutics 20120401
Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. The FEBS journal 20120401
[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120401
Chemotherapy-induced toxicity is highly heritable in Drosophila melanogaster. Pharmacogenetics and genomics 20120401
Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20120401
Recent advances in treatment of advanced urothelial carcinoma. Current urology reports 20120401
First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120401
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120401
Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine. Expert opinion on investigational drugs 20120401
Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study. HPB : the official journal of the International Hepato Pancreato Biliary Association 20120401
Meta-analysis of phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer. HPB : the official journal of the International Hepato Pancreato Biliary Association 20120401
Maintenance therapy for advanced non-small-cell lung cancer: switch versus continuation. Expert opinion on pharmacotherapy 20120401
Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer. Pancreas 20120401
Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic. Bulletin du cancer 20120401
Astellas' drug discovery strategy: focus on oncology. Japanese journal of clinical oncology 20120401
[The evaluation of chemotherapy for patients over eighty-years-old]. Gan to kagaku ryoho. Cancer & chemotherapy 20120401
Metastases from nested variant urothelial carcinoma of the urinary bladder in pancreatic allograft mimicking graft rejection. Journal of clinical medicine research 20120401
Kinase inhibitors for advanced medullary thyroid carcinoma. Clinics (Sao Paulo, Brazil) 20120401
Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer. World journal of gastroenterology 20120328
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma. British journal of cancer 20120327
Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å. Nature 20120322
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer cell 20120320
Intensity-modulated radiotherapy for pancreatic adenocarcinoma. International journal of radiation oncology, biology, physics 20120315
Mutagen-mediated enhancement of HIV-1 replication in persistently infected cells. Virology 20120315
Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro. Clinical cancer research : an official journal of the American Association for Cancer Research 20120315
One pot synthesis and anticancer activity of dimeric phloroglucinols. Bioorganic & medicinal chemistry letters 20120315
Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide. British journal of cancer 20120313
First-line treatment of metastatic pancreatic cancer. JOP : Journal of the pancreas 20120310
What options are available for refractory pancreatic cancer? JOP : Journal of the pancreas 20120310
Novel agents in early phase clinical studies on refractory pancreatic cancer. JOP : Journal of the pancreas 20120310
Translational research. New findings and potential future applications in pancreatic adenocarcinoma. JOP : Journal of the pancreas 20120310
Outcomes from combined chemoradiotherapy in unresectable and locally advanced resected cholangiocarcinoma. Journal of gastrointestinal cancer 20120301
Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Medical oncology (Northwood, London, England) 20120301
Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: a case report with a literature review. Medical oncology (Northwood, London, England) 20120301
Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients. Medical oncology (Northwood, London, England) 20120301
Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer. Medical oncology (Northwood, London, England) 20120301
Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study. Medical oncology (Northwood, London, England) 20120301
Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology 20120301
Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces. Analytical and bioanalytical chemistry 20120301
Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20120301
Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectives. Annals of oncology : official journal of the European Society for Medical Oncology 20120301
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen. Annals of oncology : official journal of the European Society for Medical Oncology 20120301
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma. Pancreas 20120301
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results. Leukemia & lymphoma 20120301
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology 20120301
RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis. Lung cancer (Amsterdam, Netherlands) 20120301
Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120301
MicroRNA miR-548d is a superior regulator in pancreatic cancer. Pancreas 20120301
Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma. Cancer chemotherapy and pharmacology 20120301
A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer. Cancer chemotherapy and pharmacology 20120301
[When should systemic chemotherapy be used for urinary bladder carcinoma?]. Der Urologe. Ausg. A 20120301
The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer. Journal of cellular biochemistry 20120301
PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. International journal of oncology 20120301
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. Journal of gastroenterology 20120301
Metastatic clear cell adenocarcinoma of the urethra in a male patient: report of a case. Clinical genitourinary cancer 20120301
Combination of hedgehog signaling blockage and chemotherapy leads to tumor reduction in pancreatic adenocarcinomas. Pancreas 20120301
Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype. International journal of oncology 20120301
Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer prevention research (Philadelphia, Pa.) 20120301
Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabine. The AAPS journal 20120301
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecologic oncology 20120301
Multicellular tumor spheroid formation in duplex microcapsules for analysis of chemosensitivity. Cancer science 20120301
Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study. Current medical research and opinion 20120301
Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis. Molecular cancer therapeutics 20120301
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120301
A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells. Oncology reports 20120301
Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines. Molecular medicine reports 20120301
Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: the experience at Children's Memorial Hospital. Journal of pediatric hematology/oncology 20120301
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. The Lancet. Oncology 20120301
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial. European journal of cancer (Oxford, England : 1990) 20120301
Re: phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75. The Journal of urology 20120301
Pancreatic cancer: medical management (novel chemotherapeutics). Gastroenterology clinics of North America 20120301
First-line chemotherapy in epithelial ovarian cancer. Clinical obstetrics and gynecology 20120301
A rational approach to the management of recurrent or persistent ovarian carcinoma. Clinical obstetrics and gynecology 20120301
Malignant pleural mesothelioma. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120301
Maintenance bevacizumab is associated with increased hemoglobin in patients with advanced, nonsquamous, non-small cell lung cancer. Cancer investigation 20120301
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. The oncologist 20120301
Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer. Asia-Pacific journal of clinical oncology 20120301
Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120301
[A case of malignant peritoneal mesothelioma successfully treated with systemic chemothrapy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20120301
Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine. Anticancer research 20120301
Phase II study of panobinostat and bortezomib in patients with pancreatic cancer progressing on gemcitabine-based therapy. Anticancer research 20120301
[Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20120301
[A case of pancreatic cancer with liver metastasis controlled effectively by chemotherapy based on chemosensitivity test and stereotactic body radiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20120301
[Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120301
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 20120301
Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation. The Korean journal of hematology 20120301
[Successful gemcitabine-nedaplatin therapy in a hemodialysis patient with ureteral carcinoma after bilateral nephroureterectomy]. Hinyokika kiyo. Acta urologica Japonica 20120301
Present status and problems on molecular targeted therapy of cancer. Cancer research and treatment : official journal of Korean Cancer Association 20120301
Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer. Cancer research and treatment : official journal of Korean Cancer Association 20120301
Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. Cancer research and treatment : official journal of Korean Cancer Association 20120301
Five cases report of solid tumor synchronously with hematologic malignancy. Cancer research and treatment : official journal of Korean Cancer Association 20120301
Drug interactions: the importance of looking inside cancer cells. Cancer discovery 20120301
nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. Cancer discovery 20120301
Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer. Collegium antropologicum 20120301
Developments in metastatic pancreatic cancer: is gemcitabine still the standard? World journal of gastroenterology 20120227
Homo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance. The Journal of biological chemistry 20120217
Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. Journal of proteomics 20120216
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood 20120216
Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. Cancer 20120215
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). British journal of cancer 20120214
[Clinical diagnosis and treatment of spontaneous urinary extravasation caused by primary lower ureteral tumor]. Zhonghua yi xue za zhi 20120214
Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes. Heart international 20120203
Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors. Investigational new drugs 20120201
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. Investigational new drugs 20120201
Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer. Investigational new drugs 20120201
Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Investigational new drugs 20120201
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. International journal of radiation oncology, biology, physics 20120201
Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients. American journal of clinical oncology 20120201
Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004. American journal of clinical oncology 20120201
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Annals of oncology : official journal of the European Society for Medical Oncology 20120201
Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs. Breast cancer research and treatment 20120201
Eribulin -- a review of preclinical and clinical studies. Critical reviews in oncology/hematology 20120201
Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer. International journal of radiation oncology, biology, physics 20120201
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors. Cancer chemotherapy and pharmacology 20120201
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). Cancer chemotherapy and pharmacology 20120201
The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine. Lung cancer (Amsterdam, Netherlands) 20120201
Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model. Journal of gastroenterology and hepatology 20120201
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma. Cancer chemotherapy and pharmacology 20120201
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology 20120201
The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis. Cancer chemotherapy and pharmacology 20120201
Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study. Cancer chemotherapy and pharmacology 20120201
Systemic chemotherapy in patients with advanced transitional cell carcinoma of the urothelium and impaired renal function. Anti-cancer drugs 20120201
Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer. Oncology reports 20120201
Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages. International journal of oncology 20120201
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. Anti-cancer drugs 20120201
HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. Cancer letters 20120201
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. Gynecologic oncology 20120201
DNA building blocks: keeping control of manufacture. Critical reviews in biochemistry and molecular biology 20120201
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms. Oncology reports 20120201
Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 20120201
Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management. Gynecologic oncology 20120201
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). Journal of pain and symptom management 20120201
Targeting quiescent tumor cells via oxygen and IGF-I supplementation. Cancer research 20120201
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer. Pharmacogenetics and genomics 20120201
Genomics and pharmacogenomics of pancreatic adenocarcinoma. The pharmacogenomics journal 20120201
Biliary-tract cancer: improving therapy by adding molecularly targeted agents. The Lancet. Oncology 20120201
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. The Lancet. Oncology 20120201
Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder. Urology 20120201
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites. Molecular cancer therapeutics 20120201
Drugs in preclinical and early-stage clinical development for pancreatic cancer. Expert opinion on investigational drugs 20120201
Diagnosis and management of leiomyosarcoma arising from ovarian vein: case report and literature review. The journal of obstetrics and gynaecology research 20120201
Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells. Anticancer research 20120201
Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST). Journal of thoracic disease 20120201
Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120201
Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review. BJU international 20120201
[A case of pancreatic cancer with celiac trunk and common hepatic artery invasion successfully resected after gemcitabine+S-1therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20120201
[A case of a patient with bladder cancer who received warfarin and showed a significantly prolonged PT-INR after gemcitabine and cisplatin combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20120201
[A case of Bellini collecting duct carcinoma with hypercalcemia in a young adult]. Hinyokika kiyo. Acta urologica Japonica 20120201
[Renal salt wasting syndrome induced by Cisplatin: a case report]. Hinyokika kiyo. Acta urologica Japonica 20120201
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British journal of cancer 20120131
EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity. Journal of controlled release : official journal of the Controlled Release Society 20120130
In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer. Journal of controlled release : official journal of the Controlled Release Society 20120130
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. The New England journal of medicine 20120126
[Phase II trial of improved regimen with gemcitabine in patients with advanced non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120120
Intravesical gemcitabine for non-muscle invasive bladder cancer. The Cochrane database of systematic reviews 20120118
Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases. International journal of pharmaceutics 20120117
Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303). Cancer 20120115
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clinical cancer research : an official journal of the American Association for Cancer Research 20120115
Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1. Journal of controlled release : official journal of the Controlled Release Society 20120110
Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110
The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. British journal of cancer 20120103
Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study. Veterinary journal (London, England : 1997) 20120101
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20120101
Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Investigative radiology 20120101
Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine. Cancer chemotherapy and pharmacology 20120101
Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial. Cancer chemotherapy and pharmacology 20120101
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). Cancer chemotherapy and pharmacology 20120101
Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells. Cancer chemotherapy and pharmacology 20120101
Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy. Lung cancer (Amsterdam, Netherlands) 20120101
Different combination schedules of gemcitabine with endostar affect antitumor efficacy. Cancer chemotherapy and pharmacology 20120101
Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. Cancer 20120101
Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployed. Cancer 20120101
Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis. Gastroenterology research and practice 20120101
Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. Lung cancer (Amsterdam, Netherlands) 20120101
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review. Journal of neuro-oncology 20120101
Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer. Clinical lung cancer 20120101
Targeting the tumor microenvironment: focus on angiogenesis. Journal of oncology 20120101
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101
Angiogenesis in acute myeloid leukemia and opportunities for novel therapies. Journal of oncology 20120101
The Role of PTEN in Tumor Angiogenesis. Journal of oncology 20120101
Lipoplatin formulation review article. Journal of drug delivery 20120101
Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase. Pancreas 20120101
Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer. Cancer science 20120101
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer. Oncology reports 20120101
Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application. Journal of oncology 20120101
Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer. Cancer letters 20120101
ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine. Oncology reports 20120101
A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists. Molecular cancer therapeutics 20120101
Carbon nanotubes in cancer therapy and drug delivery. Journal of drug delivery 20120101
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 20120101
Bevacizumab-induced laryngeal necrosis. Annals of oncology : official journal of the European Society for Medical Oncology 20120101
Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120101
Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 20120101
Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer research 20120101
[Population pharmacokinetics of gemcitabine applied to personalize the dosage used in cancer patients]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101
Basal breast cancer: a complex and deadly molecular subtype. Current molecular medicine 20120101
Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience. Neoplasma 20120101
A Review of ERCC1 Gene in Bladder Cancer: Implications for Carcinogenesis and Resistance to Chemoradiotherapy. Advances in urology 20120101
Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Annals of surgery 20120101
Angiogenesis in head and neck cancer: a review of the literature. Journal of oncology 20120101
The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma. Pharmacogenetics and genomics 20120101
Synthesis and evaluation of macrocyclic diarylether heptanoid natural products and their analogs. Bioorganic & medicinal chemistry letters 20120101
Role of myeloid-derived suppressor cells in tumor immunotherapy. Immunotherapy 20120101
Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224radium-loaded wires releasing alpha-emitting atoms. Translational research : the journal of laboratory and clinical medicine 20120101
Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis. Hepato-gastroenterology 20120101
Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. Journal of biomedicine & biotechnology 20120101
Cutaneous presentation of a distant metastasis of malignant phyllodes tumor. International journal of dermatology 20120101
Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: case report and topic review. Journal of digestive diseases 20120101
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic review. PharmacoEconomics 20120101
Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. International journal of biological sciences 20120101
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells. International journal of biological sciences 20120101
Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials. Journal of Cancer 20120101
Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. Journal of Cancer 20120101
Bevacizumab in non small cell lung cancer: development, current status and issues. Current medicinal chemistry 20120101
Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development. Journal of oncology 20120101
Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. Journal of vascular and interventional radiology : JVIR 20120101
Health effects of dietary phospholipids. Lipids in health and disease 20120101
In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line. World journal of surgical oncology 20120101
Properties of lewis lung carcinoma cells surviving curcumin toxicity. Journal of Cancer 20120101
Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy. Journal of translational medicine 20120101
A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer. Radiation oncology (London, England) 20120101
[A case of adenosquamous carcinoma of lower extrahepatic bile duct]. Gan to kagaku ryoho. Cancer & chemotherapy 20120101
[A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20120101
Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of life. BMC cancer 20120101
Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer. BMC cancer 20120101
Aflibercept in the treatment of metastatic colorectal cancer. Clinical Medicine Insights. Oncology 20120101
Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin. Clinical Medicine Insights. Oncology 20120101
BRCAness profile of sporadic ovarian cancer predicts disease recurrence. PloS one 20120101
Gemcitabine: a critical nucleoside for cancer therapy. Current medicinal chemistry 20120101
Isolation and characterization of a murine P388 leukemia line resistant to thiarabine. Nucleosides, nucleotides & nucleic acids 20120101
Ancillary testing in lung cancer diagnosis. Pulmonary medicine 20120101
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PloS one 20120101
Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals. PloS one 20120101
Cancers of unknown primary origin: current perspectives and future therapeutic strategies. Journal of translational medicine 20120101
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. International journal of nanomedicine 20120101
5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. International journal of nanomedicine 20120101
In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration. PloS one 20120101
Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models. PloS one 20120101
Isolated splenic metastasis from lung squamous cell carcinoma. World journal of surgical oncology 20120101
Acute small bowel obstruction: a rare initial presentation for the metastasis of the large-cell carcinoma of the lung. World journal of surgical oncology 20120101
In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells. Radiation oncology (London, England) 20120101
Monoclonal antibodies and Fc fragments for treating solid tumors. Biologics : targets & therapy 20120101
Eribulin mesylate in the treatment of metastatic breast cancer. Biologics : targets & therapy 20120101
Autophagy in pancreatic cancer. International journal of cell biology 20120101
Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer. International journal of breast cancer 20120101
Immunohistochemical profile for unknown primary adenocarcinoma. PloS one 20120101
Modeling haplotype-haplotype interactions in case-control genetic association studies. Frontiers in genetics 20120101
Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). Journal of translational medicine 20120101
Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma. Journal of immunotherapy (Hagerstown, Md. : 1997) 20120101
High-pressure intrapleural chemotherapy: feasibility in the pig model. World journal of surgical oncology 20120101
Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. International journal of molecular sciences 20120101
Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type. Journal of Cancer 20120101
Primary small cell carcinoma of the pancreas: rare type of pancreatic cancer and review of the literatures. World journal of surgical oncology 20120101
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders. Clinical & developmental immunology 20120101
Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells. PloS one 20120101
Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. International journal of hepatology 20120101
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients. Oncology 20120101
Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study. Neoplasma 20120101
Therapeutic strategies in epithelial ovarian cancer. Journal of experimental & clinical cancer research : CR 20120101
Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer. World journal of surgical oncology 20120101
Lymphoepithelioma-like carcinoma of the urinary bladder: A case report and review of systemic treatment options. Urology annals 20120101
Defective cell cycle checkpoints as targets for anti-cancer therapies. Frontiers in pharmacology 20120101
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948). PloS one 20120101
Cellular growth kinetics distinguish a cyclophilin inhibitor from an HSP90 inhibitor as a selective inhibitor of hepatitis C virus. PloS one 20120101
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer. ClinicoEconomics and outcomes research : CEOR 20120101
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer. PloS one 20120101
EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PloS one 20120101
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation. PloS one 20120101
Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma. PloS one 20120101
Value of current chemotherapy and surgery in advanced and metastatic bladder cancer. Urologia internationalis 20120101
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin. Journal of gynecologic oncology 20120101
Major clinical research advances in gynecologic cancer in 2011. Journal of gynecologic oncology 20120101
Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine. Nucleosides, nucleotides & nucleic acids 20120101
Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular Evidence. Journal of oncology 20120101
A simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growth. PloS one 20120101
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PloS one 20120101
Novel therapeutic approaches in pancreatic cancer based on genomic alterations. Current pharmaceutical design 20120101
A phase II study of first-line chemotherapy with weekly carboplatin plus gemcitabine in advanced non-small cell lung cancer. Chemotherapy 20120101
Intrahepatic cholangiocarcinoma with sarcomatous changes. Case reports in gastroenterology 20120101
Spindle and giant cell type undifferentiated carcinoma of the proximal bile duct. Case reports in gastroenterology 20120101
Cinacalcet for hypercalcemia caused by pulmonary squamous cell carcinoma producing parathyroid hormone-related Peptide. Case reports in oncology 20120101
MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PloS one 20120101
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiation oncology (London, England) 20120101
Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations. Current pharmaceutical design 20120101
The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways. PloS one 20120101
The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. Journal of translational medicine 20120101
First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis. PloS one 20120101
Translatability scoring in drug development: eight case studies. Journal of translational medicine 20120101
Combination of gemcitabine and carboplatin in urothelial cancer patients unfit for cisplatin due to impaired renal or cardiac function. International braz j urol : official journal of the Brazilian Society of Urology 20120101
Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC. Cancer genomics & proteomics 20120101
Progress in personalizing chemotherapy for bladder cancer. Advances in urology 20120101
Systemic delivery of oncolytic viruses: hopes and hurdles. Advances in virology 20120101
Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects. Clinical & developmental immunology 20120101
Advances in using PARP inhibitors to treat cancer. BMC medicine 20120101
Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. International journal of nanomedicine 20120101
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications. International journal of nanomedicine 20120101
Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma. BMC cancer 20120101
Clinical efficacy of vorinostat in a patient with leiomyosarcoma. Clinical Medicine Insights. Oncology 20120101
Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway. International journal of molecular sciences 20120101
A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor. International journal of molecular sciences 20120101
Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder. The Libyan journal of medicine 20120101
Safety and efficacy of pemetrexed in maintenance therapy of non-small cell lung cancer. Clinical Medicine Insights. Oncology 20120101
Targeted agents for the treatment of metastatic melanoma. OncoTargets and therapy 20120101
Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors. Medicinal chemistry (Shariqah (United Arab Emirates)) 20120101
Unusual, metastatic, or neuroendocrine tumor of the pancreas: a diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101
Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells. PloS one 20120101
Dendrimers bind antioxidant polyphenols and cisplatin drug. PloS one 20120101
Current approaches to the management of Her2-negative metastatic breast cancer. Breast cancer research : BCR 20120101
Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Radiation oncology (London, England) 20120101
NF-κB as potential target in the treatment of melanoma. Journal of translational medicine 20120101
Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. Molecular cancer 20120101
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma? BMC cancer 20120101
Efficacy and tolerability of lapatinib in the management of breast cancer. Breast cancer : basic and clinical research 20120101
Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country. PloS one 20120101
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells. PloS one 20120101
Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy. Journal of experimental & clinical cancer research : CR 20120101
Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC cancer 20120101
A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes. Hematology/oncology and stem cell therapy 20120101
Parainfluenza virus infection associated with posterior reversible encephalopathy syndrome: a case report. Journal of medical case reports 20120101
Brain metastasis of nasopharyngeal carcinoma: a case report and literature review. Case reports in medicine 20120101
Demethoxycurcumin Retards Cell Growth and Induces Apoptosis in Human Brain Malignant Glioma GBM 8401 Cells. Evidence-based complementary and alternative medicine : eCAM 20120101
Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review. Radiation oncology (London, England) 20120101
Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization. Hepato-gastroenterology 20120101
Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer management and research 20120101
Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study. Cancer management and research 20120101
The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation. PloS one 20120101
Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment. Journal of hematology & oncology 20120101
Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: a retrospective study. Journal of translational medicine 20120101
Triple-negative breast cancer: an update on neoadjuvant clinical trials. International journal of breast cancer 20120101
Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1. Internal medicine (Tokyo, Japan) 20120101
Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. BMC cancer 20120101
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. Journal of hematology & oncology 20120101
Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients. PloS one 20120101
Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry. Journal of oncology 20120101
Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer. Journal of oncology 20120101
Special Agents Hunting Down Women Silent Killer: The Emerging Role of the p38α Kinase. Journal of oncology 20120101
Akt: a double-edged sword in cell proliferation and genome stability. Journal of oncology 20120101
Animal Models in Behçet's Disease. Pathology research international 20120101
Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop? Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20120101
Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. International journal of molecular sciences 20120101
[Efficacy evaluation of high intensity focused ultrasound combined with intra-arterial infusion of gemcitabine in the treatment of pancreatic cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20120101
Genetic association studies of copy-number variation: should assignment of copy number states precede testing? PloS one 20120101
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer. Swiss medical weekly 20120101
Efficacy of the new double-layer stent for unresectable distal malignant biliary obstruction: a single-center retrospective study. Diagnostic and therapeutic endoscopy 20120101
Hedgehog pathway as a drug target: Smoothened inhibitors in development. OncoTargets and therapy 20120101
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies. Advances in virology 20120101
Effects of ginsenoside Rb₁ on skin changes. Journal of biomedicine & biotechnology 20120101
Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. PloS one 20120101
Soft-tissue metastasis revealing a pancreatic adenocarcinoma: one case report and a review of literature. The Pan African medical journal 20120101
Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20120101
Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations. Clinical Medicine Insights. Oncology 20120101
Subversion of Immunity by Leishmania amazonensis Parasites: Possible Role of Phosphatidylserine as a Main Regulator. Journal of parasitology research 20120101
A multimodal approach to the management of neuroendocrine tumour liver metastases. International journal of hepatology 20120101
Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma. Asian Pacific journal of cancer prevention : APJCP 20120101
Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. Asian Pacific journal of cancer prevention : APJCP 20120101
Molecular imaging in therapeutic efficacy assessment of targeted therapy for nonsmall cell lung cancer. Journal of biomedicine & biotechnology 20120101
Nerve-cancer interactions in the stromal biology of pancreatic cancer. Frontiers in physiology 20120101
Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells. International journal of biological sciences 20120101
Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer. PloS one 20120101
Identification of 14-3-3γ as a Mieap-interacting protein and its role in mitochondrial quality control. Scientific reports 20120101
Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series. Journal of oncology 20120101
Novel therapies for aggressive B-cell lymphoma. Advances in hematology 20120101
DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. PloS one 20120101
Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells. PloS one 20120101
Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature. PloS one 20120101
Patient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells. Journal of biomedicine & biotechnology 20120101
Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update. TheScientificWorldJournal 20120101
Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene. Case reports in dermatology 20120101
The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer. Clinical Medicine Insights. Oncology 20120101
Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus? Clinical Medicine Insights. Oncology 20120101
Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study. Sarcoma 20120101
Zymophagy: selective autophagy of secretory granules. International journal of cell biology 20120101
Primary mucinous adenocarcinoma of the testis. Case reports in medicine 20120101
The 8q24 gene desert: an oasis of non-coding transcriptional activity. Frontiers in genetics 20120101
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PloS one 20120101
Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method. PloS one 20120101
[Malignant peripheral nerve sheath tumor associated with clear cell renal cell carcinoma - case report]. Pneumonologia i alergologia polska 20120101
Evidence-based decompression in malignant biliary obstruction. Korean journal of radiology 20120101
Recent advances of biliary stent management. Korean journal of radiology 20120101
Solitary fibrous tumors and so-called hemangiopericytoma. Sarcoma 20120101
Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura. Case reports in medicine 20120101
Extended distal pancreatectomy with en bloc resection of the celiac axis for locally advanced pancreatic cancer: a case report and review of the literature. Case reports in medicine 20120101
Rectal metastases from squamous cell carcinoma: a case report and review of the literature. Case reports in medicine 20120101
Integrin signaling in cancer cell survival and chemoresistance. Chemotherapy research and practice 20120101
Molecular imaging in tracking tumor stem-like cells. Journal of biomedicine & biotechnology 20120101
Adamantyl Retinoid-Related Molecules Induce Apoptosis in Pancreatic Cancer Cells by Inhibiting IGF-1R and Wnt/β-Catenin Pathways. Journal of oncology 20120101
Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years. Chemotherapy 20120101
Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma. ISRN oncology 20120101
Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment. Clinical sarcoma research 20120101
FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer. PloS one 20120101
Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation. PloS one 20120101
Non-antioxidant properties of α-tocopherol reduce the anticancer activity of several protein kinase inhibitors in vitro. PloS one 20120101
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma. PloS one 20120101
Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. International journal of nanomedicine 20120101
Aristolactam-type alkaloids from Orophea enterocarpa and their cytotoxicities. International journal of molecular sciences 20120101
Arterial emboli complicating Cisplatin therapy. Case reports in oncological medicine 20120101
Malignant fibrous histiocytoma of the ovary: a case report. European journal of gynaecological oncology 20120101
Customized chemotherapy based on epidermal growth factor receptor mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial. BMC cancer 20120101
Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development. PloS one 20120101
Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials. PloS one 20120101
Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA. PloS one 20120101
Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels. PloS one 20120101
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy. BMC cancer 20120101
Inhaled chemotherapy in lung cancer: future concept of nanomedicine. International journal of nanomedicine 20120101
'Malignant' perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma 20120101
Combination drug delivery approaches in metastatic breast cancer. Journal of drug delivery 20120101
Chemotherapy-related thrombocytosis: does it increase the risk of thromboembolism? Oncology 20120101
Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis. PloS one 20120101
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma. BMC cancer 20120101
Surveillance and treatment of non-muscle-invasive bladder cancer in the USA. Advances in urology 20120101
Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone. Journal of oncology 20120101
Radiotherapy and erlotinib combined: review of the preclinical and clinical evidence. Frontiers in oncology 20120101
Epigenetics modifications and therapeutic prospects in human thyroid cancer. Frontiers in endocrinology 20120101
PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials. PPAR research 20120101
Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. ISRN oncology 20120101
Hepatocellular carcinoma: focus on different aspects of management. ISRN oncology 20120101
Current knowledge on pancreatic cancer. Frontiers in oncology 20120101
Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine. International journal of nanomedicine 20120101
Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. PloS one 20120101
Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature. Sarcoma 20120101
Versatility of RNA-Binding Proteins in Cancer. Comparative and functional genomics 20120101
Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report. Case reports in oncology 20120101
Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma. Case reports in oncology 20120101
Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease. PPAR research 20120101
Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5. PloS one 20120101
Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN oncology 20120101
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy. Journal of Cancer 20120101
Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma. International journal of clinical and experimental pathology 20120101
Melanoma chemotherapy leads to the selection of ABCB5-expressing cells. PloS one 20120101
Radiation, inflammation, and immune responses in cancer. Frontiers in oncology 20120101
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases. International journal of nanomedicine 20120101
A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. International journal of nanomedicine 20120101
Remarkable regression of an osteolytic lesion of large cell lung cancer treated with zoledronic Acid: a case report. Case reports in oncology 20120101
Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel. PloS one 20120101
Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer. BMC cancer 20120101
Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells. Journal of oncology 20120101
An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review. Case reports in medicine 20120101
[Basic investigation for classification of anticancer drugs by pharmacological effects]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101
Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma. Cancer management and research 20120101
Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest. Journal of oncology 20120101
Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer. Gastroenterology research and practice 20120101
Targeted therapies in sarcomas: challenging the challenge. Sarcoma 20120101
Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis. Journal of oncology 20120101
Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients. PloS one 20120101
H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer. ISRN oncology 20120101
Intermittent chemotherapy is a treatment choice for advanced urothelial cancer. Oncology 20120101
Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer. PloS one 20120101
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy. BMC cancer 20120101
[Non-small cell lung cancer: risk factors of radiation pneumonitis]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20120101
Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20120101
Surface-modified gemcitabine with mucoadhesive polymer for oral delivery. Journal of microencapsulation 20120101
Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines. Journal of toxicology and environmental health. Part A 20120101
Efficacy and safety of gemcitabine monotherapy for patients with advanced biliary tract cancer. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20120101
Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans. Asian Pacific journal of cancer prevention : APJCP 20120101
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial. PloS one 20120101
Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines. PloS one 20120101
Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20120101
Gemcitabine Plus Carboplatin in Patients with Advanced Hepatocellular Carcinoma: Results of a Phase II Study. ISRN oncology 20120101
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers. Journal of translational medicine 20120101
[Evaluation of prescription practices for drugs charged in addition to DRG-based fees in Alsace]. Therapie 20120101
Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis. PloS one 20120101
A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer. Gastrointestinal cancer research : GCR 20120101
[Combined effect of gemcitabine and lomustine in mice with intracranial transplanted lymphosarcoma LIO-1]. Voprosy onkologii 20120101
Effective use of gemcitabine in the treatment of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas with portal vein tumor thrombus. Internal medicine (Tokyo, Japan) 20120101
Cisplatin-based therapy for the treatment of elderly patients with non-small-cell lung cancer: a retrospective analysis of a single institution. Asian Pacific journal of cancer prevention : APJCP 20120101
Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study. Asian Pacific journal of cancer prevention : APJCP 20120101
Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients. Asian Pacific journal of cancer prevention : APJCP 20120101
Gemcitabine-based concurrent chemoradiotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer. Asian Pacific journal of cancer prevention : APJCP 20120101
Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. Asian Pacific journal of cancer prevention : APJCP 20120101
Synergistic effects of nanosecond pulsed electric fields combined with low concentration of gemcitabine on human oral squamous cell carcinoma in vitro. PloS one 20120101
Solitary cerebral metastasis from transitional cell carcinoma after a 14-year remission of urinary bladder cancer treated with gemcitabine: Case report and literature review. Surgical neurology international 20120101
Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma. Asian Pacific journal of cancer prevention : APJCP 20120101
Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells. PloS one 20120101
Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. Journal of experimental & clinical cancer research : CR 20120101
Localization of association signal from risk and protective variants in sequencing studies. Frontiers in genetics 20120101
Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer. OncoTargets and therapy 20120101
Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models. Nucleosides, nucleotides & nucleic acids 20120101
Preclinical combination therapy of clofarabine plus radiation. Nucleosides, nucleotides & nucleic acids 20120101
A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity. PloS one 20120101
Elective bladder preservation with multimodality treatment for bladder cancer. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20120101
Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin. Oncology research 20120101
Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. Onkologie 20120101
XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells. PloS one 20120101
Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma. PloS one 20120101
Sequential therapy with gemcitabine and Carboplatin followed by Paclitaxel as first line treatment for advanced urothelial cancer. Journal of Cancer 20120101
A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer. Gastrointestinal cancer research : GCR 20120101
Modelling non-homogeneous stochastic reaction-diffusion systems: the case study of gemcitabine-treated non-small cell lung cancer growth. BMC bioinformatics 20120101
Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro. Asian Pacific journal of cancer prevention : APJCP 20120101
Retrospective study of gemcitabine based chemotherapy for unresectable or recurrent esophagus squamous cell carcinoma refractory to first line chemotherapy. Asian Pacific journal of cancer prevention : APJCP 20120101
Involvement of phosphatidylinositol 3-kinase/Akt pathway in gemcitabine-induced apoptosis-like cell death in insulinoma cell line INS-1. Biological & pharmaceutical bulletin 20120101
Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells. Cancer letters 20111227
Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer letters 20111227
Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs 20111224
Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. Journal of medicinal chemistry 20111222
Taxane doublets for metastatic breast cancer: do we need another cytotoxic pair or another approach? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111220
Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111220
Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin. International journal of cancer 20111215
The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. Oncogene 20111215
SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner. Cancer research 20111215
Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity. Biochemical and biophysical research communications 20111209
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. Blood 20111208
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Molecular pharmaceutics 20111205
The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines. Investigational new drugs 20111201
A phase I study of topotecan and gemcitabine in advanced solid tumors. Investigational new drugs 20111201
Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer. Investigational new drugs 20111201
Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer. Medical oncology (Northwood, London, England) 20111201
Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases. Investigational new drugs 20111201
Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy. Medical oncology (Northwood, London, England) 20111201
Chemoradiation for unresectable gall bladder cancer: time to review historic nihilism? Journal of gastrointestinal cancer 20111201
Conditions causing gemcitabine crystallization. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20111201
Phase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumors. American journal of clinical oncology 20111201
Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience. Medical oncology (Northwood, London, England) 20111201
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Cancer treatment reviews 20111201
Metachronous multiple adenocarcinomas of the pancreas. International journal of clinical oncology 20111201
Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. Nanomedicine : nanotechnology, biology, and medicine 20111201
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study. International journal of radiation oncology, biology, physics 20111201
Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial. Cancer chemotherapy and pharmacology 20111201
A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity. International journal of clinical oncology 20111201
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials. Cancer chemotherapy and pharmacology 20111201
Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine : nanotechnology, biology, and medicine 20111201
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. Cancer chemotherapy and pharmacology 20111201
Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells. International journal of clinical oncology 20111201
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational 'SUN' (Survey on the lUng cancer maNagement) study. Lung cancer (Amsterdam, Netherlands) 20111201
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis. Cell death and differentiation 20111201
In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma. Toxicology in vitro : an international journal published in association with BIBRA 20111201
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas. European journal of haematology 20111201
The emerging role of poly(ADP-Ribose) polymerase inhibitors in cancer treatment. Current drug targets 20111201
Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. Journal of aerosol medicine and pulmonary drug delivery 20111201
Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation. International journal of oncology 20111201
Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer. Scandinavian journal of urology and nephrology 20111201
c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterology 20111201
A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111201
Chemotherapy in elderly patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20111201
Ultra-violet irradiation induces apoptosis via mitochondrial pathway in pancreatic cancer cells. International journal of oncology 20111201
Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice. Cancer gene therapy 20111201
Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. Oncology reports 20111201
The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer. Journal of cancer research and clinical oncology 20111201
Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01). European urology 20111201
Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer. Expert opinion on drug metabolism & toxicology 20111201
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201
Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer. Molecular cancer therapeutics 20111201
Metronomic therapy concepts in the management of adrenocortical carcinoma. Hormones & cancer 20111201
The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models. Gene therapy 20111201
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer. Gynecologic oncology 20111201
Synchronous bilateral urothelial cancer in a kidney recipient. International journal of urology : official journal of the Japanese Urological Association 20111201
High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy. International journal of urology : official journal of the Japanese Urological Association 20111201
Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy. Pharmacogenomics 20111201
Single-institution experience with solid pseudopapillary neoplasm of the pancreas. Scandinavian journal of gastroenterology 20111201
Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine-treated advanced non-small cell lung cancer patients. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111201
Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas. Veterinary and comparative oncology 20111201
Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. Expert opinion on drug delivery 20111201
Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study. Drug safety 20111201
Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells. Nucleosides, nucleotides & nucleic acids 20111201
Determination of the phosphorylated metabolites of gemcitabine and of difluorodeoxyuridine by LCMSMS. Nucleosides, nucleotides & nucleic acids 20111201
Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells. Nucleosides, nucleotides & nucleic acids 20111201
[Chemotherapy of metastatic pancreatic adenocarcinoma: challenges and encouraging results]. Bulletin du cancer 20111201
[Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111201
Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer. Asia-Pacific journal of clinical oncology 20111201
[First line therapy for local advanced or metastasized urothelial carcinoma: randomized double-blind phase II study to compare gemcitabin and cisplatin in combination with OGX-427 or placebo for advanced transitional cell carcinoma of the bladder (OGX-427 - AB 39/11 of the Working Group Urological Oncology)]. Der Urologe. Ausg. A 20111201
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. Cell death & disease 20111201
Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues. PLoS computational biology 20111201
Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy. The Yale journal of biology and medicine 20111201
[Safety profiles of gemcitabine hydrochloride(GEMZAR®)in Japanese clinical studies]. Gan to kagaku ryoho. Cancer & chemotherapy 20111201
[A long-term survivor who received S-1-based multidisciplinary therapy for unresectable advanced pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20111201
DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report. Anticancer research 20111201
[Effect of gemcitabine in enhancing the radiosensitivity of HepG2 hepatoma cells and the possible mechanism]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111201
[Influence of Shenfu Injection on the quality of life of lung cancer patients receiving chemotherapy]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111201
[A case of small cell carcinoma of the renal pelvis]. Hinyokika kiyo. Acta urologica Japonica 20111201
[Nested variant of urothelial carcinoma of bladder : a case report]. Hinyokika kiyo. Acta urologica Japonica 20111201
Requirement of nuclear factor κB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis. Neoplasia (New York, N.Y.) 20111201
Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis. Cancer research and treatment : official journal of Korean Cancer Association 20111201
Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1). Oncotarget 20111201
Lymphoma stem cells: A step toward a new therapeutic target. The Korean journal of hematology 20111201
Acupuncture-related rapid dermal spread of breast cancer: a rare case. Journal of breast cancer 20111201
Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial. Chinese medical journal 20111201
Photosensitivity reactions to vandetanib: redevelopment after sequential treatment with docetaxel. Annals of dermatology 20111201
Cytotoxicities and Quantitative Structure Activity Relationships of B13 Sulfonamides in HT-29 and A549 Cells. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 20111201
Radiotherapy: the importance of local control in pancreatic cancer. Nature reviews. Clinical oncology 20111129
[Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell]. Zhonghua yi xue za zhi 20111129
[Inhibitory effects of thymoquinone on human pancreatic carcinoma orthotopically implanted in nude mice]. Zhonghua yi xue za zhi 20111129
Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105. International journal of radiation oncology, biology, physics 20111115
Weekly gemcitabine and cisplatin in combination with radiotherapy in patients with locally advanced head-and-neck cancer: Phase I study. International journal of radiation oncology, biology, physics 20111115
Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. International journal of radiation oncology, biology, physics 20111115
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets. Biochemical pharmacology 20111115
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437. Clinical cancer research : an official journal of the American Association for Cancer Research 20111115
Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice. Cancer research 20111115
Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer. Cancer biology & therapy 20111115
Molecular predictors of gemcitabine response in pancreatic cancer. World journal of gastrointestinal oncology 20111115
Systemic management strategies for metastatic soft tissue sarcoma. Drugs 20111112
RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110
Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. British journal of cancer 20111108
Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell stem cell 20111104
Hand-foot hyperpigmentation skin lesions associated with combination gemcitabine-carboplatin (GemCarbo) therapy. American journal of therapeutics 20111101
Reversible neuropathy after chemotherapy for metastatic adenocarcinoma from an unknown primary tumor to the sural nerve. American journal of therapeutics 20111101
Congenital retroperitoneal vascular anomalies: impact on pelvic surgery. Archives of gynecology and obstetrics 20111101
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Annals of oncology : official journal of the European Society for Medical Oncology 20111101
Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group. Annals of oncology : official journal of the European Society for Medical Oncology 20111101
First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group. Cancer chemotherapy and pharmacology 20111101
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy. Cancer chemotherapy and pharmacology 20111101
Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy. Lung cancer (Amsterdam, Netherlands) 20111101
Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines. Lung cancer (Amsterdam, Netherlands) 20111101
Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo. International journal of oncology 20111101
Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101
Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence. Respirology (Carlton, Vic.) 20111101
Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis. Oncology reports 20111101
The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinase. Drug metabolism and disposition: the biological fate of chemicals 20111101
Prognostic factors in second-line treatment of urothelial cancers with gemcitabine and paclitaxel (German Association of Urological Oncology trial AB20/99). European urology 20111101
Ethnic difference in hematological toxicity in patients with non-small cell lung cancer treated with chemotherapy: a pooled analysis on Asian versus non-Asian in phase II and III clinical trials. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101
Gene set analysis of purine and pyrimidine antimetabolites cancer therapies. Pharmacogenetics and genomics 20111101
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells. Molecular cancer therapeutics 20111101
Acute digital ischemia complicating gemcitabine and carboplatin combination chemotherapy for ovarian cancer. Acta obstetricia et gynecologica Scandinavica 20111101
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer. Molecular cancer therapeutics 20111101
Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells. Molecular bioSystems 20111101
Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Molecular cancer therapeutics 20111101
Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells. The Journal of urology 20111101
Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101
Locally advanced pancreatic cancer: where should we go from here? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101
Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas 20111101
Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. Pancreas 20111101
[Strategies for preoperative downsizing in patients with local nonresectable pancreatic cancer]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20111101
A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer. Cancer investigation 20111101
Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography-triple-quadrupole mass spectrometry. Journal of separation science 20111101
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. The Lancet. Oncology 20111101
Retraction. Annals of oncology : official journal of the European Society for Medical Oncology 20111101
Carcinomas of an unknown primary origin--diagnosis and treatment. Nature reviews. Clinical oncology 20111101
Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer. Drugs & aging 20111101
[Effectiveness of systemic chemotherapy of GEM+CBDCA+5-FU/LV and hepatic arterial infusion of CDDP in a case of advanced, combined hepatocellular-cholangiocarcinoma with multiple lung metastases]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111101
[Synchronous double cancer of the gallbladder and rectum successfully treated with S-1 as second-line chemotherapy- a case report]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
An overview of recently published medical papers in Brazilian scientific journals. Clinics (Sao Paulo, Brazil) 20111101
Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases. Expert reviews in molecular medicine 20111101
Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide. Anticancer research 20111101
Intra-arterial chemoinfusion prior to chemoradiotherapy with full-dose systemic gemcitabine for management of locally advanced pancreatic cancer. Anticancer research 20111101
PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PLoS genetics 20111101
Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma. Neoplasia (New York, N.Y.) 20111101
[Granulocyte-colony-stimulating factor (G-CSF)-producing carcinoma of collecting ducts of Bellini: a case report]. Hinyokika kiyo. Acta urologica Japonica 20111101
Preventive action of curcumin in experimental acute pancreatitis in mouse. The Indian journal of medical research 20111101
[The development of a novel cancer vaccine using Peptide vaccine for patients with advanced pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case of primary malignant lymphoma of the spleen which was difficult to be diagnosed]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A rare case of huge triple-negative of accessory breast cancer enlarged during the course of chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A pilot study of intraperitoneal gemcitabine for reduction of peritoneal dissemination in advanced pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[An example case that chemoradiotherapy was succeeded for unresectable pancreas cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[An operated case of metastasis to the small intestine from lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case of distal cholangiocarcinoma with high sensitivity to neoadjuvant chemoradiation therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[Curative resection of gallbladder cancer with simultaneous liver metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case of long-term survival of a patient with intrahepatic bile duct cancer and early nodal recurrence who responded to S-1 therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A novel gemcitabine delivery system]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[Re-resection for local recurrence in the remnant pancreas after pancreaticoduodenectomy for pancreatic cancer- a case report]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case of intrahepatic cholangiocarcinoma with invasion to right adrenal gland]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy]. Gan to kagaku ryoho. Cancer & chemotherapy 20111101
[A randomized controlled trial of the efficacy of combination of gemcitabine and carboplatin or paclitaxel and combination of paclitaxel and carboplatin in the treatment for advanced non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20111101
Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer. British journal of cancer 20111025
[MicroRNA expression pattern in intraductal papillary mucinous neoplasm]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111025
CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. Life sciences 20111024
Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma. International journal of cancer 20111015
Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protein kinase. Biochemical and biophysical research communications 20111014
HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma. Blood 20111013
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study). British journal of cancer 20111011
Epidermal growth factor receptor blockers for the treatment of ovarian cancer. The Cochrane database of systematic reviews 20111005
Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer. Investigational new drugs 20111001
Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies. Investigational new drugs 20111001
Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness. Investigational new drugs 20111001
A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study. American journal of clinical oncology 20111001
A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981. American journal of clinical oncology 20111001
Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. Critical reviews in oncology/hematology 20111001
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer. Cancer chemotherapy and pharmacology 20111001
Addition of gemcitabine at the time of sunitinib resistance in metastatic renal cell cancer. BJU international 20111001
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial. Cancer chemotherapy and pharmacology 20111001
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting. Cancer chemotherapy and pharmacology 20111001
Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma. International journal of clinical oncology 20111001
Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study. International journal of clinical oncology 20111001
Treatment of borderline cases for curative resection of biliary tract cancer. Journal of surgical oncology 20111001
Evaluation of cutaneous angioimmunoblastic T-cell lymphoma. Journal of the American Academy of Dermatology 20111001
Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT. International journal of radiation oncology, biology, physics 20111001
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation. Biomedical microdevices 20111001
Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review. The Lancet. Oncology 20111001
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer immunology, immunotherapy : CII 20111001
Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111001
Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292. Clinical & experimental metastasis 20111001
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors. European urology 20111001
Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition. Cancer science 20111001
Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer. Molecular pharmacology 20111001
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial. International journal of oncology 20111001
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer. Gynecologic oncology 20111001
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL. Cancer chemotherapy and pharmacology 20111001
The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors. Experimental hematology 20111001
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Cancer biology & therapy 20111001
Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer biology & therapy 20111001
Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer. Journal of cancer research and clinical oncology 20111001
An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine. Cancer gene therapy 20111001
Management of breast cancer with nanoparticle albumin-bound (nab)-paclitaxel combination regimens: a clinical review. Breast (Edinburgh, Scotland) 20111001
Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy. Molecular cancer therapeutics 20111001
Unusual sites of extrapulmonary metastases of osteosarcoma after several lines of treatment. Pediatric hematology and oncology 20111001
FOLFIRINOX: a small step or a great leap forward? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001
Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy. Japanese journal of clinical oncology 20111001
Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20111001
Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer biotherapy & radiopharmaceuticals 20111001
Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1. Anticancer research 20111001
Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma. Anticancer research 20111001
Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study. Anticancer research 20111001
[Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001
[Evidences for adjuvant therapy of resected pancreatic cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001
Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer. Korean journal of ophthalmology : KJO 20111001
[Bellini tumours]. Bulletin du cancer 20111001
Pharmacogenomic characterization of US FDA-approved cytotoxic drugs. Pharmacogenomics 20111001
OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer. Cell death & disease 20111001
Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia (New York, N.Y.) 20111001
Systemic use of tumor necrosis factor alpha as an anticancer agent. Oncotarget 20111001
[Effect of Chinese medicine comprehensive regimen as the maintenance therapy on time to progression and quality of life of patients with advanced non-small-cell lung cancer]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20111001
Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. Nutrients 20111001
Pancreatic cancer: Animal model and molecular biology. North American journal of medical sciences 20111001
Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide. Biochemical and biophysical research communications 20110923
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet (London, England) 20110917
Combination chemotherapy for older adults with advanced non-small-cell lung cancer. Lancet (London, England) 20110917
Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 20110915
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response. Clinical cancer research : an official journal of the American Association for Cancer Research 20110915
Thrombotic microangiopathy with targeted cancer agents. Clinical cancer research : an official journal of the American Association for Cancer Research 20110915
Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro. World journal of gastroenterology 20110907
Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma. Medical oncology (Northwood, London, England) 20110901
Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901
Peripheral T-cell lymphoma--not otherwise specified. Critical reviews in oncology/hematology 20110901
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. Journal of gastrointestinal cancer 20110901
Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy. Cancer chemotherapy and pharmacology 20110901
Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer chemotherapy and pharmacology 20110901
Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer. Cancer chemotherapy and pharmacology 20110901
ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478. Lung cancer (Amsterdam, Netherlands) 20110901
Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience. Lung cancer (Amsterdam, Netherlands) 20110901
Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection. Annals of surgical oncology 20110901
Gemcitabine-induced acute myositis in a patient with duodenal cancer. Clinical oncology (Royal College of Radiologists (Great Britain)) 20110901
Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review. International journal of cancer 20110901
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma. Journal of hepato-biliary-pancreatic sciences 20110901
Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma. Anti-cancer drugs 20110901
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. International journal of radiation oncology, biology, physics 20110901
Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. Cancer immunology, immunotherapy : CII 20110901
Chemotherapy and targeted therapies for unresectable malignant mesothelioma. Lung cancer (Amsterdam, Netherlands) 20110901
Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27. Gynecologic oncology 20110901
Triphendiol (NV-196), development of a novel therapy for pancreatic cancer. Anti-cancer drugs 20110901
Chemotherapy only for localized Hodgkin lymphoma. Journal of internal medicine 20110901
Necitumumab in the treatment of advanced non-small cell lung cancer: translation from preclinical to clinical development. Expert opinion on biological therapy 20110901
Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities. Current opinion in oncology 20110901
Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells. International journal of oncology 20110901
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy. British journal of haematology 20110901
Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1. Journal of ethnopharmacology 20110901
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110901
Circulating tumor cells count and characterization in a male breast cancer patient. Cancer biology & therapy 20110901
Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20110901
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells. Molecular cancer therapeutics 20110901
Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer. HPB : the official journal of the International Hepato Pancreato Biliary Association 20110901
The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience. Anticancer research 20110901
[Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective]. Gan to kagaku ryoho. Cancer & chemotherapy 20110901
Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers in surgery and medicine 20110901
Photodynamic therapy for cholangiocarcinoma. Lasers in surgery and medicine 20110901
Survival benefits of surgical resection in recurrent cholangiocarcinoma. Journal of the Korean Surgical Society 20110901
[Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied in advanced pancreatic cancer]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20110901
[Experience with gemcitabine monotherapy in three patients with metastatic urothelial carcinoma]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20110901
β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. European journal of pharmacology 20110831
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England journal of medicine 20110825
Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 20110815
Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells. International journal of cancer 20110815
Gemcitabine in elderly patients with advanced pancreatic cancer. World journal of gastroenterology 20110814
Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines. Journal of medicinal chemistry 20110811
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. Journal of the National Cancer Institute 20110803
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. Investigational new drugs 20110801
Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors. Cancer chemotherapy and pharmacology 20110801
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer. Cancer chemotherapy and pharmacology 20110801
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs. Lung cancer (Amsterdam, Netherlands) 20110801
The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status. Lung cancer (Amsterdam, Netherlands) 20110801
The promise of a personalized genomic approach to pancreatic cancer and why targeted therapies have missed the mark. World journal of surgery 20110801
Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Cancer 20110801
Progressive multifocal leukoencephalopathy following chemotherapy for lung cancer. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110801
ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration. International journal of clinical oncology 20110801
The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen. International journal of clinical oncology 20110801
MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Annals of surgical oncology 20110801
Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy. Cancer letters 20110801
A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells. Cancer letters 20110801
Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property of gemcitabine in pancreatic cancer. Pancreas 20110801
Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment. European journal of cancer (Oxford, England : 1990) 20110801
Novel approaches to treatment of leiomyosarcomas. Current oncology reports 20110801
Medical treatment of mesothelioma: anything new? Current oncology reports 20110801
Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. Journal of surgical oncology 20110801
The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20110801
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study. Cancer immunology, immunotherapy : CII 20110801
Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer. Pancreas 20110801
Identification of genes associated to 2',2'-difluorodeoxycytidine resistance in HeLa cells with a lentiviral short-hairpin RNA library. Biochemical pharmacology 20110801
Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs. Expert opinion on drug metabolism & toxicology 20110801
Emerging pharmacotherapeutic strategies for cholangiocarcinoma. Expert opinion on pharmacotherapy 20110801
Delineation of the molecular mechanisms of nucleoside recognition by cytidine deaminase through virtual screening. ChemMedChem 20110801
Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy. Cancer biology & therapy 20110801
A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells. Cancer biology & therapy 20110801
Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil. International journal of oncology 20110801
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801
The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status. Clinical cancer research : an official journal of the American Association for Cancer Research 20110801
Differential effect of polymorphisms of CMPK1 and RRM1 on survival in advanced non-small cell lung cancer patients treated with gemcitabine or taxane/cisplatinum. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110801
Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 20110801
[New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20110801
Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer research 20110801
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer research 20110801
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801
Phase II study of gefitinib as a first-line therapy in elderly patients with pulmonary adenocarcinoma: West Japan Thoracic Oncology Group Study 0402. Japanese journal of clinical oncology 20110801
Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer. Japanese journal of clinical oncology 20110801
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer. Clinical breast cancer 20110801
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer biology & therapy 20110801
[Carcinoma of the pancreas: current status of multimodal therapy]. Zentralblatt fur Chirurgie 20110801
[First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 - AB 38/11) of AUO]. Der Urologe. Ausg. A 20110801
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. The Lancet. Oncology 20110801
Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study. Journal of chemotherapy (Florence, Italy) 20110801
Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. Cell death & disease 20110801
New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110801
Enzyme kinetics of the mitochondrial deoxyribonucleoside salvage pathway are not sufficient to support rapid mtDNA replication. PLoS computational biology 20110801
Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia. Aging 20110801
[Systemic therapy of muscle invasive bladder cancer - an update]. Wiener medizinische Wochenschrift (1946) 20110801
Stress-induced Cardiomyopathy during Pulmonary Resection (Takotsubo Syndrome) - A case report -. The Korean journal of thoracic and cardiovascular surgery 20110801
[A randomized study of gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin as the 1st line chemotherapy for advanced non-small cell lung cancer in elderly patients]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110720
DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma. Cancer 20110715
Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. Cancer 20110715
Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun. Clinical cancer research : an official journal of the American Association for Cancer Research 20110715
Suppression of apoptosis by PIF1 helicase in human tumor cells. Cancer research 20110715
Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. Cancer research 20110715
Response to radiation in renal medullary carcinoma. Rare tumors 20110711
An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report. World journal of clinical oncology 20110710
Pancreatic neoplasm in 2011: an update. JOP : Journal of the pancreas 20110708
Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the '2011 ASCO Annual Meeting'. Chicago, IL, USA; June 3-7, 2011. JOP : Journal of the pancreas 20110708
Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the '2011 ASCO Annual Meeting'. Chicago, IL, USA; June 3-7, 2011. JOP : Journal of the pancreas 20110708
Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the '2011 ASCO Annual Meeting'. Chicago, IL, USA; June 3-7, 2011. JOP : Journal of the pancreas 20110708
Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the '2011 ASCO Annual Meeting'. Chicago, IL, USA; June 3-7, 2011. JOP : Journal of the pancreas 20110708
Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drug. The Analyst 20110707
Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors. Cancer chemotherapy and pharmacology 20110701
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer chemotherapy and pharmacology 20110701
Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients. Cancer chemotherapy and pharmacology 20110701
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA). Lung cancer (Amsterdam, Netherlands) 20110701
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer. The Lancet. Oncology 20110701
The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy. BJU international 20110701
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study. Annals of oncology : official journal of the European Society for Medical Oncology 20110701
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Annals of oncology : official journal of the European Society for Medical Oncology 20110701
A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer. Breast cancer (Tokyo, Japan) 20110701
Biliary metal stents are superior to plastic stents for preoperative biliary decompression in pancreatic cancer. Surgical endoscopy 20110701
Overcoming drug resistance in pancreatic cancer. Expert opinion on therapeutic targets 20110701
Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20110701
Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma. Gynecologic oncology 20110701
Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial. Breast cancer (Tokyo, Japan) 20110701
UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicity. Biochemical pharmacology 20110701
Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer. Anti-cancer drugs 20110701
Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study. Gynecologic oncology 20110701
Metastatic pancreatic cancer: old drugs, new paradigms. Current opinion in oncology 20110701
NeoGemTax: gemcitabine and docetaxel as neoadjuvant treatment for locally advanced nonmetastasized pancreatic cancer. World journal of surgery 20110701
Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL. International journal of oncology 20110701
Review on clinical trials of targeted treatments in malignant mesothelioma. Cancer chemotherapy and pharmacology 20110701
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group. European journal of cancer (Oxford, England : 1990) 20110701
Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1. Molecular cancer therapeutics 20110701
Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children. Journal of pediatric hematology/oncology 20110701
Novel approaches to target pancreatic cancer. Current cancer drug targets 20110701
Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patients. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110701
Squamous cell carcinoma of the lung in an autistic child who has never smoked. Journal of pediatric hematology/oncology 20110701
Bowel perforation after erlotinib treatment in a patient with non-small cell lung cancer. Yonsei medical journal 20110701
Increased expression of DNA repair genes in invasive human pancreatic cancer cells. Pancreas 20110701
A man with a testicular mass and a colon stenosis. Diagnosis: Metastatic pancreatic adenocarcinoma to the gonads. Gastroenterology 20110701
Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer. Japanese journal of clinical oncology 20110701
Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer. Pancreas 20110701
Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma. BJU international 20110701
[Intracranial metastasis of thymoma: report of three cases]. No shinkei geka. Neurological surgery 20110701
[Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110701
Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110701
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110701
[Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin]. Hinyokika kiyo. Acta urologica Japonica 20110701
Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system. Anticancer research 20110701
Towards translation of 212Pb as a clinical therapeutic; getting the lead in! Dalton transactions (Cambridge, England : 2003) 20110621
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620
[Gemcitabine in RRM1-negative advanced refractory non-small cell lung cancer (NSCLC): a case report]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110620
Comment on 'Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer,' i.e., all we are saying is, give C a chance. Free radical biology & medicine 20110615
A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003. Cancer 20110615
Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases. British journal of cancer 20110607
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer. Oncogene 20110602
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models. Investigational new drugs 20110601
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors. Investigational new drugs 20110601
Gemcitabine and cisplatin in patients with carcinoma of unknown primary site. Medical oncology (Northwood, London, England) 20110601
Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy. Critical reviews in oncology/hematology 20110601
Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer. International journal of radiation oncology, biology, physics 20110601
A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer. Cancer chemotherapy and pharmacology 20110601
Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer epidemiology 20110601
Stromal biology and therapy in pancreatic cancer. Gut 20110601
Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT. Annals of hematology 20110601
Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes. Annals of oncology : official journal of the European Society for Medical Oncology 20110601
Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy. Integrative cancer therapies 20110601
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20110601
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group. Cancer science 20110601
DNA repair: the culprit for tumor-initiating cell survival? Cancer metastasis reviews 20110601
Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20110601
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes. Cancer immunology, immunotherapy : CII 20110601
Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells. Cancer science 20110601
Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells. International journal of radiation oncology, biology, physics 20110601
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free radical biology & medicine 20110601
Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine. Oncology reports 20110601
[Collecting duct renal cell carcinoma]. Actas urologicas espanolas 20110601
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clinical & experimental metastasis 20110601
Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis. Laboratory investigation; a journal of technical methods and pathology 20110601
A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. Japanese journal of clinical oncology 20110601
Treatment of metastatic renal cell carcinoma and renal pelvic cancer. Clinical and experimental nephrology 20110601
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 20110601
Current treatment options for pancreatic carcinoma. Current oncology reports 20110601
Combination therapy for the treatment of pancreatic cancer. Anti-cancer agents in medicinal chemistry 20110601
Anti-angiogenic agents in pancreatic cancer: a review. Anti-cancer agents in medicinal chemistry 20110601
High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells. Molecular cancer research : MCR 20110601
Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20110601
Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: a substudy of the Avastin in Lung trial. Asia-Pacific journal of clinical oncology 20110601
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia. Asia-Pacific journal of clinical oncology 20110601
Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan. Asia-Pacific journal of clinical oncology 20110601
Other options in the treatment of advanced breast cancer. Seminars in oncology 20110601
Early clinical development of ARQ 197, a selective, non-ATP-competitive inhibitor targeting MET tyrosine kinase for the treatment of advanced cancers. The oncologist 20110601
Molecular imaging of akt enables early prediction of response to molecular targeted therapy. Translational oncology 20110601
Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 20110601
p21-activated kinase 1: PAK'ed with potential. Oncotarget 20110601
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20110601
[A case of pancreatic well-differentiated neuroendocrine carcinoma surviving 8 years and 5 months with treatments for multiple liver tumors diagnosed as carcinoid tumor]. Gan to kagaku ryoho. Cancer & chemotherapy 20110601
Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors. Drugs in R&D 20110601
Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110601
[Palliative chemotherapy of non small lung cancer in Tunisia. Prospective study of the cost and impact on the quality of life]. La Tunisie medicale 20110601
Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer research 20110601
Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review. Anticancer research 20110601
Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer. Journal of chemotherapy (Florence, Italy) 20110601
Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results. The Korean journal of hepatology 20110601
[Retroperitoneal extraskeletal Ewing's sarcoma difficult to differentiate from adrenocortical carcinoma : a case report]. Hinyokika kiyo. Acta urologica Japonica 20110601
Predictive value of in vitro adenosine triphosphate-based chemotherapy response assay in advanced gastric cancer patients who received oral 5-Fluorouracil after curative resection. Cancer research and treatment : official journal of Korean Cancer Association 20110601
A novel effective therapy for refractory angiosarcoma of the face and scalp. Clinical advances in hematology & oncology : H&O 20110601
Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes. Journal of breast cancer 20110601
Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy. Journal of breast cancer 20110601
Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein. Journal of the Korean Surgical Society 20110601
Emerging therapies in pancreas cancer. Journal of gastrointestinal oncology 20110601
Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part. British journal of cancer 20110524
[Advances of drug resistance marker of gemcitabine for non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110520
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood 20110519
AACR highlights: promise for treating pancreatic cancer. Journal of the National Cancer Institute 20110518
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. International journal of pharmaceutics 20110516
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England journal of medicine 20110512
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties. British journal of cancer 20110510
Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer. British journal of cancer 20110510
Recent advances and limitations of surgical treatment for pancreatic cancer. World journal of clinical oncology 20110510
Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma. World journal of gastroenterology 20110507
Acinar cell carcinoma of the pancreas associated with subcutaneous panniculitis. JOP : Journal of the pancreas 20110506
Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib. Journal of the National Cancer Institute 20110504
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer. Critical reviews in oncology/hematology 20110501
Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. International journal of radiation oncology, biology, physics 20110501
The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype. Cancer chemotherapy and pharmacology 20110501
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. Journal of cancer research and clinical oncology 20110501
New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer. Archives of gynecology and obstetrics 20110501
Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20110501
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma. Acta oncologica (Stockholm, Sweden) 20110501
Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs. Cancer science 20110501
Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis. Oncology reports 20110501
An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis. Biomaterials 20110501
Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells. International journal of oncology 20110501
Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens. International journal of urology : official journal of the Japanese Urological Association 20110501
Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research 20110501
MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research 20110501
Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis. American journal of kidney diseases : the official journal of the National Kidney Foundation 20110501
Nonsurgical therapy of biliary tract cancer. Current opinion in gastroenterology 20110501
Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine. Clinics and research in hepatology and gastroenterology 20110501
Are we making progress in curing advanced cervical cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501
Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer. Cancer investigation 20110501
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Annals of surgical oncology 20110501
Multicystic mesothelioma of the pericardium. Pathology international 20110501
Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia (New York, N.Y.) 20110501
An increasing role for trabectedin in gynecological cancers: efficacy in uterine sarcomas. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110501
Primary ovary transitional cell carcinoma after renal transplantation. Journal of the Chinese Medical Association : JCMA 20110501
Outcomes in unresectable and locally advanced resected cholangiocarcinoma. Expert review of anticancer therapy 20110501
[Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20110501
[A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20110501
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501
CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer. Epigenetics 20110501
Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. Health technology assessment (Winchester, England) 20110501
Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions. Anticancer research 20110501
Off-label use of oxaliplatin in patients with metastatic breast cancer. Anticancer research 20110501
Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501
Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors. Oncotarget 20110501
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110501
Combined treatment with anticancer vaccine using genetically modified endothelial cells and imatinib in bladder cancer. Korean journal of urology 20110501
[Postoperative adjuvant treatment for pancreatic cancer]. Nihon Geka Gakkai zasshi 20110501
[Therapeutic perspectives of cutaneous T-cell lymphoma]. Annales de dermatologie et de venereologie 20110501
[Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110501
[Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110501
Rare tumors in the pancreatic region. North American journal of medical sciences 20110501
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British journal of cancer 20110426
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110420
[Relations between RRM1 protein expression levels and effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer patients]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110420
Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. Langmuir : the ACS journal of surfaces and colloids 20110419
Eribulin mesylate (Halaven) for breast cancer. The Medical letter on drugs and therapeutics 20110418
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives. Free radical biology & medicine 20110415
Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway. Clinical cancer research : an official journal of the American Association for Cancer Research 20110415
Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder. Journal of the American Veterinary Medical Association 20110415
Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Nature chemical biology 20110413
Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. The Cochrane database of systematic reviews 20110413
The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. British journal of cancer 20110412
Peri-ampullary mixed acinar-endocrine carcinoma. Rare tumors 20110404
Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine. Investigational new drugs 20110401
Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. American journal of clinical oncology 20110401
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. American journal of clinical oncology 20110401
The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. Journal of cellular and molecular medicine 20110401
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer. Cancer chemotherapy and pharmacology 20110401
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology 20110401
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy. Cancer chemotherapy and pharmacology 20110401
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors. Cancer chemotherapy and pharmacology 20110401
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer. Cancer chemotherapy and pharmacology 20110401
A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas. Acta oncologica (Stockholm, Sweden) 20110401
Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma. Acta oncologica (Stockholm, Sweden) 20110401
Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies. Annals of oncology : official journal of the European Society for Medical Oncology 20110401
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG). Annals of oncology : official journal of the European Society for Medical Oncology 20110401
Perioperative intra-arterial and systemic chemotherapy for pancreatic cancer. Annals of surgical oncology 20110401
Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20110401
Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer. Annals of surgical oncology 20110401
Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway. European journal of nuclear medicine and molecular imaging 20110401
A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study. Gynecologic oncology 20110401
Treatment for metastatic nasopharyngeal carcinoma. European annals of otorhinolaryngology, head and neck diseases 20110401
Weekly paclitaxel combining with gemcitabine is an effective and safe treatment for advanced breast cancer patients. Japanese journal of clinical oncology 20110401
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy. European journal of cancer (Oxford, England : 1990) 20110401
Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression. Oncology reports 20110401
Uterine sarcomas--recent progress and future challenges. European journal of radiology 20110401
The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110401
Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma. Pancreas 20110401
Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor. Molecular cancer therapeutics 20110401
Effect of its deaminated metabolite, 2',2'-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells. Biochemical pharmacology 20110401
Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenase. Matrix biology : journal of the International Society for Matrix Biology 20110401
Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochemical and biophysical research communications 20110401
Development of second-generation VEGFR tyrosine kinase inhibitors: current status. Current oncology reports 20110401
Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening. Molecular cancer therapeutics 20110401
Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells. Clinical & experimental metastasis 20110401
Optimizing pemetrexed-gemcitabine combination in patients with advanced non-small cell lung cancer: a pharmacogenetic approach. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110401
[Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over]. Presse medicale (Paris, France : 1983) 20110401
Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. Journal of immunotherapy (Hagerstown, Md. : 1997) 20110401
A novel antiangiogenic approach for adjuvant therapy of pancreatic carcinoma. Langenbeck's archives of surgery 20110401
Management strategies in pancreatic cancer. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110401
Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer 20110401
Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110401
[Biliary diseases - new insights and developments]. Deutsche medizinische Wochenschrift (1946) 20110401
Advances in early diagnosis and therapy of pancreatic cancer. Hepatobiliary & pancreatic diseases international : HBPD INT 20110401
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nature medicine 20110401
Acute transverse myelopathy probably related to intravenous gemcitabine plus cisplatin. The Annals of pharmacotherapy 20110401
Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma. Expert review of anticancer therapy 20110401
Second-line therapy for small-cell lung cancer. Expert review of anticancer therapy 20110401
Kinetics of host cell recruitment during dissemination of diffuse malignant peritoneal mesothelioma. Cancer microenvironment : official journal of the International Cancer Microenvironment Society 20110401
Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells. Anticancer research 20110401
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer. Anticancer research 20110401
Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation. Anticancer research 20110401
Pharmacological manipulation of the cell cycle and metabolism to protect normal tissues against conventional anticancer drugs. Oncotarget 20110401
[Second line chemotherapy for pancreatic cancer]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell death & disease 20110401
Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells. Chinese medical journal 20110401
E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma. Chinese medical journal 20110401
Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational study. Indian journal of pharmacology 20110401
[Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110401
In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system. Journal of nanoscience and nanotechnology 20110401
Solid variant of serous cystadenoma of the pancreas. Archives of medical science : AMS 20110401
Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma. North American journal of medical sciences 20110401
Resectable pancreatic small cell carcinoma. Rare tumors 20110330
Lung carcinoma with hypertrophic osteoarthropathy in a teenager. Rare tumors 20110330
Expression of NRG1 and its receptors in human bladder cancer. British journal of cancer 20110329
Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R. British journal of cancer 20110329
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer. British journal of cancer 20110329
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science (New York, N.Y.) 20110325
[Randomize trial of cisplatin plus gemcitabine with either sorafenib or placebo as first-line therapy for non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110320
The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies. International journal of cancer 20110315
Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies. Cancer 20110315
Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310
Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers. World journal of clinical oncology 20110310
First-line treatment for advanced pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. JOP : Journal of the pancreas 20110309
Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. JOP : Journal of the pancreas 20110309
Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. JOP : Journal of the pancreas 20110309
Treatment for refractory pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. JOP : Journal of the pancreas 20110309
Novel agents in the management of pancreatic adenocarcinoma: phase I studies. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. JOP : Journal of the pancreas 20110309
Translational research in pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. JOP : Journal of the pancreas 20110309
Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. JOP : Journal of the pancreas 20110309
Overall survival of patients with advanced pancreatic cancer improved with an increase in second-line chemotherapy after gemcitabine-based therapy. JOP : Journal of the pancreas 20110309
Combinatorial pharmacologic effects of gemcitabine and its metabolite dFdU. ChemMedChem 20110307
High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy. Medical oncology (Northwood, London, England) 20110301
A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib. Medical oncology (Northwood, London, England) 20110301
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer chemotherapy and pharmacology 20110301
A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas. Cancer chemotherapy and pharmacology 20110301
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. Cancer chemotherapy and pharmacology 20110301
Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine. International journal of cancer 20110301
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents. Cancer chemotherapy and pharmacology 20110301
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines. Cancer chemotherapy and pharmacology 20110301
Pancreatic cancer cells resistant to chemoradiotherapy rich in 'stem-cell-like' tumor cells. Digestive diseases and sciences 20110301
Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110301
NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. Surgery 20110301
Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. International journal of cancer 20110301
Induction chemotherapy for unresectable urothelial carcinoma of the bladder. BJU international 20110301
Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Annals of surgical oncology 20110301
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110301
Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on. Journal of hepatology 20110301
Bayesian hierarchical changepoint methods in modeling the tumor growth profiles in xenograft experiments. Clinical cancer research : an official journal of the American Association for Cancer Research 20110301
Novel postoperative adjuvant strategy prevents early hepatic recurrence after resection of pancreatic cancer. Journal of hepato-biliary-pancreatic sciences 20110301
Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines. Biochemical pharmacology 20110301
Adenovirus-mediated Drosophila melanogaster deoxyribonucleoside kinase mutants combined with gemcitabine harbor a safe cancer treatment profile. International journal of oncology 20110301
Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd). Cancer science 20110301
Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells. Cellular & molecular biology letters 20110301
High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. International journal of oncology 20110301
Pulmonary cryptococcus infection after mono-chemotherapy with gemcitabine. Respiratory care 20110301
Arguments against toxic effects of chemotherapy on liver injury and regeneration in an experimental model of partial hepatectomy. Liver international : official journal of the International Association for the Study of the Liver 20110301
Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. British journal of clinical pharmacology 20110301
Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110301
Targeted therapies for metastatic esophagogastric cancer. Current treatment options in oncology 20110301
Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British journal of cancer 20110301
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. British journal of cancer 20110301
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. The Lancet. Oncology 20110301
Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association 20110301
How fast can pancreatic cancer grow? A case of pancreatic carcinoma developed within 5 months after a negative examination to the advanced stage with multiple liver and bone metastases. Pancreas 20110301
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172). Leukemia & lymphoma 20110301
Systematic review: quality of life after treatment for upper gastrointestinal cancer. Current opinion in supportive and palliative care 20110301
A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer. Drug safety 20110301
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C. Asia-Pacific journal of clinical oncology 20110301
CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells. Cancer research 20110301
Premature chromosome condensation induced by caffeine, 2-aminopurine, staurosporine and sodium metavanadate in S-phase arrested HeLa cells is associated with a decrease in Chk1 phosphorylation, formation of phospho-H2AX and minor cytoskeletal rearrangements. Histochemistry and cell biology 20110301
Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre. BJU international 20110301
Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre. BJU international 20110301
Histology-driven chemotherapy in soft tissue sarcomas. Current treatment options in oncology 20110301
RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum. Journal of Zhejiang University. Science. B 20110301
[Signet ring cell carcinoma of the ampulla of Vater]. Gastroenterologia y hepatologia 20110301
Connexin-26 is a key factor mediating gemcitabine bystander effect. Molecular cancer therapeutics 20110301
Recent advances in anti-angiogenic therapy of cancer. Oncotarget 20110301
[Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20110301
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 20110301
New drug therapies in peripheral T-cell lymphoma. Expert review of anticancer therapy 20110301
[Effect of inhibiting the expression of hSMG-1 on chemosensitivity of human non-small cell lung cancer H1299 cells]. Zhonghua yi xue za zhi 20110301
The effect of cytostatics and hyperthermia on RAJI human lymphoma cells. Experimental oncology 20110301
Personalizing therapy with targeted agents in non-small cell lung cancer. Oncotarget 20110301
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors. Clinical advances in hematology & oncology : H&O 20110301
Vascular co-option in lung cancer metastatic to the eye after treatment with bevacizumab. Journal of ophthalmic inflammation and infection 20110301
Does erlotinib restore chemosensitivity to chemotherapy in pancreatic cancer? A case series. Anticancer research 20110301
Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer. Cancer research and treatment : official journal of Korean Cancer Association 20110301
Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer. Cancer research and treatment : official journal of Korean Cancer Association 20110301
Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study. Clinical lung cancer 20110301
Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats. Die Pharmazie 20110301
[Relationship between the protein expression of ERCC1, BRCA, β-tubulin and K-ras and the efficacy and prognosis in advanced non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110301
[Chemotherapy for urological cancer : usefulness and feasibility of current protocols]. Hinyokika kiyo. Acta urologica Japonica 20110301
[The prognostic significance of human equilibrative nucleoside transporter1 (hENT1) expression in metastatic bladder cancer patients treated with gemcitabine-cisplatin based combination chemotherapy]. Hinyokika kiyo. Acta urologica Japonica 20110301
Brief commentary: largest randomized trial of biliary tract cancer treatment with cisplatin plus gemcitabine versus gemcitabine alone: an excellent opportunity to evaluate the prognostic value of tumor marker CA 19-9. Clinical colorectal cancer 20110301
Saudi Oncology Society clinical management guidelines for testicular germ cell tumors. Urology annals 20110301
Saudi Oncology Society clinical management guidelines for renal cell carcinoma. Urology annals 20110301
Saudi Oncology Society clinical management guidelines for urinary bladder cancer. Urology annals 20110301
Genetic and epigenetic alterations in pancreatic carcinogenesis. Current genomics 20110301
Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110301
Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. ACS nano 20110222
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110220
Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2. Biochemical and biophysical research communications 20110218
A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. Cancer 20110215
Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial. Cancer 20110215
Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma. British journal of cancer 20110215
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma. British journal of cancer 20110215
Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21. British journal of cancer 20110215
Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity. British journal of cancer 20110215
Effects of open-air temperature on air temperature inside biological safety cabinet. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110214
Integrating pharmacogenetics into gemcitabine dosing--time for a change? Nature reviews. Clinical oncology 20110208
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative study. Investigational new drugs 20110201
Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial. Investigational new drugs 20110201
Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan. American journal of clinical oncology 20110201
Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study. American journal of clinical oncology 20110201
Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301). American journal of clinical oncology 20110201
Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer. Cancer chemotherapy and pharmacology 20110201
In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects. Cancer chemotherapy and pharmacology 20110201
Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer. Journal of cancer research and clinical oncology 20110201
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer. Cancer chemotherapy and pharmacology 20110201
Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Bioscience reports 20110201
Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice. Cancer chemotherapy and pharmacology 20110201
A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone. Cancer chemotherapy and pharmacology 20110201
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma. American journal of clinical oncology 20110201
Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20110201
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]. Annals of oncology : official journal of the European Society for Medical Oncology 20110201
Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Annals of surgical oncology 20110201
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54). European journal of haematology 20110201
Acycloguanosyl 5'-thymidyltriphosphate, a thymidine analogue prodrug activated by telomerase, reduces pancreatic tumor growth in mice. Gastroenterology 20110201
A phase II study of outpatient biweekly gemcitabine-oxaliplatin in advanced biliary tract carcinomas. Japanese journal of clinical oncology 20110201
Characteristics of triple-negative breast cancer. Journal of cancer research and clinical oncology 20110201
Chemotherapy for thymic tumors: induction, consolidation, palliation. Thoracic surgery clinics 20110201
A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20110201
Cytotoxic effects of new trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolines and their interaction with antitumoral drugs gemcitabine and paclitaxel on cellular lines of human breast cancer. Chemico-biological interactions 20110201
Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer research 20110201
Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells. International journal of oncology 20110201
Targeted combined aerosol chemotherapy in dogs and radiologic toxicity grading. Journal of aerosol medicine and pulmonary drug delivery 20110201
How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system? Journal of molecular graphics & modelling 20110201
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer. Cancer science 20110201
Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment. Annals of oncology : official journal of the European Society for Medical Oncology 20110201
A phase III randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110201
Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells. Molecular cancer therapeutics 20110201
Antisense inhibition of survivin expression as a cancer therapeutic. Molecular cancer therapeutics 20110201
Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study. British journal of cancer 20110201
Microcystic/reticular schwannoma of the pancreas: a potential diagnostic pitfall. Pathology international 20110201
Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. Clinical cancer research : an official journal of the American Association for Cancer Research 20110201
Response to combined molecular targeting: defining the role of P-STAT3. Clinical cancer research : an official journal of the American Association for Cancer Research 20110201
Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities. Hepatology (Baltimore, Md.) 20110201
[Pharmacogenomic research for avoiding adverse reactions by anti-cancer drugs]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110201
Peritoneal fibrosis leading to small bowel obstruction two years after first-line intraperitoneal chemotherapy for optimally debulked ovarian cancer. The Australian & New Zealand journal of obstetrics & gynaecology 20110201
[AUO-study AB34/09: an open-label, randomised, multicentre, phase II study to evaluate the efficacy of chemotherapy with gemcitabine and cisplatin in combination with the EGF receptor antibody panitumumab (GemCisP) versus GemCis in the first-line therapy of locally advanced/metastatic urothelial carcinoma in patients with wild-type HRAS - PURO]. Der Urologe. Ausg. A 20110201
Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110201
First- and second-line therapy for metastatic urothelial carcinoma of the bladder. Current oncology (Toronto, Ont.) 20110201
Adjuvant therapy for pancreas adenocarcinoma: where are we going? Expert review of anticancer therapy 20110201
Relationship between single nucleotide polymorphisms in the deoxycytidine kinase gene and chemosensitivity of gemcitabine in six pancreatic cancer cell lines. Chinese medical journal 20110201
[A case of coexisting malignant mesothelioma and squamous cell carcinoma of the lung]. Gan to kagaku ryoho. Cancer & chemotherapy 20110201
[Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20110201
[A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1]. Gan to kagaku ryoho. Cancer & chemotherapy 20110201
[Contribution of microCT structural imaging to preclinical evaluation of hepatocellular carcinoma chemotherapeutics on orthotopic graft in ACI rats]. Bulletin du cancer 20110201
[A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer]. Hinyokika kiyo. Acta urologica Japonica 20110201
Words of Wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. European urology 20110201
Treatment of early-stage pancreatic cancer. Oncology (Williston Park, N.Y.) 20110201
Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20110201
Carboplatin and gemcitabine combination in metastatic triple-negative anthracycline- and taxane-pretreated breast cancer patients: a phase II study. Journal of chemotherapy (Florence, Italy) 20110201
EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer. Journal of biomedical nanotechnology 20110201
[Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine]. Yao xue xue bao = Acta pharmaceutica Sinica 20110201
Talactoferrin immunotherapy in metastatic renal cell carcinoma: a case series of four long-term survivors. Journal of clinical medicine research 20110201
Non-pancreatic cancer tumors in the pancreatic region. North American journal of medical sciences 20110201
High-throughput 3-D cell-based proliferation and cytotoxicity assays for drug screening and bioprocess development. Journal of biotechnology 20110120
Iniparib plus chemotherapy in metastatic triple-negative breast cancer. The New England journal of medicine 20110120
[A meta-analysis of pemetrexed plus platinum chemotherapy versus gemcitabine plus platinum chemotherapy for advanced non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110120
Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer. British journal of cancer 20110118
Single agent and combination studies of pralatrexate and molecular correlates of sensitivity. British journal of cancer 20110118
Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system. Biomacromolecules 20110110
A rare case of thyroid metastasis from pancreatic adenocarcinoma. JOP : Journal of the pancreas 20110105
Medical therapy for advanced pancreatic cancer: work in progress. JOP : Journal of the pancreas 20110105
Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Molecular therapy : the journal of the American Society of Gene Therapy 20110104
The role of FKBP5 in cancer aetiology and chemoresistance. British journal of cancer 20110104
Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urologic oncology 20110101
The effects of Gemcitabine and Vinorelbine on inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) distribution of MCF-7 breast cancer cells. Acta histochemica 20110101
Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients. Evidence-based complementary and alternative medicine : eCAM 20110101
Types of pancreatic cancer in EUS-FNA and chemotherapy. American journal of therapeutics 20110101
Successful use of biweekly gemcitabine plus nab-paclitaxel in two male patients with stage iv breast cancer: case reports and review of the literature. American journal of therapeutics 20110101
Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer. Cancer chemotherapy and pharmacology 20110101
Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase. Cancer chemotherapy and pharmacology 20110101
Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers. International journal of radiation oncology, biology, physics 20110101
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC). Current cancer drug targets 20110101
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Annals of oncology : official journal of the European Society for Medical Oncology 20110101
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval. Annals of oncology : official journal of the European Society for Medical Oncology 20110101
Structure-activity relationships and the cytotoxic effects of novel diterpenoid alkaloid derivatives against A549 human lung carcinoma cells. Journal of natural medicines 20110101
Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1. Biochemical pharmacology 20110101
The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20110101
Human SMG-1 is involved in gemcitabine-induced primary microRNA-155/BIC up-regulation in human pancreatic cancer PANC-1 cells. Pancreas 20110101
Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo. Anti-cancer drugs 20110101
Outcomes and tolerability of systemic chemotherapy for pancreatic or biliary cancer patients aged 75 years or older. Japanese journal of clinical oncology 20110101
Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. Cancer chemotherapy and pharmacology 20110101
Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Drug metabolism and disposition: the biological fate of chemicals 20110101
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. European journal of cancer (Oxford, England : 1990) 20110101
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. Cancer immunology, immunotherapy : CII 20110101
T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications. Advances in hematology 20110101
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients. Advances in hematology 20110101
Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer. Journal of biomedicine & biotechnology 20110101
Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. Journal of oncology 20110101
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer. European journal of cancer (Oxford, England : 1990) 20110101
Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: results of a phase 2 study. Cancer 20110101
Cancer stem cells in head and neck squamous cell carcinoma. Journal of oncology 20110101
Erlotinib resistance is altered after gemcitabine chemotherapy for recurrent non-small-cell lung cancer. Clinical drug investigation 20110101
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101
Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer. International journal of oncology 20110101
Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101
KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine. Chemotherapy 20110101
Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Molecular cancer therapeutics 20110101
Reviewing the safety of erlotinib in non-small cell lung cancer. Expert opinion on drug safety 20110101
Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101
Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer. Journal of immunotherapy (Hagerstown, Md. : 1997) 20110101
Current therapeutic approaches in metastatic and recurrent ewing sarcoma. Sarcoma 20110101
Interstitial lung disease under erlotinib plus gemcitabine for pancreatic carcinoma: a therapeutic dilemma. Pancreas 20110101
Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma. Bioorganic & medicinal chemistry 20110101
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent. Radiation research 20110101
Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer. AJR. American journal of roentgenology 20110101
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110101
Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101
Cancer stem cells: repair gone awry? Journal of oncology 20110101
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors. Journal of biomedicine & biotechnology 20110101
Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? Journal of biomedicine & biotechnology 20110101
Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis. BMC cancer 20110101
Gene Expression Profiling for In Silico Microdissection of Hodgkin's Lymphoma Microenvironment and Identification of Prognostic Features. Advances in hematology 20110101
Diagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification. Journal of biomedicine & biotechnology 20110101
Development of a serum biomarker assay that differentiates tumor-associated MUC5AC (NPC-1C ANTIGEN) from normal MUC5AC. Journal of biomedicine & biotechnology 20110101
Targeting angiogenesis in childhood sarcomas. Sarcoma 20110101
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures. BMC medical genomics 20110101
Epstein Barr Virus-positive large T-cell lymphoma presenting as acute appendicitis 17 years after cadaveric renal transplant: a case report. Journal of medical case reports 20110101
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer. BMC cancer 20110101
Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen. Ear, nose, & throat journal 20110101
Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells. Journal of Cancer 20110101
Smoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinoma. Journal of Cancer 20110101
The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis. Radiation oncology (London, England) 20110101
Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110101
Intracranial metastasis from primary transitional cell carcinoma of female urethra: case report & review of the literature. BMC cancer 20110101
Liposarcoma: molecular genetics and therapeutics. Sarcoma 20110101
Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib. Journal of hematology & oncology 20110101
Memantine effects on liver and adrenal gland of rats exposed to cold stress. International archives of medicine 20110101
Chemosensitization of tumors by resveratrol. Annals of the New York Academy of Sciences 20110101
Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine. PloS one 20110101
Pancreatic cancer: Gemcitabine confirmed as the first-line therapy for pancreatic cancer. Nature reviews. Gastroenterology & hepatology 20110101
[Muscle metastasis revealing bronchial adenocarcinoma]. Revue des maladies respiratoires 20110101
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program. Journal of translational medicine 20110101
Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. PloS one 20110101
The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells. PloS one 20110101
Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma. PloS one 20110101
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular cancer 20110101
IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA. mAbs 20110101
Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PloS one 20110101
The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PloS one 20110101
Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines. BMC medical genomics 20110101
Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies. Advances in hematology 20110101
Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma. Radiation oncology (London, England) 20110101
Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. International journal of biochemistry and molecular biology 20110101
Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110101
Mestastatic gastric cancer from malignant fibrous histiocytoma. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110101
Sunitinib malate synergistically potentiates anti-tumor effect of gemcitabine in human bladder cancer cells. Korean journal of urology 20110101
Orbital metastases as the first manifestation of lung adenocarcinoma. Case reports in ophthalmology 20110101
RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PloS one 20110101
Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer. Radiation oncology (London, England) 20110101
GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets. PloS one 20110101
Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer. BMC cancer 20110101
[PARP inhibitors for cancer therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20110101
[Effectiveness of adjuvant chemotherapy using gemcitabine for resected pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20110101
[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20110101
Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer. Radiation oncology (London, England) 20110101
Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. Archives of medical research 20110101
The HDAC inhibitor FK228 enhances adenoviral transgene expression by a transduction-independent mechanism but does not increase adenovirus replication. PloS one 20110101
Bevacizumab in the treatment of ovarian cancer. Biologics : targets & therapy 20110101
Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer. BMC cancer 20110101
Vaccines targeting the neovasculature of tumors. Vascular cell 20110101
MicroRNA Expression in Selected Carcinomas of the Gastrointestinal Tract. Pathology research international 20110101
Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011). Trials 20110101
From antiangiogenesis to hypoxia: current research and future directions. Cancer management and research 20110101
Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PloS one 20110101
Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PloS one 20110101
CXCL12 expression by healthy and malignant ovarian epithelial cells. BMC cancer 20110101
Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20110101
Conceptual aspects of large meta-analyses with publicly available microarray data: a case study in oncology. Bioinformatics and biology insights 20110101
Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. International journal of nanomedicine 20110101
Potent anti-tumor effect generated by a novel human papillomavirus (HPV) antagonist peptide reactivating the pRb/E2F pathway. PloS one 20110101
Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PloS one 20110101
Common secondary causes of resistant hypertension and rational for treatment. International journal of hypertension 20110101
Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation. PloS one 20110101
High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area. Journal of translational medicine 20110101
Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Molecular cancer 20110101
Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Korean journal of radiology 20110101
Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development. Journal of pharmacy & bioallied sciences 20110101
Transfer kinetics from colloidal drug carriers and liposomes to biomembrane models: DSC studies. Journal of pharmacy & bioallied sciences 20110101
AIDS-Related EBV-Associated Smooth Muscle Tumors: A Review of 64 Published Cases. Pathology research international 20110101
Therapeutics formulated to target cancer stem cells: Is it in our future? Cancer cell international 20110101
A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma. Journal of hematology & oncology 20110101
Replicase-based plasmid DNA shows anti-tumor activity. BMC cancer 20110101
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer. Drug design, development and therapy 20110101
Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial. Chemotherapy 20110101
[Nephropathy following administration of angiogenesis inhibitors]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101
Combined treatment of uveal melanoma liver metastases. European journal of medical research 20110101
HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts. PloS one 20110101
Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB. Molecular medicine reports 20110101
Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC gastroenterology 20110101
Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome. Case reports in oncology 20110101
An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development. Journal of Cancer 20110101
A retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies found in literature. Journal of Cancer 20110101
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine. BMC cancer 20110101
In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice. Journal of Cancer 20110101
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study. Journal of experimental & clinical cancer research : CR 20110101
NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells. PloS one 20110101
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis. BMC cancer 20110101
Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma. Journal of veterinary internal medicine 20110101
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Molecular cancer 20110101
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. BMC cancer 20110101
[F]fluoro-2-deoxy-d-glucose incorporation by mcf-7 breast tumour cells in vitro is modulated by treatment with tamoxifen, Doxorubicin, and docetaxel: relationship to chemotherapy-induced changes in ATP content, hexokinase activity, and glucose transport. International journal of molecular imaging 20110101
Apoptotic sphingolipid ceramide in cancer therapy. Journal of lipids 20110101
C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing. Journal of lipids 20110101
Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PloS one 20110101
Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines. Journal of experimental & clinical cancer research : CR 20110101
Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes. Radiation oncology (London, England) 20110101
In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer. International journal of nanomedicine 20110101
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride. Clinical Medicine Insights. Oncology 20110101
Trabectedin: safety and efficacy in the treatment of advanced sarcoma. Clinical Medicine Insights. Oncology 20110101
Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia. Molecular cancer 20110101
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP. Journal of hematology & oncology 20110101
Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer. Hepato-gastroenterology 20110101
Molecular characteristics of pancreatic ductal adenocarcinoma. Pathology research international 20110101
Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients. Neoplasma 20110101
Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancer. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20110101
Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report. Case reports in oncology 20110101
Facial nerve palsy: an unusual presenting feature of small cell lung cancer. Case reports in oncology 20110101
Novel serum proteomic signatures in a non-human primate model of retinal injury. Molecular vision 20110101
WEE1 inhibition sensitizes osteosarcoma to radiotherapy. BMC cancer 20110101
Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment. Case reports in oncology 20110101
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis. International journal of molecular sciences 20110101
MicroRNA gene dosage alterations and drug response in lung cancer. Journal of biomedicine & biotechnology 20110101
Target therapies in lung cancer. Journal of biomedicine & biotechnology 20110101
Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial. Journal of biomedicine & biotechnology 20110101
Toxicity profile and adherence to the pharmacotherapeutic regimen of gemcitabine-carboplatin in non-small cell lung cancer. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101
Off-label use of anti-cancer drugs in India: to be or not to be! Journal of cancer research and therapeutics 20110101
Integrin targeted therapeutics. Theranostics 20110101
Maintenance therapy in NSCLC: why? To whom? Which agent? Journal of experimental & clinical cancer research : CR 20110101
Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets. OncoTargets and therapy 20110101
Diagnosis of metastatic breast cancer to an intraabdominal lymph node by endoscopic ultrasound. Case reports in gastroenterology 20110101
Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model. Sarcoma 20110101
Primary pericardial sarcoma: a case report and a brief review. Cardiology research and practice 20110101
Safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-Cisplatin in patients with advanced cancer. Journal of oncology 20110101
UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cells. PloS one 20110101
Design paper: a phase II study of bevacizumab and erlotinib in patients with non-squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous treatment (BEST). Trials 20110101
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. Journal of experimental & clinical cancer research : CR 20110101
Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PloS one 20110101
[Concurrent versus sequential systemic chemotherapy and whole brain radiation therapy for brain matastases in non-small-cell lung cancer patients]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110101
Massive upper gastrointestinal bleeding secondary to duodenal metastasis of transitional cell carcinoma of the urinary bladder. Case reports in gastroenterology 20110101
Concordance of self-reported and medical chart information on cancer diagnosis and treatment. BMC medical research methodology 20110101
Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial. Trials 20110101
Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer. Chemotherapy 20110101
Systemic therapy for elderly patients with gastrointestinal cancer. Clinical Medicine Insights. Oncology 20110101
Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer. Breast cancer : basic and clinical research 20110101
Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression. BMC cancer 20110101
Clusterin confers gemcitabine resistance in pancreatic cancer. World journal of surgical oncology 20110101
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. Journal of translational medicine 20110101
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report. Journal of medical case reports 20110101
Successful treatment with GEMOX in patient with metastatic pancreatic adenosquamous carcinoma. Tumori 20110101
Interleukin-11-induced capillary leak syndrome in primary hepatic carcinoma patients with thrombocytopenia. BMC cancer 20110101
Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein. Molecular cancer 20110101
Interpreting clinical assays for histone deacetylase inhibitors. Cancer management and research 20110101
Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. Asian Pacific journal of cancer prevention : APJCP 20110101
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. BMC cancer 20110101
Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PloS one 20110101
The role of proteasome inhibition in nonsmall cell lung cancer. Journal of biomedicine & biotechnology 20110101
Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines. Swiss medical weekly 20110101
Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells. PloS one 20110101
Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma. BMC cancer 20110101
Transport processes of radiopharmaceuticals and -modulators. Radiation oncology (London, England) 20110101
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC cancer 20110101
Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery: A Case Report and Review of the Literature. Sarcoma 20110101
Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells. PloS one 20110101
Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. PloS one 20110101
Gefitinib in non small cell lung cancer. Journal of biomedicine & biotechnology 20110101
Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer. Hepato-gastroenterology 20110101
Surgical therapy of exocrine pancreatic carcinoma--results at an academic teaching hospital and evaluation of prognostic factors. Hepato-gastroenterology 20110101
GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer. Hepato-gastroenterology 20110101
Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC gastroenterology 20110101
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer. BMC cancer 20110101
Cancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine. International journal of molecular sciences 20110101
Changes of constituents and activity to apoptosis and cell cycle during fermentation of tea. International journal of molecular sciences 20110101
Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. PloS one 20110101
PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib. BMC cancer 20110101
Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancer. Oncology 20110101
Intensity modulated radiotherapy for elderly bladder cancer patients. Radiation oncology (London, England) 20110101
The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future. Advances in hematology 20110101
Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy. Journal of translational medicine 20110101
Solitary Internal Mammary Lymph Node Metastases Detected by F-FDG-PET/CT in Ovarian Cancer. Case reports in oncology 20110101
Thrombotic thrombocytopenic purpura and gemcitabine. Case reports in oncology 20110101
An update on TroVax for the treatment of progressive castration-resistant prostate cancer. OncoTargets and therapy 20110101
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC. OncoTargets and therapy 20110101
Predicting selective drug targets in cancer through metabolic networks. Molecular systems biology 20110101
Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancer. Clinical Medicine Insights. Oncology 20110101
Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer. Clinical Medicine Insights. Oncology 20110101
Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer. Clinical Medicine Insights. Oncology 20110101
A case of late-onset gemcitabine lung toxicity. Clinical Medicine Insights. Oncology 20110101
Henoch Schönlein purpura associated with pulmonary adenocarcinoma. Journal of medical case reports 20110101
M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PloS one 20110101
Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells. PloS one 20110101
Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model. BMC medical imaging 20110101
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast cancer research : BCR 20110101
A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer. Oncology 20110101
Early-onset postirradiation sarcoma of the tongue after pseudotumor phase. ORL; journal for oto-rhino-laryngology and its related specialties 20110101
Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers. BMC cancer 20110101
Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC cancer 20110101
Successful management of metastatic urothelial carcinoma with gemcitabine and Paclitaxel chemotherapy in a hemodialysis patient. Urologia internationalis 20110101
Sustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix. Nanoscale research letters 20110101
Synchronous carcinoma of the ampulla of vater and colon cancer. Case reports in gastroenterology 20110101
Promising molecular targeted therapies in breast cancer. Indian journal of pharmacology 20110101
Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma. Oncology 20110101
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PloS one 20110101
Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides. Arthritis research & therapy 20110101
Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells. Molecular cancer 20110101
Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. BMC cancer 20110101
Shorter course of trastuzumab: Caveat emptor. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101
Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. Oncology 20110101
Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies. Cancer management and research 20110101
Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PloS one 20110101
Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PloS one 20110101
Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis. PloS one 20110101
Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene. Case reports in dermatology 20110101
Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance. Neoplasma 20110101
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer. BMC cancer 20110101
Hepatic actinomycosis mimicking an isolated tumor recurrence. World journal of surgical oncology 20110101
Primitive neuroectodermal tumor/Ewing's sarcoma in adult uro-oncology: A case series from a developing country. Urology annals 20110101
Proteomic analysis identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer. International journal of molecular sciences 20110101
Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications. International journal of molecular sciences 20110101
Oncolytic bluetongue viruses: promise, progress, and perspectives. Frontiers in microbiology 20110101
Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway. PloS one 20110101
Metastatic collecting duct carcinoma of the kidney treated with sunitinib. World journal of surgical oncology 20110101
Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma. BMC cancer 20110101
Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC cancer 20110101
Cancer cachexia: mechanisms and clinical implications. Gastroenterology research and practice 20110101
Urothelial bladder cancer with cavitary lung metastases. Canadian respiratory journal 20110101
Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Case reports in gastroenterology 20110101
Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells. BMC pharmacology 20110101
Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. Journal of oncology 20110101
Molecular Imaging and Pharmacokinetic Analysis of Carbon-11 Labeled Antisense Oligonucleotide LY2181308 in Cancer Patients. Theranostics 20110101
The use of radioactive marker as a tool to evaluate the drug release in plasma and particle biodistribution of block copolymer nanoparticles. Journal of drug delivery 20110101
Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. Journal of molecular signaling 20110101
Teratoma with malignant transformation: a case report with pathological, cytogenetic, and immunohistochemistry analysis. Sarcoma 20110101
A 26-year-old male with mesothelioma due to asbestos exposure. Case reports in medicine 20110101
A conjugate of gemcitabine with bisphosphonate (Gem/BP) shows potential as a targeted bone-specific therapeutic agent in an animal model of human breast cancer bone metastases. Oncology research 20110101
Anti-cancer natural products isolated from chinese medicinal herbs. Chinese medicine 20110101
5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma. Oncology 20110101
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast cancer research : BCR 20110101
Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer. Tumori 20110101
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study. BMC cancer 20110101
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies. Head & neck oncology 20110101
Current therapeutic strategies for invasive and metastatic bladder cancer. OncoTargets and therapy 20110101
Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval. OncoTargets and therapy 20110101
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer. Cancer management and research 20110101
Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients. Radiation oncology (London, England) 20110101
A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression. Molecular cancer 20110101
Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients. PloS one 20110101
Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature. BMC cancer 20110101
Methodological reporting of randomized controlled trials in major hepato-gastroenterology journals in 2008 and 1998: a comparative study. BMC medical research methodology 20110101
Metals and breast cancer: risk factors or healing agents? Journal of toxicology 20110101
[Role of gemcitabine in treatment of metastatic breast cancer]. Voprosy onkologii 20110101
[Investigation of gemcitabine plus lomustine treatment in mice with transplantable lymphosarcoma LIO-1]. Voprosy onkologii 20110101
A functional proteomic method for biomarker discovery. PloS one 20110101
EphB6 receptor modulates micro RNA profile of breast carcinoma cells. PloS one 20110101
Suprapubic transvesical single-port technique for control of lower end of ureter during laparoscopic nephroureterectomy for upper tract transitional cell carcinoma. Indian journal of urology : IJU : journal of the Urological Society of India 20110101
Intravesical therapy for urothelial carcinoma of the bladder. Indian journal of urology : IJU : journal of the Urological Society of India 20110101
Role of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder. Indian journal of urology : IJU : journal of the Urological Society of India 20110101
Drug therapy for hereditary cancers. Hereditary cancer in clinical practice 20110101
Pure seminoma: a review and update. Radiation oncology (London, England) 20110101
Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells. PloS one 20110101
Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. Radiation oncology (London, England) 20110101
Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis. PloS one 20110101
Prognostic significance of erythropoietin in pancreatic adenocarcinoma. PloS one 20110101
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). BMC cancer 20110101
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer. Journal of translational medicine 20110101
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer. Clinical Medicine Insights. Oncology 20110101
Current and emerging pharmacotherapies for the treatment of relapsed small cell lung cancer. Clinical Medicine Insights. Oncology 20110101
The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1. Molecular cancer 20110101
Current neoadjuvant treatment options for HER2-positive breast cancer. Biologics : targets & therapy 20110101
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01). BMC cancer 20110101
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt. Journal of Cancer 20110101
Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy. Radiation oncology (London, England) 20110101
Tumor-initiating cells are enriched in CD44(hi) population in murine salivary gland tumor. PloS one 20110101
Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PloS one 20110101
Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PloS one 20110101
Regulation of apoptotic effects by erythrocarpine E, a cytotoxic limonoid from Chisocheton erythrocarpus in HSC-4 human oral cancer cells. PloS one 20110101
Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. PloS one 20110101
Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese medicine 20110101
Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients. Digestion 20110101
Management options in triple-negative breast cancer. Breast cancer : basic and clinical research 20110101
Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit? BMC cancer 20110101
Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90. Molecular cancer 20110101
Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PloS one 20110101
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Molecular cancer 20110101
Cutaneous metastasis as the initial manifestation of lung adenocarcinoma. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20110101
Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer? Breast cancer research : BCR 20110101
Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer. PloS one 20110101
Desmoplastic malignant mesothelioma of the pericardium: Description of a case and review of the literature. Lung India : official organ of Indian Chest Society 20110101
Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions. PloS one 20110101
Fermented wheat germ extract--nutritional supplement or anticancer drug? Nutrition journal 20110101
KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy. Oncology 20110101
Dermal fibrosis related to combination chemotherapy with carboplatin and gemcitabine. European journal of dermatology : EJD 20110101
Assessment of anti-cytogenotoxic effects of quercetin in animals treated with topotecan. Oxidative medicine and cellular longevity 20110101
The stability of a model substrate for topoisomerase 1-mediated DNA religation depends on the presence of mismatched base pairs. Journal of nucleic acids 20110101
Prostatic adenocarcinoma metastatic to pleomorphic liposarcoma, a 'collision phenomenon': report of a case with review of pelvic collision tumors. Pathology research international 20110101
Chemotherapy in advanced bladder cancer: current status and future. Journal of hematology & oncology 20110101
The impact of surgical outcome after pancreaticoduodenectomy in elderly patients. World journal of surgical oncology 20110101
Randomized phase II study of two schedules of carboplatin and gemcitabine for stage IIIB and IV advanced non-small cell lung cancer (JACCRO LC-01 study). Chemotherapy 20110101
CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer. International journal of molecular imaging 20110101
Sarcomatoid peritoneal malignant mesothelioma. Internal medicine (Tokyo, Japan) 20110101
Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma. Oncology 20110101
Current immunotherapeutic approaches in pancreatic cancer. Clinical & developmental immunology 20110101
Stenting of the superior vena cava and left brachiocephalic vein with preserving the central venous catheter in situ. Korean journal of radiology 20110101
An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma. Journal of translational medicine 20110101
Palliative enteric bypass for malignant gastric outflow obstruction after pancreaticoduodenectomy in early recurrent pancreatic cancer. Hepato-gastroenterology 20110101
Ribonucleotide reductase M1 expression in intrahepatic cholangiocarcinoma. Hepato-gastroenterology 20110101
Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients. Hepato-gastroenterology 20110101
Cancer patient-centered home care: a new model for health care in oncology. Therapeutics and clinical risk management 20110101
Long-time survival of a patient with metastatic pancreatic cancer: a case report. Case reports in oncology 20110101
Carcinomatous meningitis: the natural history of successfully treated metastatic bladder cancer. Case reports in oncology 20110101
Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV). Case reports in oncology 20110101
Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival. Radiation oncology (London, England) 20110101
Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report. Journal of medical case reports 20110101
Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia. OncoTargets and therapy 20110101
[Peculiarities of urinary bladder cancer tumor cells apoptosis response on neoadjuvant chemotherapy]. TSitologiia i genetika 20110101
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiation oncology (London, England) 20110101
The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer. Advances in surgery 20110101
Non-small cell lung carcinoma in an adolescent manifested by acute paraplegia due to spinal metastases: a case report. Journal of medical case reports 20110101
HuR's role in gemcitabine efficacy: an exception or opportunity? Wiley interdisciplinary reviews. RNA 20110101
Squamous cell carcinoma of the hilar bile duct. Case reports in gastroenterology 20110101
A very rapid visual recovery of posterior reversible encephalopathy syndrome. Journal of clinical imaging science 20110101
Platinum resistance in breast and ovarian cancer cell lines. Journal of experimental & clinical cancer research : CR 20110101
Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder. Urology annals 20110101
Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients. Cancer genomics & proteomics 20110101
Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system. International journal of nanomedicine 20110101
Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PloS one 20110101
Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway. PloS one 20110101
The eminent need for an academic program in universities to teach nanomedicine. International journal of nanomedicine 20110101
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. Journal of translational medicine 20110101
STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice. PloS one 20110101
Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines. BMC cancer 20110101
Targeted therapy in hepatocellular carcinoma. International journal of hepatology 20110101
The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale research letters 20110101
Clinical application of CT-guided (125)I seed interstitial implantation for local recurrent rectal carcinoma. Radiation oncology (London, England) 20110101
Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management. Obstetrics and gynecology international 20110101
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study. Journal of translational medicine 20110101
Looking to the future: biomarkers in the management of pancreatic adenocarcinoma. International journal of molecular sciences 20110101
Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3. PloS one 20110101
A case of signet ring cell adenocarcinoma of the bladder with spontaneous urinary extravasation. Indian journal of urology : IJU : journal of the Urological Society of India 20110101
Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer. PloS one 20110101
Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations. PloS one 20110101
Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells. PloS one 20110101
Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma. European journal of medical research 20110101
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials. Oncology 20110101
Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer. Journal of cardiothoracic surgery 20110101
Sunitinib induced pyoderma gangrenosum-like ulcerations. European journal of medical research 20110101
Primary malignant fibrous histiocytoma: a rare case. Case reports in medicine 20110101
Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines. PloS one 20110101
Oncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosing. PloS one 20110101
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1. BMC cancer 20110101
Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer. Radiation oncology (London, England) 20110101
Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies. Radiation oncology (London, England) 20110101
The relationship between treatment time of gemcitabine and development of hematologic toxicity in cancer patients. Biological & pharmaceutical bulletin 20110101
Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells. BMC cancer 20110101
Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy. Bone marrow research 20110101
Translesion DNA synthesis in the context of cancer research. Cancer cell international 20110101
DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance. PloS one 20110101
Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. PloS one 20110101
Mitochondrial peroxiredoxin III is a potential target for cancer therapy. International journal of molecular sciences 20110101
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. BMC gastroenterology 20110101
Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence. BMC cancer 20110101
Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation. Molecular cancer 20110101
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. Journal of experimental & clinical cancer research : CR 20110101
Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma. Therapeutics and clinical risk management 20110101
Re: gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial. The Journal of urology 20110101
Clinical characteristics and treatment outcomes in 132 patients with malignant mesothelioma. Lung India : official organ of Indian Chest Society 20110101
In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein. Breast cancer : basic and clinical research 20110101
Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model. Clinical Medicine Insights. Oncology 20110101
Proteomics in pancreatic cancer research. International journal of proteomics 20110101
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. ISRN hematology 20110101
Metastatic bladder cancer: a review of current management. ISRN urology 20110101
Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Head & neck oncology 20110101
Paraneoplastic syndrome mimicking adult-onset Still's disease caused by advanced lung cancer: a case report. BMC cancer 20110101
Can gemcitabine instillation ablate solitary low-risk non-muscle-invasive bladder cancer? Results of a phase II marker lesion study. Urologia internationalis 20110101
Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a case. Hepato-gastroenterology 20110101
Small bowel adenocarcinoma presenting with refractory iron deficiency anemia - case report and review of literature. Case reports in oncology 20110101
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PloS one 20110101
Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PloS one 20110101
Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro. Cancer cell international 20110101
Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective. ISRN oncology 20110101
Novel strategy with gemcitabine for advanced pancreatic cancer. ISRN oncology 20110101
A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study. Oncology 20110101
Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy. PloS one 20110101
Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer. PloS one 20110101
Spatial and temporal genetic heterogeneity of epidermal growth factor receptor gene status in a patient with non-small cell lung cancer: a case report. Journal of medical case reports 20110101
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. Clinical & developmental immunology 20110101
Long circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: a new theranostic avenue for leukemia therapy. PloS one 20110101
S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer. PloS one 20110101
Review of small cell carcinomas of the prostate. Prostate cancer 20110101
Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles. International journal of nanomedicine 20110101
Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease? Case reports in oncology 20110101
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review. PloS one 20110101
Silencing of X-linked inhibitor of apoptosis decreases resistance to cisplatin and paclitaxel but not gemcitabine in non-small cell lung cancer. The Journal of international medical research 20110101
Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer. Oncology 20110101
Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma. World journal of surgical oncology 20110101
Update on chemotherapy in the treatment of urothelial carcinoma. TheScientificWorldJournal 20110101
Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. Marine drugs 20110101
Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function. PloS one 20110101
A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients. Journal of experimental & clinical cancer research : CR 20110101
Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids. PloS one 20110101
Nephrotoxicity of anticancer drugs--an underestimated problem? Acta clinica Belgica 20110101
Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials. BMC medical research methodology 20110101
A case of thyroid metastasis of nasopharyngeal cancer. Tumori 20110101
A new era of cancer treatment: carbon nanotubes as drug delivery tools. International journal of nanomedicine 20110101
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer. OncoTargets and therapy 20110101
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. PloS one 20110101
Extensive tumor thrombus in a case of carcinoma lung detected by F18-FDG-PET/CT. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India 20110101
Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer. World journal of surgical oncology 20110101
Paclitaxel-based chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy failure: a case series of 5 patients. Case reports in oncology 20110101
Radiotherapy and 'new' drugs-new side effects? Radiation oncology (London, England) 20110101
Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families. Journal of carcinogenesis 20110101
The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma. Clinical & developmental immunology 20110101
From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors. Clinical & developmental immunology 20110101
The immune response to tumors as a tool toward immunotherapy. Clinical & developmental immunology 20110101
Brain metastases from ovarian carcinoma. ISRN oncology 20110101
[Results of chemotherapy for gynecologic cancer patients in ambulatory care]. Voprosy onkologii 20110101
Skull base metastases from a malignant solitary fibrous tumor of the liver. A case report and literature review. Diagnostic pathology 20110101
FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells. PloS one 20110101
Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil. PloS one 20110101
A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance. PloS one 20110101
A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival. BMC research notes 20110101
Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment. Thoracic surgical science 20110101
Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin. PloS one 20110101
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research. Journal of experimental & clinical cancer research : CR 20110101
Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PloS one 20110101
Targeted therapies development in the treatment of advanced nonsmall cell lung cancer. Journal of biomedicine & biotechnology 20110101
Napsin a and thyroid transcription factor-1-positive cerebellar tumor with epidermal growth factor receptor mutation. Case reports in oncology 20110101
Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study. International journal of immunopathology and pharmacology 20110101
Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study). Hepato-gastroenterology 20110101
Monoclonal antibodies in gynecological cancer: a critical point of view. Clinical & developmental immunology 20110101
New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond. Therapeutics and clinical risk management 20110101
Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer. OncoTargets and therapy 20110101
Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells. Chemotherapy 20110101
[Five year-results of chemoresistance testing in cancer patients]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101
Predicting antitumor activity of peptides by consensus of regression models trained on a small data sample. International journal of molecular sciences 20110101
Pilot study: alteration of deleted in liver cancer1 and phosphorylated focal adhesion kinase Y397 cytoplasmic expression and the prognostic value in advanced epithelial ovarian carcinoma. International journal of molecular sciences 20110101
New drug therapies, dedicated specialists and desperately-ill patients-but who will fly the flag for service developments in lung cancer as NHS budgets come under pressure? Ecancermedicalscience 20110101
The state of research into children with cancer across Europe: new policies for a new decade. Ecancermedicalscience 20110101
Tips and tricks in triple-negative breast cancer: how to manage patients in real-life practice? Ecancermedicalscience 20110101
Muscle metastases from gallbladder cancer. Ecancermedicalscience 20110101
Atypical presentation of a hormonally active adrenocortical tumor in an adolescent leading to delayed diagnosis. Hormones (Athens, Greece) 20110101
An update on the management of peripheral T-cell lymphoma and emerging treatment options. Journal of blood medicine 20110101
Gemcitabine adsorbed onto carbon particles increases drug concentrations at the injection site and in the regional lymph nodes in an animal experiment and a clinical study. The Journal of international medical research 20110101
Lipoplatin treatment in lung and breast cancer. Chemotherapy research and practice 20110101
A comparison of association methods for cytotoxicity mapping in pharmacogenomics. Frontiers in genetics 20110101
Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data. International journal of surgical oncology 20110101
The current role of lymph node dissection in the management of renal cell carcinoma. International journal of surgical oncology 20110101
Treatment of pancreatic and periampullary cancers at a community hospital: successful application of tertiary care treatment standards. International journal of surgical oncology 20110101
Triple-negative breast cancer: adjuvant therapeutic options. Chemotherapy research and practice 20110101
Neurotoxicity caused by the treatment with platinum analogues. Chemotherapy research and practice 20110101
Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. Asian Pacific journal of cancer prevention : APJCP 20110101
Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101
Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy. Scientific reports 20110101
Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer: experience at Sindh Institute of Urology & Transplantation (SIUT). JPMA. The Journal of the Pakistan Medical Association 20110101
Involvement of bone in epithelial ovarian cancer: case report of an uncommon late metastatic event. Case reports in oncology 20110101
[Synergism of antitumor activity of gemcitabine and dioxadet in mice with ascitic Ehrlich's tumor]. Voprosy onkologii 20110101
HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer. Asian Pacific journal of cancer prevention : APJCP 20110101
Pancreatic cancer: chemotherapy and radiotherapy. North American journal of medical sciences 20110101
Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101
Bilateral angiosarcoma of breast in a young lady. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101
Chronic inflammation in cancer development. Frontiers in immunology 20110101
A case report of urinary bladder carcinosarcoma and review of the literature. Case reports in urology 20110101
Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer. Frontiers in oncology 20110101
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer. Frontiers in oncology 20110101
Targeting apoptosis signaling pathways for anticancer therapy. Frontiers in oncology 20110101
Protease addiction and synthetic lethality in cancer. Frontiers in oncology 20110101
Adjuvant chemotherapy for early stage non-small cell lung cancer. Frontiers in oncology 20110101
Ribonucleotide reductase inhibitors: a new look at an old target for radiosensitization. Frontiers in oncology 20110101
Investigational approaches for mesothelioma. Frontiers in oncology 20110101
BOOP as a rare complication of gemcitabine therapy. BMJ case reports 20110101
Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling. Experimental and therapeutic medicine 20110101
A case of pancreatic acinar cell carcinoma metastatic to skin. Rare tumors 20101231
Solitary fibrous tumor. Rare tumors 20101231
[Clinical efficacy and adverse effects of taxol plus carboplatin or gemcitabine plus carboplatin in patients with advanced non-small-cell lung carcinoma]. Zhonghua yi xue za zhi 20101221
Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release. Angewandte Chemie (International ed. in English) 20101217
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3. Cancer 20101215
Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase. Cell cycle (Georgetown, Tex.) 20101215
Pancreatic cancer: will incremental advances begin to make a difference? Journal of the National Cancer Institute 20101215
Explaining marginal benefits to patients, when 'marginal' means additional but not necessarily small. Clinical cancer research : an official journal of the American Association for Cancer Research 20101215
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma. Cancer letters 20101208
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. British journal of cancer 20101207
ERCC1 Expression Analysis to Guide Therapy in Non-Small Cell Lung Cancer. PLoS currents 20101206
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1. Oncogene 20101202
Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes. Investigational new drugs 20101201
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Investigational new drugs 20101201
The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater. Medical oncology (Northwood, London, England) 20101201
Pharmacogenetics and pharmacoepigenetics of gemcitabine. Medical oncology (Northwood, London, England) 20101201
Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Medical oncology (Northwood, London, England) 20101201
A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20101201
Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20101201
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study). Lung cancer (Amsterdam, Netherlands) 20101201
Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patients. BJU international 20101201
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Annals of oncology : official journal of the European Society for Medical Oncology 20101201
High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients. Cancer investigation 20101201
Autophagy and tumorigenesis. Seminars in immunopathology 20101201
Pharmacokinetic study to optimize the intravesical administration of gemcitabine. BJU international 20101201
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochimica et biophysica acta 20101201
Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed. Japanese journal of clinical oncology 20101201
CD40-targeted recombinant adenovirus significantly enhances the efficacy of antitumor vaccines based on dendritic cells and B cells. Human gene therapy 20101201
Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805). Japanese journal of clinical oncology 20101201
Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites. Japanese journal of clinical oncology 20101201
Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study. Japanese journal of clinical oncology 20101201
Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20101201
Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial. International journal of clinical oncology 20101201
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharmaceutical research 20101201
Chemoresistance testing of human ovarian cancer cells and its in vitro model. Toxicology in vitro : an international journal published in association with BIBRA 20101201
Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecologic oncology 20101201
[Digital necrosis related to gemcitabine]. Presse medicale (Paris, France : 1983) 20101201
Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials 20101201
Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells. The Journal of pharmacology and experimental therapeutics 20101201
Simultaneous quantification of ten cytotoxic drugs by a validated LC-ESI-MS/MS method. Analytical and bioanalytical chemistry 20101201
CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer biology & therapy 20101201
Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. Clinical and experimental immunology 20101201
Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101201
Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma. Pediatric blood & cancer 20101201
E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents. International journal of oncology 20101201
Evaluation of the effectiveness of a chemoprevention model of pancreatic adenocarcinoma using protein chip technology. International journal of oncology 20101201
Parameters for individualizing systemic therapy in non-small cell lung cancer. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20101201
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study. The Lancet. Oncology 20101201
[Chemotherapy in gallbladder carcinoma]. Presse medicale (Paris, France : 1983) 20101201
Myelinoid bodies in a patient with membranoproliferative glomerulonephritis. Pathology 20101201
A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment. Asia-Pacific journal of clinical oncology 20101201
Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo. Expert opinion on drug delivery 20101201
Histone deacetylase inhibitors in Hodgkin lymphoma. Investigational new drugs 20101201
[Case of intrahepatic cholangiocarcinoma drained through a fistula of the duodenal bulb]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20101201
Pemetrexed in heavily pretreated non-small-cell lung cancer patients: case report and review of the literature. Future oncology (London, England) 20101201
Cutaneous metastasis of pancreatic adenocarcinoma after kidney transplant: a case report and review of the literature. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20101201
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). The oncologist 20101201
The DAC system and associations with acute leukemias and myelodysplastic syndromes. Investigational new drugs 20101201
A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse. Clinical lymphoma, myeloma & leukemia 20101201
[Survival benefits of chemotherapy for unresectable biliary tract cancer--a multicenter retrospective analysis]. Gan to kagaku ryoho. Cancer & chemotherapy 20101201
Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy. The Canadian journal of urology 20101201
[Right ventricular metastasis of leiomyosarcoma]. Kardiologia polska 20101201
Gender differences in gemcitabine (Gemzar) efficacy in cancer cells: effect of indole-3-carbinol. Anticancer research 20101201
Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma. Frontiers of medicine in China 20101201
[Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer]. Bulletin du cancer 20101201
The molecular targets for the diagnosis and treatment of pancreatic cancer. Gut and liver 20101201
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era. Cancer research and treatment : official journal of Korean Cancer Association 20101201
Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anti-cancer agents in medicinal chemistry 20101201
[Emodin enhances antitumor effect of gemcitabine in model of SW1990 cell xenograft on athymic mouse]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20101201
Digital ischemic events related to gemcitabine: Report of two cases and a systematic review. Radiology and oncology 20101201
Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101120
Critical role for hyperpolarization-activated cyclic nucleotide-gated channel 2 in the AIF-mediated apoptosis. The EMBO journal 20101117
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer. Cancer 20101115
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. Cancer 20101115
Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives. Bioorganic & medicinal chemistry 20101115
Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells. Chemical research in toxicology 20101115
Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer. Oncogene 20101111
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients. British journal of cancer 20101109
Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor. British journal of cancer 20101109
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials. British journal of cancer 20101109
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. British journal of cancer 20101109
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer. Cancer chemotherapy and pharmacology 20101101
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer. Cancer chemotherapy and pharmacology 20101101
Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. International journal of radiation oncology, biology, physics 20101101
Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation study. Lung cancer (Amsterdam, Netherlands) 20101101
Surgical morbidity and mortality of pediatric brain tumors: a single center audit. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20101101
Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations. Lung cancer (Amsterdam, Netherlands) 20101101
A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects. Shock (Augusta, Ga.) 20101101
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism. Annals of oncology : official journal of the European Society for Medical Oncology 20101101
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Annals of oncology : official journal of the European Society for Medical Oncology 20101101
The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma. Japanese journal of clinical oncology 20101101
Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma. Journal of gastroenterology 20101101
Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Cancer 20101101
Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms. Molecular therapy : the journal of the American Society of Gene Therapy 20101101
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma. Cancer gene therapy 20101101
Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. Cancer science 20101101
The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions. Journal of hepatology 20101101
Overcoming platinum resistance in ovarian carcinoma. Expert opinion on investigational drugs 20101101
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report. Pediatric hematology and oncology 20101101
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment. Cancer research 20101101
A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101101
Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101
Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer. Pancreas 20101101
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). Gut 20101101
Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results. Cancer science 20101101
Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. Cancer prevention research (Philadelphia, Pa.) 20101101
SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics. Molecular cancer therapeutics 20101101
Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. British journal of cancer 20101101
Current status of adjuvant therapy for pancreatic cancer. The oncologist 20101101
Radiation recall with anticancer agents. The oncologist 20101101
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. British journal of cancer 20101101
Microemulsions for intravesical delivery of gemcitabine. Chemical & pharmaceutical bulletin 20101101
Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS). Gastroenterologie clinique et biologique 20101101
Enhanced antitumor effect of coincident intravesical gemcitabine plus BCG therapy in an orthotopic bladder cancer model. Urology 20101101
[Prediction of gemcitabine treatment discontinuation based on platelet count before first administration]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma? British journal of cancer 20101101
Granulomatous mycosis fungoides with large cell transformation misdiagnosed as leprosy. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20101101
Sorafenib modulates the gene expression of multi-drug resistance mediating ATP-binding cassette proteins in experimental hepatocellular carcinoma. Anticancer research 20101101
Analysis of the cytotoxic activity of carboplatin and gemcitabine combination. Anticancer research 20101101
Additive growth inhibition after combined treatment of 2-methoxyestradiol and conventional chemotherapeutic agents in human pancreatic cancer cells. Anticancer research 20101101
A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer. Anticancer research 20101101
A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer. Anticancer research 20101101
XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. Anticancer research 20101101
[Pancreatic cancer]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20101101
Human health risk assessment of pharmaceuticals in water: issues and challenges ahead. International journal of environmental research and public health 20101101
EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 20101101
[Successful long-term management of hepatic and lymph nodes metastases of ureteral cancer by multimodal treatment including radiofrequency ablation]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20101101
[Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer]. Zhonghua fu chan ke za zhi 20101101
[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101101
[Locally advanced pancreatic cancer successfully treated by arterial infusion chemotherapy combined with stereotactic radiotherapy--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
[Two cases of pancreatic cancer with fairly good prognosis]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
[A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
[The case of a person who let to umbilicus metastasis at a year after PD]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
[A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
[Evaluation of systemic chemotherapy for unresectable gallbladder carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
[A case of unresectable advanced gallbladder cancer successfully treated by a combined administration of gemcitabine + CDDP]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
[A long-term survival case of unresectable intrahepatic cholangiocarcinoma treated with chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20101101
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future. Oncotarget 20101101
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget 20101101
Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding. Journal of medicinal chemistry 20101028
Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. British journal of cancer 20101026
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. British journal of cancer 20101026
Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types. British journal of cancer 20101026
Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Biochemical and biophysical research communications 20101022
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020
Postoperative recurrence of an IPMN of the pancreas with a fistula to the stomach. World journal of gastrointestinal endoscopy 20101016
Analysis of multi-arm tumor growth trials in xenograft animals using phase change adaptive piecewise quadratic models. Statistics in medicine 20101015
Dose escalation of gemcitabine concomitant with radiation and cisplatin for nonsmall cell lung cancer: a phase 1-2 study. Cancer 20101015
Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. Journal of controlled release : official journal of the Controlled Release Society 20101015
Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin. Cancer research 20101015
A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells. Bioorganic & medicinal chemistry letters 20101015
Cetuximab in small bowel adenocarcinoma: a new friend? British journal of cancer 20101012
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010
Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer. Investigational new drugs 20101001
Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status. Critical reviews in oncology/hematology 20101001
PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population. Molecular biology reports 20101001
Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III breast cancer patients. American journal of clinical oncology 20101001
Renal atrophy secondary to chemoradiotherapy of abdominal malignancies. International journal of radiation oncology, biology, physics 20101001
Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient. International journal of clinical oncology 20101001
Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis. Cancer letters 20101001
Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer. International journal of clinical oncology 20101001
Impact of S-1 on the survival of patients with advanced pancreatic cancer. Pancreas 20101001
A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904). Japanese journal of clinical oncology 20101001
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20101001
Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo. Drug metabolism and disposition: the biological fate of chemicals 20101001
Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs. Biomaterials 20101001
A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin. Gynecologic oncology 20101001
Activity of anticancer agents in a three-dimensional cell culture model. Assay and drug development technologies 20101001
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer. Clinical breast cancer 20101001
Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis. Lung 20101001
Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20101001
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. European journal of cancer (Oxford, England : 1990) 20101001
Safety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaïve patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101001
Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation. International journal of oncology 20101001
The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. International journal of oncology 20101001
Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma. International journal of oncology 20101001
Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20101001
Chemotherapy: Gemcitabine alone or plus cisplatin for biliary tract cancer? Nature reviews. Clinical oncology 20101001
Intertriginous lymphomatoid drug eruption. International journal of dermatology 20101001
Dynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors. Translational oncology 20101001
Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer. Neoplasia (New York, N.Y.) 20101001
Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia (New York, N.Y.) 20101001
Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer. The oncologist 20101001
Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens. The oncologist 20101001
Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review. The oncologist 20101001
[A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20101001
Challenges of drug resistance in the management of pancreatic cancer. Expert review of anticancer therapy 20101001
Simultaneous breast and ovarian metastasis from gallbladder carcinoma. Hepatobiliary & pancreatic diseases international : HBPD INT 20101001
Histology-driven chemotherapy of soft-tissue sarcoma. Annals of oncology : official journal of the European Society for Medical Oncology 20101001
Advances in the treatment of metastatic or unresectable biliary tract cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20101001
[A case of malignant peritoneal mesothelioma treated effectively with cisplatin and gemcitabine]. Gan to kagaku ryoho. Cancer & chemotherapy 20101001
[A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20101001
[A case of liver metastasis of pancreatic acinar cell carcinoma treated with S-1 and intra-arterial CDDP combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20101001
Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity. Anticancer research 20101001
Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin. Anticancer research 20101001
A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer. Anticancer research 20101001
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer. Health technology assessment (Winchester, England) 20101001
Gemox: a widely useful therapy against solid tumors-review and personal experience. Journal of chemotherapy (Florence, Italy) 20101001
[Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia]. Zhongguo shi yan xue ye xue za zhi 20101001
Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure. Anti-cancer agents in medicinal chemistry 20101001
Natural antisense transcript: a concomitant engagement with protein-coding transcript. Oncotarget 20101001
Serotype chimeric human adenoviruses for cancer gene therapy. Viruses 20101001
Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins 20101001
Molecular characterization of interdigitating dendritic cell sarcoma. Rare tumors 20100930
Primary pericardial malignant mesothelioma and response to radiation therapy. Rare tumors 20100930
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes. European journal of histochemistry : EJH 20100926
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920
TTF-1 is useful for primary site determination in duodenal metastasis. World journal of gastrointestinal oncology 20100915
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 20100908
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma. British journal of cancer 20100907
Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A. Evidence-based complementary and alternative medicine : eCAM 20100901
Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway. Medical oncology (Northwood, London, England) 20100901
Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report. Medical oncology (Northwood, London, England) 20100901
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Critical reviews in oncology/hematology 20100901
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Annals of oncology : official journal of the European Society for Medical Oncology 20100901
MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer letters 20100901
ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology 20100901
Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma. European journal of gastroenterology & hepatology 20100901
Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Annals of surgical oncology 20100901
Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. Laboratory investigation; a journal of technical methods and pathology 20100901
microRNAs: a role in drug resistance in parasitic nematodes? Trends in parasitology 20100901
Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism. European journal of clinical pharmacology 20100901
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Cancer 20100901
Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies. Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901
Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma. Human pathology 20100901
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Breast cancer research and treatment 20100901
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20100901
Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experience. Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901
Exploiting drug repositioning for discovery of a novel HIV combination therapy. Journal of virology 20100901
Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites. Chemosphere 20100901
Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100901
Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100901
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model. Molecular cancer therapeutics 20100901
Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study. Journal of immunotherapy (Hagerstown, Md. : 1997) 20100901
One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin. Oncology reports 20100901
A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients. Oncology reports 20100901
Liposomal cisplatin: a new cisplatin formulation. Anti-cancer drugs 20100901
Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity. Southern medical journal 20100901
Inhibition of cancer cell invasion and metastasis by genistein. Cancer metastasis reviews 20100901
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients. Annals of surgery 20100901
Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer. IDrugs : the investigational drugs journal 20100901
Finding the tumor copycat: approximating a human cancer. Nature medicine 20100901
Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia (New York, N.Y.) 20100901
Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors. The Korean journal of internal medicine 20100901
Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancer. The Korean journal of internal medicine 20100901
[A case of gallbladder cancer which completely responded to gemcitabine]. Gan to kagaku ryoho. Cancer & chemotherapy 20100901
[S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy 20100901
[Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20100901
[A phase II study of gemcitabine and carboplatin bi-weekly combination chemotherapy for complete resected non-small-cell lung cancer patients]. Kyobu geka. The Japanese journal of thoracic surgery 20100901
[Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)]. Revue de pneumologie clinique 20100901
[Granulocyte-colony stimulating factor producing squamous cell carcinoma of the renal pelvis: a case report]. Hinyokika kiyo. Acta urologica Japonica 20100901
[A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term]. Hinyokika kiyo. Acta urologica Japonica 20100901
Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer research 20100901
Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model. Anticancer research 20100901
Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. Anticancer research 20100901
Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over. Anticancer research 20100901
Eribulin mesilate, a halichondrin B analogue, in the treatment of breast cancer. Drugs of today (Barcelona, Spain : 1998) 20100901
Chemotherapy for advanced non-small-cell lung cancer patients with poor performance. Expert review of clinical pharmacology 20100901
Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer. Cancer letters 20100828
Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabine. Journal of medicinal chemistry 20100826
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. British journal of cancer 20100824
Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy. British journal of cancer 20100824
Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs. International journal of pharmaceutics 20100816
Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report. World journal of gastroenterology 20100814
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. British journal of cancer 20100810
[Anti-tumor efficacy of interventional chemotherapy with liposomal doxorubicin for hepatic metastasis of pancreatic cancer in nude mouse model]. Zhonghua yi xue za zhi 20100810
[Concurrent chemoradiotherapy for stage III non-small cell lung cancer]. Zhonghua yi xue za zhi 20100803
Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs. Journal of aerosol medicine and pulmonary drug delivery 20100801
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer. American journal of clinical oncology 20100801
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy. Cancer chemotherapy and pharmacology 20100801
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Cancer chemotherapy and pharmacology 20100801
Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines. Cancer chemotherapy and pharmacology 20100801
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. International journal of radiation oncology, biology, physics 20100801
Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial. International journal of radiation oncology, biology, physics 20100801
Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy? European journal of gastroenterology & hepatology 20100801
Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer? Cancer treatment reviews 20100801
Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502. Lung cancer (Amsterdam, Netherlands) 20100801
Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. Pancreas 20100801
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100801
Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Annals of surgical oncology 20100801
Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer. International journal of clinical oncology 20100801
Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas. International journal of clinical oncology 20100801
Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells. Cancer gene therapy 20100801
Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents. Current clinical pharmacology 20100801
Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20100801
Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor. Acta oncologica (Stockholm, Sweden) 20100801
Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study. Biochimica et biophysica acta 20100801
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology 20100801
Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta medica 20100801
Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan. Japanese journal of clinical oncology 20100801
Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. European journal of cancer (Oxford, England : 1990) 20100801
Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. Journal of aerosol medicine and pulmonary drug delivery 20100801
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugs. Current opinion in pharmacology 20100801
Postoperative bowel function and nutritional status following distal pancreatectomy with en-bloc celiac axis resection. Digestive surgery 20100801
Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium. Leukemia & lymphoma 20100801
Synthesis and anti-HCV activity of 3',4'-oxetane nucleosides. Bioorganic & medicinal chemistry letters 20100801
ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139. International journal of oncology 20100801
Monoclonal antibody (mAb)-induced down-regulation of RON receptor tyrosine kinase diminishes tumorigenic activities of colon cancer cells. International journal of oncology 20100801
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms. Clinical pharmacokinetics 20100801
Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma. Upsala journal of medical sciences 20100801
Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Molecular cancer therapeutics 20100801
Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro. Journal of digestive diseases 20100801
Survival analysis of pancreatic and periampullary collision cancers. Journal of digestive diseases 20100801
A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080. Journal of pharmacokinetics and pharmacodynamics 20100801
Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens. The Journal of thoracic and cardiovascular surgery 20100801
Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100801
A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801
Gemcitabine-induced acute eosinophilic pneumonia. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801
Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study. HPB : the official journal of the International Hepato Pancreato Biliary Association 20100801
Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? The oncologist 20100801
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study. The oncologist 20100801
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. Expert review of gastroenterology & hepatology 20100801
Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer. Molecular cancer therapeutics 20100801
Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20100801
Low dose fractionated cisplatin plus gemcitabine for elderly patients with advanced non small cell lung cancer: a retrospective analysis. Journal of chemotherapy (Florence, Italy) 20100801
Quantification of gemcitabine incorporation into human DNA by LC/MS/MS as a surrogate measure for target engagement. Analytical chemistry 20100801
Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system. Cell cycle (Georgetown, Tex.) 20100801
[A dialysis patient with advanced lung adenocarcinoma who was safely given biweekly gemcitabine therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20100801
[Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine]. Gan to kagaku ryoho. Cancer & chemotherapy 20100801
[An effective case of gemcitabine therapy with post-operative peritoneal recurrence of intrahepatic cholangiocarcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy 20100801
[A case of recurrent gallbladder cancer with a remarkable tumor response to S-1]. Gan to kagaku ryoho. Cancer & chemotherapy 20100801
[Rituximab-mediated sensitization of B-NHL cell lines to apoptosis induced by gemcitabine and Navelbine in vitro]. Zhongguo shi yan xue ye xue za zhi 20100801
Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy. Lung cancer (Amsterdam, Netherlands) 20100801
Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany. Lung cancer (Amsterdam, Netherlands) 20100801
Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC). Lung cancer (Amsterdam, Netherlands) 20100801
Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20100801
Efficacy of bladder-preserving therapy for patients with t3b, t4a, and t4b transitional cell carcinoma of the bladder. Korean journal of urology 20100801
Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation. Nanoscale 20100801
[Expression and predictive role of excision repair cross complementation group 1, ribonucleotide reductase subunit M1, and β-tubulin 3 in postoperative patients with non-small cell lung cancer receiving adjuvant chemotherapy]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801
[Efficacy of gemcitabine combined with erlotinib in patients with advanced pancreatic cancer]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801
[Efficacy and safety of chemotherapy combined with interstitial (125)I seed implantation brachytherapy in unresectable stage IIIa/IIIb non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100801
Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib. World journal of gastroenterology 20100728
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study. British journal of cancer 20100727
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. International journal of cancer 20100715
Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer. British journal of cancer 20100713
Cisplatin plus gemcitabine for biliary tract cancer. The New England journal of medicine 20100708
Cisplatin plus gemcitabine for biliary tract cancer. The New England journal of medicine 20100708
Combinatorial drug conjugation enables nanoparticle dual-drug delivery. Small (Weinheim an der Bergstrasse, Germany) 20100705
Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the '2010 ASCO Annual Meeting'. Chicago, IL, USA. June 4-8, 2010. JOP : Journal of the pancreas 20100705
First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the '2010 ASCO Annual Meeting'. Chicago, IL, USA. June 4-8, 2010. JOP : Journal of the pancreas 20100705
Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2010 ASCO Annual Meeting'. Chicago, IL, USA. June 4-8, 2010. JOP : Journal of the pancreas 20100705
Effects of taxane-based chemotherapy on inhibin B and gonadotropins as biomarkers of spermatogenesis. Fertility and sterility 20100701
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer. Cancer chemotherapy and pharmacology 20100701
Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation. International journal of cancer 20100701
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial. Lung cancer (Amsterdam, Netherlands) 20100701
Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey. International journal of radiation oncology, biology, physics 20100701
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer. Cancer chemotherapy and pharmacology 20100701
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial). Annals of oncology : official journal of the European Society for Medical Oncology 20100701
Economic evaluation of docetaxel-gemcitabine versus vinorelbine-cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis. Annals of oncology : official journal of the European Society for Medical Oncology 20100701
Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. European radiology 20100701
Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer letters 20100701
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Annals of surgical oncology 20100701
Failure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options. BJU international 20100701
Oral metastasis from primary transitional cell carcinoma of the renal pelvis: report of a case. International journal of oral and maxillofacial surgery 20100701
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer. Cancer chemotherapy and pharmacology 20100701
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. European journal of cancer (Oxford, England : 1990) 20100701
[Hemolytic uremic syndrome in adults]. Nephrologie & therapeutique 20100701
Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel - pretreated ovarian carcinoma. Gynecologic oncology 20100701
Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase. Anti-cancer drugs 20100701
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy? Current hematologic malignancy reports 20100701
Bladder cancer: can we move beyond chemotherapy? Current oncology reports 20100701
Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial. Anti-cancer drugs 20100701
CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system. Leukemia & lymphoma 20100701
Adenocarcinoma of the small bowel: changes in the landscape? Current opinion in oncology 20100701
Does rituximab have a place in treating classic hodgkin lymphoma? Current hematologic malignancy reports 20100701
Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer. Cancer biology & therapy 20100701
Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents. Oncology reports 20100701
Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas. Current opinion in oncology 20100701
Targeted treatment and new agents in peripheral T-cell lymphoma. International journal of hematology 20100701
Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine. Experimental biology and medicine (Maywood, N.J.) 20100701
1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer 20100701
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Molecular cancer therapeutics 20100701
Adjuvant chemoradiation therapy in gallbladder cancer. Journal of surgical oncology 20100701
Leveraging combinatorial chemotherapy to improve outcomes in patients with pancreatic cancer. Cancer biology & therapy 20100701
Volumetric modulated arc therapy for advanced pancreatic cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20100701
[Adjuvant chemotherapy in resected non small cell lung cancer: preliminary results about 8 cases]. La Tunisie medicale 20100701
Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Molecular cancer therapeutics 20100701
A Comparison of white and African American outcomes from a three-arm, randomized, phase III multicenter trial of advanced or metastatic non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100701
Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro. American journal of veterinary research 20100701
Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Molecular cancer therapeutics 20100701
Novel therapies for pancreatic cancer: setbacks and progress. Future oncology (London, England) 20100701
Proton-pump inhibitor as palliative care for chemotherapy-induced gastroesophageal reflux disease in pancreatic cancer patients. Journal of palliative medicine 20100701
A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS medicine 20100701
[Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20100701
[Effective therapeutic regimens for patients with triple-negative (ER/PgR/HER2-negative) metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20100701
[A case of pancreatic cancer treated by gemcitabine with sequential radiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20100701
[Combination chemotherapy resulting in complete response of huge lymph node metastases in undifferentiated gastric cancer--case report]. Gan to kagaku ryoho. Cancer & chemotherapy 20100701
[Renal medullary carcinoma: remission with gemcitabine-cisplatin and review of therapeutic perspectives]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20100701
Antineoplastic effects of gamma linolenic Acid on hepatocellular carcinoma cell lines. Journal of clinical biochemistry and nutrition 20100701
Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells. Anticancer research 20100701
Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study. Anticancer research 20100701
Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer research 20100701
[Vertigo as a symptom of psychosocial pain]. Wiener medizinische Wochenschrift (1946) 20100701
[Primary urothelial carcinoma with sarcomatous transformation of the prostate]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100701
Assessment of pancreatic carcinoma cell chemosensitivity using a three-dimensional culture system. Chinese medical journal 20100701
Words of wisdom. Re: randomized phase III Trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. European urology 20100701
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20100701
[Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20100701
Treating advanced non-small cell lung cancer in the elderly. Therapeutic advances in medical oncology 20100701
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. British journal of cancer 20100629
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. British journal of cancer 20100629
Quercetin aglycone is bioavailable in murine pancreas and pancreatic xenografts. Journal of agricultural and food chemistry 20100623
Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1. Biochemistry 20100615
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer research 20100615
Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies. British journal of cancer 20100608
Gemcitabine and lenalidomide combination in a patient with metastatic pancreatic cancer: a case study. Medical oncology (Northwood, London, England) 20100601
Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer. Investigational new drugs 20100601
Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients. Lung cancer (Amsterdam, Netherlands) 20100601
The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20100601
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients. Lung cancer (Amsterdam, Netherlands) 20100601
A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease. International journal of radiation oncology, biology, physics 20100601
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). Annals of oncology : official journal of the European Society for Medical Oncology 20100601
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer. The pharmacogenomics journal 20100601
[Is there still a place for radiotherapy for the treatment of pancreatic cancers?]. Presse medicale (Paris, France : 1983) 20100601
An unusual case of pancreatic cancer with leptomeningeal infiltration. Journal of gastrointestinal cancer 20100601
[Digital ischemia in two patients treated with gemcitabine]. Journal des maladies vasculaires 20100601
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. Journal of controlled release : official journal of the Controlled Release Society 20100601
Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506. Japanese journal of clinical oncology 20100601
S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure. Japanese journal of clinical oncology 20100601
Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism. European journal of clinical pharmacology 20100601
Cisplatin-gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients. Breast (Edinburgh, Scotland) 20100601
Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20100601
Gemcitabine and epirubicin plasma concentration-related excretion in saliva in patients with non-small cell lung cancer. Therapeutic drug monitoring 20100601
Chemotherapy followed by chemoradiotherapy for locally advanced non-metastatic pancreatic cancer - a new paradigm? Clinical oncology (Royal College of Radiologists (Great Britain)) 20100601
Improved survival of left-sided pancreas cancer after surgery. Japanese journal of clinical oncology 20100601
ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial. European journal of cancer (Oxford, England : 1990) 20100601
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC). European journal of cancer (Oxford, England : 1990) 20100601
Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. Endocrine-related cancer 20100601
Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100601
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer. Pharmaceutical research 20100601
Potentiation of gemcitabine by Turmeric Force in pancreatic cancer cell lines. Oncology reports 20100601
Chemoprevention strategies for pancreatic cancer. Nature reviews. Gastroenterology & hepatology 20100601
Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. Current molecular medicine 20100601
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer research 20100601
Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma. Journal of surgical oncology 20100601
Antiproliferative effect of Toona sinensis leaf extract on non-small-cell lung cancer. Translational research : the journal of laboratory and clinical medicine 20100601
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]. Bulletin du cancer 20100601
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models. Nature biotechnology 20100601
Emerging treatment with systemic chemotherapy and targeted agents for biliary cancers. Current opinion in investigational drugs (London, England : 2000) 20100601
Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancer. Current opinion in investigational drugs (London, England : 2000) 20100601
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer. Clinical breast cancer 20100601
An instruction on the in vivo shell-less chorioallantoic membrane 3-dimensional tumor spheroid model. Cytotechnology 20100601
Pattern of failure in bladder cancer patients treated with radical cystectomy: rationale for adjuvant radiotherapy. Journal of Korean medical science 20100601
Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells. Acta pharmacologica Sinica 20100601
Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer. Acta pharmacologica Sinica 20100601
Two lung masses with different responses to pemetrexed. The Korean journal of internal medicine 20100601
Salirasib in the treatment of pancreatic cancer. Future oncology (London, England) 20100601
Locally advanced breast cancer: pulmonary toxicity secondary to gemcitabine. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100601
Pasteurella multocida thymidine kinase 1 efficiently activates pyrimidine nucleoside analogs. Nucleosides, nucleotides & nucleic acids 20100601
The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues. Nucleosides, nucleotides & nucleic acids 20100601
Induction of resistance to the lipophilic cytarabine prodrug elacytarabine (CP-4055) in CEM leukemic cells. Nucleosides, nucleotides & nucleic acids 20100601
Methylation specific PCR to characterize methylation of the promoter of deoxycytidine kinase. Nucleosides, nucleotides & nucleic acids 20100601
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells. Nucleosides, nucleotides & nucleic acids 20100601
Localizing putative markers in genetic association studies by incorporating linkage disequilibrium into bayesian hierarchical models. Human heredity 20100601
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy. Asia-Pacific journal of clinical oncology 20100601
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery. Journal of chemotherapy (Florence, Italy) 20100601
[A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20100601
[A case of abdominal wall metastasis from pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20100601
Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. Current oncology (Toronto, Ont.) 20100601
Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. British journal of pharmacology 20100601
Suppression of renin-angiotensin system and cancer therapy (discussion). Nihon rinsho. Japanese journal of clinical medicine 20100601
Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells. Anticancer research 20100601
Words of wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. European urology 20100601
Improved plasma stability and sustained release profile of gemcitabine via polypeptide conjugation. International journal of pharmaceutics 20100531
Interaction between DNA Polymerase lambda and anticancer nucleoside analogs. The Journal of biological chemistry 20100528
A successful treatment by hepatic arterial infusion therapy for advanced, unresectable biliary tract cancer. World journal of hepatology 20100527
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. British journal of cancer 20100525
Guidelines for the welfare and use of animals in cancer research. British journal of cancer 20100525
Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. World journal of gastroenterology 20100521
Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine: the question is still ongoing. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510
First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer. JOP : Journal of the pancreas 20100505
Options for the treatment of gemcitabine-resistant advanced pancreatic cancer: are we there yet? JOP : Journal of the pancreas 20100505
The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing. Toxicology letters 20100504
[Oncological treatment of patients with pancreatic cancer]. Ugeskrift for laeger 20100503
Gemcitabine induced digital ischaemia and necrosis. European journal of cancer care 20100501
Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20100501
Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided. Lung cancer (Amsterdam, Netherlands) 20100501
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer. Cancer chemotherapy and pharmacology 20100501
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer chemotherapy and pharmacology 20100501
Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer. Cancer chemotherapy and pharmacology 20100501
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial. Annals of oncology : official journal of the European Society for Medical Oncology 20100501
Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer. Cancer letters 20100501
Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature. European journal of cancer care 20100501
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. Cancer investigation 20100501
ABC transporter gene expression in benign and malignant ovarian tissue. Gynecologic oncology 20100501
The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100501
Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance. Pancreas 20100501
EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer. Annals of surgical oncology 20100501
Achievements and unmet needs in the management of advanced ovarian cancer. Gynecologic oncology 20100501
Pancreatic cancer: progress made. Acta oncologica (Stockholm, Sweden) 20100501
Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer treatment reviews 20100501
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer. Journal of cellular physiology 20100501
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology 20100501
Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival. Japanese journal of clinical oncology 20100501
Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501
Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501
The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma. Cancer 20100501
Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine? Pediatric blood & cancer 20100501
Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. Journal of cellular biochemistry 20100501
Epstein-Barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent. Journal of pediatric hematology/oncology 20100501
Marker lesion experiments in bladder cancer--what have we learned? The Journal of urology 20100501
Vinorelbine for non-small cell lung cancer. Expert opinion on drug safety 20100501
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leukemia & lymphoma 20100501
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy. Current cancer drug targets 20100501
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review). Oncology reports 20100501
Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells. Oncology reports 20100501
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. Journal of immunotherapy (Hagerstown, Md. : 1997) 20100501
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer research 20100501
Any progress in pancreatic cancer? Well, but progress for Acta Oncologica. Acta oncologica (Stockholm, Sweden) 20100501
Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study. Acta oncologica (Stockholm, Sweden) 20100501
Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer. The oncologist 20100501
Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer. Clinical lung cancer 20100501
Haemolytic uraemic syndrome associated with gemcitabine. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100501
[A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for bile duct cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20100501
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. Health technology assessment (Winchester, England) 20100501
Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. Health technology assessment (Winchester, England) 20100501
Medical applications and toxicities of gallium compounds. International journal of environmental research and public health 20100501
Pancreatic cancer. The New England journal of medicine 20100429
Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420
Conventional and complementary therapies: a tale of two research standards? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420
[Clinical application of adjuvant treatment after operation in patients with stage IIIa non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100420
Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial. Cancer 20100415
N-aryltriazole ribonucleosides with potent antiproliferative activity against drug-resistant pancreatic cancer. Bioorganic & medicinal chemistry letters 20100415
5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer research 20100415
alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate. British journal of cancer 20100413
The definition of locally advanced pancreatic cancer. British journal of cancer 20100413
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. The New England journal of medicine 20100408
A step forward in the treatment of advanced biliary tract cancer. The New England journal of medicine 20100408
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? Journal of the National Cancer Institute 20100407
Stromal depletion goes on trial in pancreatic cancer. Journal of the National Cancer Institute 20100407
New insight of pancreatic imaging: from 'unexplored' to 'explored'. Abdominal imaging 20100401
The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbeck's archives of surgery 20100401
Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial. Investigational new drugs 20100401
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial. Lung cancer (Amsterdam, Netherlands) 20100401
Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20100401
Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy. American journal of clinical oncology 20100401
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma. American journal of clinical oncology 20100401
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer chemotherapy and pharmacology 20100401
Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer letters 20100401
Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells. Pancreas 20100401
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Annals of oncology : official journal of the European Society for Medical Oncology 20100401
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients. Annals of oncology : official journal of the European Society for Medical Oncology 20100401
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. Annals of oncology : official journal of the European Society for Medical Oncology 20100401
Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy. Annals of surgical oncology 20100401
Leiomyosarcoma of the inferior vena cava: case report and treatment of recurrence with repeat surgery. Annals of vascular surgery 20100401
Survival prediction for pancreatic cancer patients receiving gemcitabine treatment. Molecular & cellular proteomics : MCP 20100401
Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anti-cancer drugs 20100401
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Annals of surgical oncology 20100401
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment. Cancer science 20100401
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer biology & therapy 20100401
An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change? Anti-cancer drugs 20100401
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab. Cancer chemotherapy and pharmacology 20100401
Management of borderline resectable pancreatic cancer. Surgical oncology clinics of North America 20100401
Update on adjuvant trials for pancreatic cancer. Surgical oncology clinics of North America 20100401
Novel targets for pancreatic cancer therapy. Surgical oncology clinics of North America 20100401
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06). The Lancet. Oncology 20100401
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401
PARP inhibition: PARP1 and beyond. Nature reviews. Cancer 20100401
Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer. Journal of clinical gastroenterology 20100401
Toxicities of gemcitabine in patients with severe hepatic dysfunction. The Annals of pharmacotherapy 20100401
A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy. Clinical breast cancer 20100401
Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer. Cancer research 20100401
Novel agents in development for peripheral T-cell lymphoma. Seminars in hematology 20100401
Metronomic chemotherapy for renal cancer in the landscape of targeted therapy. The Lancet. Oncology 20100401
Adjuvant and neoadjuvant therapy in curable pancreatic cancer. The Surgical clinics of North America 20100401
Curative radiation therapy for pancreatic malignancies. The Surgical clinics of North America 20100401
Palliative chemotherapy for pancreatic malignancies. The Surgical clinics of North America 20100401
Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature. Canadian Urological Association journal = Journal de l'Association des urologues du Canada 20100401
Adjuvant therapy of pancreatic cancer. Expert review of anticancer therapy 20100401
Evolution of systemic therapy for advanced pancreatic cancer. Expert review of anticancer therapy 20100401
One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine. Current oncology (Toronto, Ont.) 20100401
The road not taken and choices in radiation oncology. The oncologist 20100401
Recent advances in combined modality therapy. The oncologist 20100401
Clinical medicine and clinical trials. The oncologist 20100401
[Cost-effectiveness analysis of chemotherapy with GEM or S-1 for patients with non-resectable pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20100401
[Influence of gemcitabine on expression of C-myc gene and its apoptosis-inducing effect on HL-60 cells]. Zhongguo shi yan xue ye xue za zhi 20100401
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS medicine 20100401
Chemotherapy in pancreatic adenocarcinoma. European review for medical and pharmacological sciences 20100401
[Gemcitabine combined with cisplatin and methylprednisolone sodium succinate in chemotherapy for relapsed or refractory T cell non-Hodgkin lymphoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100401
A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database. HPB : the official journal of the International Hepato Pancreato Biliary Association 20100401
[Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20100401
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium. European urology 20100401
Phytochemicals in cancer prevention and therapy: truth or dare? Toxins 20100401
Transport characteristics of mouse concentrative nucleoside transporter 1. International journal of pharmaceutics 20100330
Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. Virology 20100330
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. British journal of cancer 20100330
[A meta analysis of gemcitabine plus platinum chemotherapy compared with single-agent chemotherapy in the treatment of non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100320
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. British journal of cancer 20100316
Sperm protein 17 is a novel marker for predicting cisplatin response in esophageal squamous cancer cell lines. International journal of cancer 20100315
Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100310
Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer. World journal of gastroenterology 20100307
Pharmacotherapy options for locally advanced and advanced cervical cancer. Drugs 20100305
Options for the treatment of gemcitabine-resistant advanced pancreatic cancer. JOP : Journal of the pancreas 20100305
Translational research in pancreatic cancer. Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010. JOP : Journal of the pancreas 20100305
Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010. JOP : Journal of the pancreas 20100305
Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010. JOP : Journal of the pancreas 20100305
The first-line treatment for advanced pancreatic cancer. Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010. JOP : Journal of the pancreas 20100305
Any second-line therapy for advanced pancreatic cancer? Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010. JOP : Journal of the pancreas 20100305
Management of skin toxicities of anti-EGFR agents in patients with pancreatic cancer and other GI tumors by using electronic communication: effective and convenient. JOP : Journal of the pancreas 20100305
Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer. JOP : Journal of the pancreas 20100305
Pulmonary toxicity associated with gemcitabine. JOP : Journal of the pancreas 20100305
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. British journal of cancer 20100302
External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study. International journal of radiation oncology, biology, physics 20100301
Structural lung damage after chemotherapy fact or fiction? Lung cancer (Amsterdam, Netherlands) 20100301
A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 20100301
Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100301
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer. Cancer chemotherapy and pharmacology 20100301
Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial. Cancer chemotherapy and pharmacology 20100301
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. International journal of cancer 20100301
Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma. Annals of hematology 20100301
Apoptosis- and necrosis-induced changes in light attenuation measured by optical coherence tomography. Lasers in medical science 20100301
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Annals of oncology : official journal of the European Society for Medical Oncology 20100301
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20100301
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology 20100301
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301
A case report of gemcitabine treatment for duodenal cancer: the good (a sustained response) and the bad (life threatening refractory thrombotic thrombocytopenic purpura). Journal of gastrointestinal cancer 20100301
Functional analysis of LOXL2 in pancreatic carcinoma. International journal of colorectal disease 20100301
Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB. Anti-cancer drugs 20100301
Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma. Virchows Archiv : an international journal of pathology 20100301
Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience. Expert opinion on drug safety 20100301
Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival. Annals of surgery 20100301
Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents. Bioorganic & medicinal chemistry 20100301
Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase. Cell cycle (Georgetown, Tex.) 20100301
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 20100301
Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer. Pancreas 20100301
Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV). Medical science monitor : international medical journal of experimental and clinical research 20100301
Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer. Nature reviews. Clinical oncology 20100301
Clinical characteristics of pulmonary embolism with underlying malignancy. The Korean journal of internal medicine 20100301
[Gemcitabine therapy for unresectable pancreatic cancer in elderly patients]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100301
Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database. British journal of clinical pharmacology 20100301
Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. AAPS PharmSciTech 20100301
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment]. Gan to kagaku ryoho. Cancer & chemotherapy 20100301
[A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge]. Gan to kagaku ryoho. Cancer & chemotherapy 20100301
[A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 20100301
[Treatment possibilities in breast cancer progressing after anthracyclines and/or taxanes]. Magyar onkologia 20100301
Molecular therapy of pancreatic cancer. Minerva endocrinologica 20100301
[A case of a pulmonary pleomorphic carcinoma with fever which responded well to chemotherapy]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20100301
Establishment and characterization of multidrug-resistant gastric cancer cell lines. Anticancer research 20100301
Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report. Clinical therapeutics 20100301
Impact of biomarkers on non-small cell lung cancer treatment. Targeted oncology 20100301
[Management of bladder cancer in unfit patients]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20100301
Systemic therapy for metastatic pancreatic adenocarcinoma. Therapeutic advances in medical oncology 20100301
Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles. World journal of gastroenterology 20100227
Study on intestinal absorption sites of mizoribine and ribavirin, substrates for concentrative nucleoside transporter(s), in rats. European journal of pharmacology 20100225
Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2',2'-difluoro-2'-deoxycytidine 5'-triphosphate: adenosylcobalamin destruction and formation of a nucleotide-based radical. Biochemistry 20100223
Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2',2'-difluoro-2'-deoxycytidine 5'-triphosphate: covalent modification. Biochemistry 20100223
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. The Journal of biological chemistry 20100219
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. British journal of cancer 20100216
Treatment options for small cell lung cancer - do we have more choice? British journal of cancer 20100216
Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine. Biochemical pharmacology 20100215
Pancreatic cancer presenting with paraneoplastic thrombophlebitis--case report. Journal of medicine and life 20100215
Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer. World journal of gastroenterology 20100214
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. British journal of cancer 20100202
The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy. British journal of cancer 20100202
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer. British journal of cancer 20100202
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model. Investigational new drugs 20100201
Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity. International journal of laboratory hematology 20100201
Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial. Investigational new drugs 20100201
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503. Investigational new drugs 20100201
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology 20100201
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer. Cancer chemotherapy and pharmacology 20100201
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer. Cancer chemotherapy and pharmacology 20100201
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer. Cancer chemotherapy and pharmacology 20100201
Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers. Cancer chemotherapy and pharmacology 20100201
Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer. American journal of clinical oncology 20100201
Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer. Molecular therapy : the journal of the American Society of Gene Therapy 20100201
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201
Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment. Clinical oncology (Royal College of Radiologists (Great Britain)) 20100201
Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. Molecular pharmaceutics 20100201
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. International journal of colorectal disease 20100201
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma. Cancer chemotherapy and pharmacology 20100201
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer. Cancer science 20100201
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy. Cancer investigation 20100201
Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer. Cancer investigation 20100201
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. European journal of cancer (Oxford, England : 1990) 20100201
High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine. Therapeutic drug monitoring 20100201
Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumour. European journal of cancer (Oxford, England : 1990) 20100201
Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1. International journal of oncology 20100201
Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase? Oncology reports 20100201
Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorganic & medicinal chemistry 20100201
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100201
A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer. Molecular cancer therapeutics 20100201
Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. Cancer research 20100201
Role of chemotherapy in the management of soft tissue sarcomas. Expert review of anticancer therapy 20100201
Visceral disease in patients with metastatic breast cancer: efficacy and safety of treatment with ixabepilone and other chemotherapeutic agents. Clinical breast cancer 20100201
Current management of gallbladder carcinoma. The oncologist 20100201
Transverse leukonychia (Mees' lines) associated with docetaxel. The Journal of dermatology 20100201
Fixed-dose-rate gemcitabine: a viable first-line treatment option for advanced pancreatic and biliary tract cancer. The oncologist 20100201
[Cerebral vasculitis associated with gemcitabine]. Der Urologe. Ausg. A 20100201
Gerson regimen. Oncology (Williston Park, N.Y.) 20100201
Efficient syntheses of clofarabine and gemcitabine from 2-deoxyribonolactone. Nucleosides, nucleotides & nucleic acids 20100201
Chemotherapy-induced reversible posterior leucoencephalopathy syndrome. Internal medicine journal 20100201
Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study. Indian journal of pharmacology 20100201
Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytes. Genes & cancer 20100201
Concomitant leiomyosarcoma of the right kidney and squamous cell carcinoma of the cervix - an unusual clinical presentation. Hematology reports 20100126
Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochemical pharmacology 20100115
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group. Cancer 20100115
[An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20100115
6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents. Journal of medicinal chemistry 20100114
Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance. World journal of gastroenterology 20100114
[Efficacy study of single-agent gemcitabine versus gemcitabine plus carboplatin in untreated elderly patients with stage IIIb/IV non-small-cell lung cancer]. Zhonghua yi xue za zhi 20100112
[Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells]. Zhonghua yi xue za zhi 20100112
Engineering of poly(butylcyanoacrylate) nanoparticles for the enhancement of the antitumor activity of gemcitabine. Biomacromolecules 20100111
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. Journal of the National Cancer Institute 20100106
A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. British journal of cancer 20100105
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib. British journal of cancer 20100105
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. British journal of cancer 20100105
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. British journal of cancer 20100105
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. British journal of cancer 20100105
A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate. British journal of cancer 20100105
Combined modality treatment with bladder preservation for muscle invasive bladder cancer. Urologic oncology 20100101
Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. Urologic oncology 20100101
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. Lung cancer (Amsterdam, Netherlands) 20100101
Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study. Cancer chemotherapy and pharmacology 20100101
Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumors. Cancer chemotherapy and pharmacology 20100101
Metastatic pancreatic adenocarcinoma: current standards, future directions. American journal of therapeutics 20100101
Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. European radiology 20100101
Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: role of thymidine kinase 2. Biochemical pharmacology 20100101
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100101
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG). Breast cancer research and treatment 20100101
Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers. Japanese journal of clinical oncology 20100101
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'. Anti-cancer drugs 20100101
Phase I clinical and pharmacokinetic study of RAD001 (everolimus) administered daily to Japanese patients with advanced solid tumors. Japanese journal of clinical oncology 20100101
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer. Anti-cancer drugs 20100101
Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study. Acta oncologica (Stockholm, Sweden) 20100101
The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer. Current drug targets 20100101
Role of pemetrexed and platinums combination in patients with non-small cell lung cancer. Current drug targets 20100101
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme. Cancer chemotherapy and pharmacology 20100101
Acute aortic dissection during sorafenib-containing therapy. Annals of oncology : official journal of the European Society for Medical Oncology 20100101
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial. Anti-cancer drugs 20100101
Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100101
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. Annals of oncology : official journal of the European Society for Medical Oncology 20100101
Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. Annals of oncology : official journal of the European Society for Medical Oncology 20100101
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. The Lancet. Oncology 20100101
Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100101
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. European journal of cancer (Oxford, England : 1990) 20100101
Stage III: definitive chemoradiotherapy. Frontiers of radiation therapy and oncology 20100101
Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel. International journal of oncology 20100101
The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of neuro-oncology 20100101
Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity. Acta pharmacologica Sinica 20100101
Protein kinase Calpha: disease regulator and therapeutic target. Trends in pharmacological sciences 20100101
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research 20100101
Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100101
Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. Journal of oncology 20100101
Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data. Applied health economics and health policy 20100101
Histological and genetic markers for non-small-cell lung cancer: customizing treatment based on individual tumor biology. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100101
Current and emerging therapies for patients with advanced non-small-cell lung cancer. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100101
The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer. Yonsei medical journal 20100101
The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer. Journal of oncology 20100101
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106. Molecular cancer therapeutics 20100101
Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias. International journal of technology assessment in health care 20100101
Targeting the EGF receptor for ovarian cancer therapy. Journal of oncology 20100101
Treatment for recurrent ovarian cancer-at first relapse. Journal of oncology 20100101
A current review of targeted therapeutics for ovarian cancer. Journal of oncology 20100101
Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer. Journal of oncology 20100101
A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells. Neoplasia (New York, N.Y.) 20100101
Antivascular therapy for epithelial ovarian cancer. Journal of oncology 20100101
Vesicular phospholipid gels. Methods in molecular biology (Clifton, N.J.) 20100101
Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. Zeitschrift fur Gastroenterologie 20100101
Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer. Clinical lung cancer 20100101
Histology matters: individualizing treatment in non-small cell lung cancer. The oncologist 20100101
Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report. Journal of hematology & oncology 20100101
miR-21: an oncomir on strike in prostate cancer. Molecular cancer 20100101
Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapy. Journal of experimental & clinical cancer research : CR 20100101
Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells. PloS one 20100101
Memoirs of differential radiation doses: Gemcitabine induced radiation recall. Acta oncologica (Stockholm, Sweden) 20100101
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B). Molecular cancer 20100101
[Combination chemotherapy with gemcitabine and paclitaxel in a hemodialysis patient with metastatic urothelial carcinoma]. Hinyokika kiyo. Acta urologica Japonica 20100101
Targeted therapies in epithelial ovarian cancer. Journal of oncology 20100101
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy. Journal of translational medicine 20100101
Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population. BMC cancer 20100101
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC cancer 20100101
Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Molecular cancer 20100101
[Effects of gemcitabine and pemetrexed on the proliferation of pancreatic cancer cell lines BXPC-3 and PANC-1 in vitro]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100101
Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells. Biological & pharmaceutical bulletin 20100101
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression. PloS one 20100101
A randomized controlled pilot trial of 'Feiji Recipe' on quality of life of non-small cell lung cancer patients. The American journal of Chinese medicine 20100101
Targeted therapy in ovarian cancer. Journal of oncology 20100101
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. Journal of hematology & oncology 20100101
The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. Journal of translational medicine 20100101
NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3. Molecular cancer 20100101
Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells. Anticancer research 20100101
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors. Anticancer research 20100101
Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer. BMC cancer 20100101
Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. Journal of biomedical science 20100101
[A case of refractory pulmonary peripheral T cell lymphoma successfully treated with Cisplatin Plus Gemcitabine Plus Solumedrol]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20100101
Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer. Onkologie 20100101
Primary metastatic leiomyosarcoma of the fallopian tube: a rare case report. Onkologie 20100101
Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial. Cancer journal (Sudbury, Mass.) 20100101
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC cancer 20100101
Bacillus Calmette-Guérin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study. Urologia internationalis 20100101
In vitro and in vivo characterization of highly purified human mesothelioma derived cells. BMC cancer 20100101
Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment. BMC cancer 20100101
Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma. BMC cancer 20100101
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC cancer 20100101
Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer. Journal of experimental & clinical cancer research : CR 20100101
BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer. Journal of oncology 20100101
What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies. Reviews on recent clinical trials 20100101
Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test. Diagnostic pathology 20100101
Role of senescence and mitotic catastrophe in cancer therapy. Cell division 20100101
Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model. PloS one 20100101
The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer. PloS one 20100101
Cucurbitacin: ancient compound shedding new light on cancer treatment. TheScientificWorldJournal 20100101
Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer. BMC cancer 20100101
[Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100101
Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Current medicinal chemistry 20100101
Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya. Oncology 20100101
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer. Journal of hematology & oncology 20100101
Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis. BMC gastroenterology 20100101
RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy. Journal of hematology & oncology 20100101
A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer. Hematology/oncology and stem cell therapy 20100101
Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract. Urologia internationalis 20100101
Late presentation of a mucinous ovarian adenocarcinoma which was initially diagnosed as a primary pancreatic carcinoma: a case report and review of the literature. Journal of medical case reports 20100101
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance. BMC cancer 20100101
Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101
Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology. Journal of hematology & oncology 20100101
Phase I trial of gemcitabine dose escalation with concurrent radiotherapy for patients with locally advanced pancreatic cancer. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101
Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent. PloS one 20100101
The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. International journal of cell biology 20100101
Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer. Revista da Associacao Medica Brasileira (1992) 20100101
The detection, treatment, and biology of epithelial ovarian cancer. Journal of ovarian research 20100101
Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathway. Molecular cancer 20100101
Cancer-drug associations: a complex system. PloS one 20100101
Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells. BMC cancer 20100101
Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence. Radiation oncology (London, England) 20100101
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells. Molecular cancer 20100101
A theoretical quantitative model for evolution of cancer chemotherapy resistance. Biology direct 20100101
A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors. Chemotherapy 20100101
Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast. World journal of surgical oncology 20100101
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Molecular cancer 20100101
A preliminary result of three-dimensional microarray technology to gene analysis with endoscopic ultrasound-guided fine-needle aspiration specimens and pancreatic juices. Journal of experimental & clinical cancer research : CR 20100101
Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PloS one 20100101
Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients. Journal of experimental & clinical cancer research : CR 20100101
Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice. Journal of translational medicine 20100101
[New data on pancreatic cancer]. Onkologie 20100101
Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology. Journal of hematology & oncology 20100101
c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589. PloS one 20100101
Tumor angiogenesis: insights and innovations. Journal of oncology 20100101
Identification, characterization, and effects of Xenopus laevis PNAS-4 gene on embryonic development. Journal of biomedicine & biotechnology 20100101
Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model. PloS one 20100101
Intrahepatic sarcomatoid cholangiocarcinoma. Journal of oncology 20100101
Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast cancer research : BCR 20100101
Immunoglobulin E-mediated severe anaphylaxis to paclitaxel. Journal of investigational allergology & clinical immunology 20100101
[Treatment of recurrent ovarian cancer--a retrospective study]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20100101
Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells. Arthritis research & therapy 20100101
Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: a prospective randomized trial in Algeria. Journal of cancer research and therapeutics 20100101
Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel. BMC cancer 20100101
Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin. BMC cancer 20100101
The radiosensitization effects of Endostar on human lung squamous cancer cells H-520. Cancer cell international 20100101
Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP. Journal of experimental & clinical cancer research : CR 20100101
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PloS one 20100101
Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts. Chinese medicine 20100101
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. Molecular cancer 20100101
Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiation oncology (London, England) 20100101
The investigation of effects of quercetin and its combination with Cisplatin on malignant mesothelioma cells in vitro. Journal of biomedicine & biotechnology 20100101
Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma. Sarcoma 20100101
Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity. Journal of biomedicine & biotechnology 20100101
TGFBI expression is associated with a better response to chemotherapy in NSCLC. Molecular cancer 20100101
Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma. Journal of hematology & oncology 20100101
Analysis of chemiotherapeutic protocols efficiency in therapy of advanced non small cell lung cancer. Medicinski arhiv 20100101
Overexpression of S100A4 in human cancer cell lines resistant to methotrexate. BMC cancer 20100101
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. Oncology 20100101
Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach. BMC genomics 20100101
Ovarian metastasis following gallbladder carcinoma: a case report. European journal of gynaecological oncology 20100101
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo. Molecular cancer 20100101
Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC). Drug design, development and therapy 20100101
Management of patients with advanced non-small cell lung cancer: role of gefitinib. Biologics : targets & therapy 20100101
[Bladder cancer and new drugs]. Bulletin du cancer 20100101
Update on management of seminoma. Indian journal of urology : IJU : journal of the Urological Society of India 20100101
Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy. Molecular cancer 20100101
Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis. Journal of experimental & clinical cancer research : CR 20100101
Glycogen synthase kinase 3 beta: can it be a target for oral cancer. Molecular cancer 20100101
Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma. Chemotherapy 20100101
Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. BMC cancer 20100101
Therapeutic antibodies for the treatment of pancreatic cancer. TheScientificWorldJournal 20100101
Accurate non-invasive image-based cytotoxicity assays for cultured cells. BMC biotechnology 20100101
Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model. Journal of experimental & clinical cancer research : CR 20100101
Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines. BMC cancer 20100101
Non-small cell lung cancer presenting with choroidal metastasis as first sign and showing good response to chemotherapy alone: a case report. Journal of medical case reports 20100101
Treatment of metachronous and simultaneous liver metastases of pancreatic cancer. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20100101
Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PloS one 20100101
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. Breast cancer research : BCR 20100101
Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer. Radiation oncology (London, England) 20100101
Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC cancer 20100101
Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells. BMC cancer 20100101
Fusariosis and skin T cell lymphoma: concomitant more than a differential diagnosis. La Clinica terapeutica 20100101
Unusually young age distribution of primary hepatic leiomyosarcoma: case series and review of the adult literature. World journal of surgical oncology 20100101
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo. Journal of experimental & clinical cancer research : CR 20100101
Gallbladder adenocarcinoma with human chorionic gonadotropin: a case report and review of literature. Diagnostic pathology 20100101
Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF. Journal of oncology 20100101
The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Radiation oncology (London, England) 20100101
Anti-angiogenesis therapies: their potential in cancer management. OncoTargets and therapy 20100101
The dual kinase complex FAK-Src as a promising therapeutic target in cancer. OncoTargets and therapy 20100101
Therapeutic cancer vaccines in combination with conventional therapy. Journal of biomedicine & biotechnology 20100101
PROFESS: a PROtein function, evolution, structure and sequence database. Database : the journal of biological databases and curation 20100101
Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line. Journal of oncology 20100101
Molecular and clinical aspects of targeting the VEGF pathway in tumors. Journal of oncology 20100101
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. BMC cancer 20100101
New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Molecular cancer 20100101
Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient. BMC research notes 20100101
Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors. Journal of experimental & clinical cancer research : CR 20100101
Expression of chemoresistance-related genes and heat shock protein 72 in hyperthermic isolated limb perfusion of malignant melanoma: an experimental study. Journal of oncology 20100101
Guidelines for the management of soft tissue sarcomas. Sarcoma 20100101
Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC cancer 20100101
Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides. Journal of oncology 20100101
Biological markers in lung cancer: A clinician's perspective. Cancer biomarkers : section A of Disease markers 20100101
Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case report. Journal of medical case reports 20100101
Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PloS one 20100101
Epidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancer. Current gerontology and geriatrics research 20100101
The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer. Medicina (Kaunas, Lithuania) 20100101
PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1. Journal of experimental & clinical cancer research : CR 20100101
Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells. Biological & pharmaceutical bulletin 20100101
Scope of nanotechnology in ovarian cancer therapeutics. Journal of ovarian research 20100101
Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation. European journal of medical research 20100101
Trends in cancer immunotherapy. Clinical Medicine Insights. Oncology 20100101
Strategies for cancer vaccine development. Journal of biomedicine & biotechnology 20100101
Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases. Sarcoma 20100101
Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer. BMC cancer 20100101
Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells. Chemotherapy 20100101
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma. Molecular cancer 20100101
Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells. BMC cancer 20100101
In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells. BMC cancer 20100101
Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy. World journal of surgical oncology 20100101
[Specific features of toxicological profile of gemcitabine, an antitumour agent from the group of anti-metabolites]. Sudebno-meditsinskaia ekspertiza 20100101
The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy. Journal of experimental therapeutics & oncology 20100101
Systemic and local drug delivery for treating diseases of the central nervous system in rodent models. Journal of visualized experiments : JoVE 20100101
Improved overall survival with 12 cycles of single-agent paclitaxel maintenance therapy following a complete response to induction chemotherapy in advanced ovarian carcinoma. Oncology 20100101
Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro. Journal of experimental & clinical cancer research : CR 20100101
CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma. PloS one 20100101
Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis. PloS one 20100101
The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung. PloS one 20100101
Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes. Journal of biomedicine & biotechnology 20100101
Rapid-Onset Acute Respiratory Distress Syndrome (ARDS) in a Patient Undergoing Metastatic Liver Resection: A Case Report and Review of the Literature. Anesthesiology research and practice 20100101
Frontline gefitinib in advanced non-small cell lung cancer: Meta-analysis of published randomized trials. Annals of thoracic medicine 20100101
HSV Recombinant Vectors for Gene Therapy. The open virology journal 20100101
Design and evaluation of liposomal formulation of pilocarpine nitrate. Indian journal of pharmaceutical sciences 20100101
The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC cancer 20100101
Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients. BMC cancer 20100101
Vitamin D in combination cancer treatment. Journal of Cancer 20100101
Clinical observations on safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion. Asian Pacific journal of cancer prevention : APJCP 20100101
Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma. Tumori 20100101
Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression. Molecular cancer 20100101
Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer. BMC cancer 20100101
Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells. Journal of biomedical science 20100101
Cytotoxicity screening of Bangladeshi medicinal plant extracts on pancreatic cancer cells. BMC complementary and alternative medicine 20100101
Current and emerging therapies for the treatment of pancreatic cancer. OncoTargets and therapy 20100101
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer. Biologics : targets & therapy 20100101
Aggressive approach in a case of cancer cervix with uremia. Indian journal of palliative care 20100101
Self-contained gene-set analysis of expression data: an evaluation of existing and novel methods. PloS one 20100101
Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy. Case reports in medicine 20100101
A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer. Radiation oncology (London, England) 20100101
Protein network prediction and topological analysis in Leishmania major as a tool for drug target selection. BMC bioinformatics 20100101
Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. Metal-based drugs 20100101
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts. BMC cancer 20100101
Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer. BMC medical genomics 20100101
Mesothelin as a potential therapeutic target in human cholangiocarcinoma. Journal of Cancer 20100101
Chemotherapy in Ewing's sarcoma. Indian journal of orthopaedics 20100101
Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutrition and cancer 20100101
Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough. Cough (London, England) 20100101
Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer. Chemotherapy 20100101
The role of the focal adhesion protein PINCH1 for the radiosensitivity of adhesion and suspension cell cultures. PloS one 20100101
Non-small cell lung carcinoma presenting as carcinomatous meningitis. Lung India : official organ of Indian Chest Society 20100101
The potential of nanomedicine therapies to treat neovascular disease in the retina. Journal of angiogenesis research 20100101
Unexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysis. Clinical & developmental immunology 20100101
Neuroendocrine carcinoma of the seminal vesicles presenting with Lambert Eaton syndrome: a case report. Journal of medical case reports 20100101
Gemcitabine plus infusional 5-fluorouracil and high dose leucovorin in advanced stage pancreatic cancer. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer. F1000 biology reports 20100101
Optimal timing of chemotherapy and cystectomy. F1000 medicine reports 20100101
Human γδ T lymphocytes for immunotherapeutic strategies against cancer. F1000 medicine reports 20100101
Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancer. F1000 medicine reports 20100101
Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer. BMC cancer 20100101
Pegylated liposomal doxorubicin in the management of ovarian cancer. Therapeutics and clinical risk management 20100101
Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report. BMC cancer 20100101
Eosinophilic and neutrophilic leukemoid reaction in a woman with spindle cell sarcoma: a case report. Journal of medical case reports 20100101
Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma. Tumori 20100101
Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review. Journal of experimental & clinical cancer research : CR 20100101
Treatment effect or secret nature: long-term remissions in metastatic pancreatic cancer. Onkologie 20100101
Sustained partial remission of metastatic pancreatic cancer following systemic chemotherapy with gemcitabine and oxaliplatin plus adjunctive treatment with mistletoe extract. Onkologie 20100101
Tumor antigen cross-presentation and the dendritic cell: where it all begins? Clinical & developmental immunology 20100101
Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor. PloS one 20100101
Modulation of the ribonucleotide reductase-antimetabolite drug interaction in cancer cell lines. Journal of nucleic acids 20100101
Treatment options for patients with triple-negative breast cancer. Journal of hematology & oncology 20100101
Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice. Molecular pain 20100101
Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review. Clinical Medicine Insights. Oncology 20100101
Long-term survival of a woman with well differentiated papillary mesothelioma of the peritoneum: a case report and review of the literature. Journal of medical case reports 20100101
Gemcitabine in arterial injection chemotherapy for pancreatic cancer does not cause catheter obstruction or any other complication. Hepato-gastroenterology 20100101
A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation. Genetic vaccines and therapy 20100101
Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers. BMC cancer 20100101
TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling. Journal of molecular signaling 20100101
New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib. OncoTargets and therapy 20100101
The bevacizumab experience in advanced renal cell carcinoma. OncoTargets and therapy 20100101
Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study. OncoTargets and therapy 20100101
Present and future evolution of advanced breast cancer therapy. Breast cancer research : BCR 20100101
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast cancer research : BCR 20100101
Triple-negative breast cancer. Breast cancer research : BCR 20100101
Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutrition and cancer 20100101
Statistical methods for detecting and comparing periodic data and their application to the nycthemeral rhythm of bodily harm: A population based study. Journal of circadian rhythms 20100101
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells. Molecular cancer 20100101
The therapeutic value of monoclonal antibodies directed against immunogenic tumor glycoproteins. Journal of Cancer 20100101
Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastoma. PloS one 20100101
[The role of membrane transporters in cellular resistance of pancreatic carcinoma to gemcitabine]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20100101
Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma. BMC cancer 20100101
Treatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 cases. Oncology 20100101
Antiangiogenic therapy for breast cancer. Breast cancer research : BCR 20100101
Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer. BMC cancer 20100101
Molecularly targeted therapy using bevacizumab for non-small cell lung cancer: a pilot study for the new CT response criteria. Korean journal of radiology 20100101
Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer. Oncology 20100101
Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line. Journal of experimental & clinical cancer research : CR 20100101
Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. PloS one 20100101
Pre-clinical drug prioritization via prognosis-guided genetic interaction networks. PloS one 20100101
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. BMC cancer 20100101
What's new in therapy of pancreatic cancer? Digestive diseases (Basel, Switzerland) 20100101
Adjuvant therapy in pancreatic cancer. Digestive diseases (Basel, Switzerland) 20100101
A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer. BMC cancer 20100101
The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine. Molecular cancer 20100101
Targeted therapy in lymphoma. Journal of hematology & oncology 20100101
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma. BMC cancer 20100101
The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer. Chemotherapy 20100101
Advanced or metastatic pancreatic cancer: molecular targeted therapies. The Mount Sinai journal of medicine, New York 20100101
Dysregulation of miR-15a and miR-214 in human pancreatic cancer. Journal of hematology & oncology 20100101
Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons. Molecular pain 20100101
Bioresponsive matrices in drug delivery. Journal of biological engineering 20100101
Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase. Molecular cancer 20100101
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy. BMC medical genetics 20100101
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer. Biologics : targets & therapy 20100101
Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis. Marine drugs 20100101
Brain metastasis in malignant pleural mesothelioma presenting as intratumoral hemorrhage. Neurologia medico-chirurgica 20100101
Cucurbitacin I inhibits cell motility by indirectly interfering with actin dynamics. PloS one 20100101
Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation. PloS one 20100101
Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors. Asian Pacific journal of cancer prevention : APJCP 20100101
Sustained complete remission of human epidermal growth factor receptor 2-positive metastatic breast cancer in the liver during long-term trastuzumab (Herceptin) maintenance therapy in a woman: a case report. Journal of medical case reports 20100101
Unusual histological findings after partial pancreaticoduodenectomy including benign multicystic mesothelioma, adenomyoma of the ampulla of Vater, and undifferentiated carcinoma, sarcomatoid variant: a case series. Journal of medical case reports 20100101
Idiopathic hyperammonemia after chemotherapy with vinorelbine, topotecan, and cisplatin in a patient with acute lymphocytic leukemia. Hematology/oncology and stem cell therapy 20100101
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis. Gastroenterology research and practice 20100101
pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs. PloS one 20100101
Critical appraisal of cabazitaxel in the management of advanced prostate cancer. Clinical interventions in aging 20100101
Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer. BMC cancer 20100101
Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PloS one 20100101
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PloS one 20100101
Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience. Radiation oncology (London, England) 20100101
Management of metastatic renal cell carcinoma in patients with poor prognosis. Cancer management and research 20100101
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer. Cancer management and research 20100101
Ixabepilone development across the breast cancer continuum: a paradigm shift. Cancer management and research 20100101
New developments in treatment of ovarian carcinoma: focus on trabectedin. Cancer management and research 20100101
An update in management of noncutaneous T-cell lymphomas. Advances in hematology 20100101
Pancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy. HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 20100101
Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC bioinformatics 20100101
Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy. Case reports in medicine 20100101
Treatment of cachexia in oncology. Indian journal of palliative care 20100101
Peripheral T-cell lymphoma: review and updates of current management strategies. Advances in hematology 20100101
Clinical trials and progress with paclitaxel in ovarian cancer. International journal of women's health 20100101
Role of vitamin d in the prevention of pancreatic cancer. Journal of nutrition and metabolism 20100101
The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients. Cancer management and research 20100101
Cancer chemotherapy: targeting folic acid synthesis. Cancer management and research 20100101
Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature. Tumori 20100101
[Neuroendocrine small-cell bladder cancer: our experience]. Urologia 20100101
Green tea epigallocatechin gallate exhibits anticancer effect in human pancreatic carcinoma cells via the inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor. Journal of biomedicine & biotechnology 20100101
Primary splenic angiosarcoma. JSLS : Journal of the Society of Laparoendoscopic Surgeons 20100101
Inflammatory skin metastasis as a first sign of progression of lung cancer--a